Processing 00000000.tx.1: Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice David E. 

Phrase: "Expression of mutant human epidermal receptor 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "lung fibrosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034069:LUNG FIBROSIS [Disease or Syndrome]
   861   C0016059:Fibrosis [Pathologic Function]
   789 E C0334129:Fibrotic [Functional Concept]

Phrase: "and"

Phrase: "improves"

Phrase: "survival in mice David E."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
Processing 00000000.tx.2: Nethery,1 Bethany B. 

Phrase: "Nethery,"

Phrase: "1 Bethany B."
Processing 00000000.tx.3: Moore,2 George Minowada,1 James Carroll,3 Jihane A. 

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "2 George Minowada,"

Phrase: "1 James Carroll,"

Phrase: "3 Jihane A."
Processing 00000000.tx.4: Faress,1 and Jeffrey A. 

Phrase: "Faress,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "Jeffrey A."
Processing 00000000.tx.5: Kern1 1Department of Internal Medicine, Pulmonary and Critical Care Division, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio; 

Phrase: "Kern1 1Department of Internal Medicine,"

Phrase: "Pulmonary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024109:pulmonary [Body Part, Organ, or Organ Component]
  1000   C2707265:Pulmonary [Clinical Attribute]
  1000   C2709248:Pulmonary [Qualitative Concept]

Phrase: "and"

Phrase: "Critical Care Division,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1293097:Division [Therapeutic or Preventive Procedure]
   827   C2919030:Division [Organization]
   827   C2919031:Division [Activity]
   734   C0010337:Critical Care [Health Care Activity]

Phrase: "University Hospitals of Cleveland,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0020028:Hospitals, University [Health Care Related Organization,Manufactured Object]
   770   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
   770   C0041740:University [Manufactured Object,Organization]
   770   C1609061:Hospitals [Intellectual Product]
   737 E C1510665:Hospital [Qualitative Concept]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028905:Ohio [Geographic Area]

Phrase: ";"
Processing 00000000.tx.6: 2Department of Internal Medicine, Division of Pulmonary and Critical Medicine, University of Michigan Medical School, Ann Arbor, Michigan; 

Phrase: "2Department of Internal Medicine,"

Phrase: "Division of Pulmonary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Critical Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Michigan Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   804   C0036375:School [Manufactured Object,Organization]

Phrase: "Ann Arbor,"

Phrase: "Michigan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025939:Michigan [Geographic Area]

Phrase: ";"
Processing 00000000.tx.7: and 3Department of Internal Medicine, Pulmonary and Critical Care Division, Roy J. and Lucille A. 

Phrase: "and"

Phrase: "3Department of Internal Medicine,"

Phrase: "Pulmonary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024109:pulmonary [Body Part, Organ, or Organ Component]
  1000   C2707265:Pulmonary [Clinical Attribute]
  1000   C2709248:Pulmonary [Qualitative Concept]

Phrase: "and"

Phrase: "Critical Care Division,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1293097:Division [Therapeutic or Preventive Procedure]
   827   C2919030:Division [Organization]
   827   C2919031:Division [Activity]
   734   C0010337:Critical Care [Health Care Activity]

Phrase: "Roy J."

Phrase: "and"

Phrase: "Lucille A."
Processing 00000000.tx.8: Carver College of Medicine, Iowa City, Iowa Submitted 7 December 2004 ; accepted in final form 19 February 2005  ABSTRACT TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  Neuregulin-1 (NRG-1), binding to the human epidermal growth factor receptor HER2/HER3, plays a role in pulmonary epithelial cell proliferation and recovery from injury in vitro. 

Phrase: "Carver College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "Iowa City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0022037:Iowa [Geographic Area]
   861   C1555231:Iowa [Population Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "Iowa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022037:Iowa [Geographic Area]
  1000   C1555231:Iowa [Population Group]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "7 December 2004"

Phrase: ";"

Phrase: "accepted in final form 19 February 2005  ABSTRACT TOP ABSTRACT MATERIALS"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   738   C0000857:Abstract [Occupational Activity]
   738   C0205088:Final [Temporal Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0520510:Materials [Substance]
   738   C0600678:Abstract [Intellectual Product]
   738   C1272684:Accepted [Qualitative Concept]
   738   C1522492:Form [Functional Concept]
   738   C1546485:Final [Idea or Concept]
   738   C1548435:Accepted [Idea or Concept]
   738   C1552863:Abstract [Idea or Concept]
   738   C1704458:Top [Spatial Concept]
   704 E C1548601:Accept [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Neuregulin-1 (NRG-1),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "binding to the human epidermal growth factor receptor HER2/HER3,"
Meta Candidates (Total=30; Excluded=0; Pruned=0; Remaining=30)
   813   C1323367:epidermal growth factor receptor binding [Molecular Function]
           epidermal growth factor
           EGFR binding
   797   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   797   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   797   C1509244:human epidermal growth factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   797   C2825836:HUMAN EPIDERMAL GROWTH FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   792   C1522951:epidermal growth factor binding [Molecular Function]
   792   C2753925:growth factor receptor binding [Molecular Function]
   775   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   775   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   772   C1149299:Growth Factor Binding [Molecular Function]
   770   C1523772:HER3 receptor binding [Molecular Function]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0597358:Receptor Binding [Molecular Function]
   738   C0014520:Epidermal [Tissue]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0086418:Human [Human]
   738   C0220844:growth [Physiologic Function]
   738   C0221920:Epidermal [Spatial Concept]
   738   C0243122:binding [Functional Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0812265:HER3 [Gene or Genome]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1521761:Factor [Functional Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1704825:HER3 [Gene or Genome]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in pulmonary epithelial cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "recovery from injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237820:Recovery [Activity]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.9: We hypothesized that activation of HER2/HER3 by NRG-1 would also play a role in recovery from in vivo lung injury. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that activation of HER2/HER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "by NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "would"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in recovery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "from in vivo lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0273115:Lung Injury [Injury or Poisoning]
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.10: We tested this hypothesis using bleomycin lung injury of transgenic mice incapable of signaling through HER2/HER3 due to lung-specific dominant-negative HER3 (DNHER3) expression. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bleomycin lung injury of transgenic mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0273115:Injury of lung [Injury or Poisoning]
           Lung Injury
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]

Phrase: "incapable of signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "through HER2/HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]

Phrase: "due to lung-specific dominant-negative HER3 (DNHER3) expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: In animals expressing DNHER3, protein leak, cell infiltration, and NRG-1 levels in bronchoalveolar lavage fluid increased after injury, similar to that in nontransgenic littermate control animals. 

Phrase: "In animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "expressing"

Phrase: "DNHER3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "protein leak,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332234:Leak [Functional Concept]
   861   C1608322:Leak NOS [Finding]
   861   C1881366:LEAK [Phenomenon or Process]

Phrase: "cell infiltration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "and"

Phrase: "NRG-1 levels in bronchoalveolar lavage fluid"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased after injury,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3263722:Injury [Injury or Poisoning]
   790   C3263723:Injury [Injury or Poisoning]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in nontransgenic littermate control animals."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1511501:Control Animal [Animal]
   812   C0003062:Animals [Animal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.12: However, HER2/HER3 was not activated, and DNHER3 animals displayed fewer lung morphological changes at 10 and 21 days after injury (P = 0.01). 

Phrase: "However,"

Phrase: "HER2/HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "DNHER3 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "fewer lung morphological changes at 10"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0543482:morphological [Spatial Concept]
   723   C1260954:Morphologic change [Anatomical Abnormality]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "21 days after injury"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "(P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.13: In addition, they contained 51% less collagen in injured lungs (P = 0.04). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "they"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "51% less collagen in injured lungs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C1167364:collagen [Cell Component]

Phrase: "(P = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.14: Transforming growth factor-1 did not increase in bronchoalveolar lavage fluid from DNHER3 mice compared with nontransgenic littermate mice (P = 0.001), suggesting that a mechanism for the decreased fibrosis was lack of transforming growth factor-1 induction in DNHER3 mice. 

Phrase: "Transforming growth factor-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase in bronchoalveolar lavage fluid"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   862   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   806   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   806   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C3641255:Lavage Fluid [Body Substance]
   760   C0005889:FLUID [Body Substance]
   760   C0022100:Lavage [Therapeutic or Preventive Procedure]
   760   C0302908:fluid [Substance]
   760   C0442805:Increase [Functional Concept]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1546689:Lavage [Intellectual Product]
   760   C1704353:Fluid [Substance]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "from DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "compared with nontransgenic littermate mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1707455:Compared [Activity]

Phrase: "(P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a mechanism for the decreased fibrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "was"

Phrase: "lack of transforming growth factor-1 induction"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0476242:Lack of growth [Finding]
   804   C1442754:Lack of growth [Finding]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205263:Induction [Functional Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0332268:lack [Qualitative Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in DNHER3 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.15: Severe lung injury (0.08 units bleomycin) resulted in 80% mortality of nontransgenic mice, but only 35% mortality of DNHER3 transgenic mice (P = 0.04). 

Phrase: "Severe lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0273115:Lung Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "(0.08 units bleomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: ")"

Phrase: "resulted in 80% mortality of nontransgenic mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026565:Mortality [Quantitative Concept]
   748   C0026566:mortality [Quantitative Concept]
   748   C0026809:Mice [Mammal]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "but"

Phrase: "only 35% mortality of DNHER3 transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026565:Mortality [Quantitative Concept]
   742   C0026566:mortality [Quantitative Concept]

Phrase: "(P = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.16: Thus inhibition of HER2/HER3 signaling protects against pulmonary fibrosis and improves survival. lung injury; 

Phrase: "Thus inhibition of HER2/HER3 signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "protects against pulmonary fibrosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   770   C0016059:Fibrosis [Pathologic Function]
   770   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   770   C2707265:Pulmonary [Clinical Attribute]
   770   C2709248:Pulmonary [Qualitative Concept]

Phrase: "and"

Phrase: "improves"

Phrase: "survival. lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0273115:Lung Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: ";"
Processing 00000000.tx.17: bleomycin; 

Phrase: "bleomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: ";"
Processing 00000000.tx.18: growth factors; 

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.19: receptor tyrosine kinases; 

Phrase: "receptor tyrosine kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.20: neuregulin ACUTE LUNG INJURY ELICITS a variety of epithelial cell responses, including the upregulation of growth factors (20, 32), suggesting a role for this class of proteins in recovery from lung injury. 

Phrase: "neuregulin ACUTE LUNG INJURY"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0242488:Acute Lung Injury [Injury or Poisoning]
   861   C0273115:Lung Injury [Injury or Poisoning]
   814   C0740766:Acute Pneumonia [Disease or Syndrome]
   812   C0024109:Lung [Body Part, Organ, or Organ Component]
   812   C0205178:acute [Temporal Concept]
   812   C0819757:LUNG [Tissue]
   812   C1278908:Lung [Body Part, Organ, or Organ Component]
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]
   756 E C2707265:Pulmonary [Clinical Attribute]
   756 E C2709248:Pulmonary [Qualitative Concept]
   719 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "ELICITS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "a variety of epithelial cell responses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the upregulation of growth factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1160196:up-regulation of growth [Organism Function]
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "(20,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for this class of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "from lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.21: In rodent lungs, increased levels of epidermal growth factor (EGF) and transforming growth factor (TGF)- are found in airways and alveolar epithelia following intratracheal instillation of asbestos, naphthalene, or bleomycin (19, 20, 22, 35). 

Phrase: "In rodent lungs,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   827 E C0819757:LUNG [Tissue]
   827 E C1278908:Lung [Body Part, Organ, or Organ Component]
   789 E C2707265:Pulmonary [Clinical Attribute]
   789 E C2709248:Pulmonary [Qualitative Concept]
   761 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "increased levels of epidermal growth factor (EGF)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "transforming growth factor (TGF)-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "are"

Phrase: "found in airways"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0150312:Found [Quantitative Concept]
   790   C0178987:airways [Medical Device]
   790   C0458827:Airways [Body Part, Organ, or Organ Component]
   756 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "alveolar epithelia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0225694:Alveolar epithelium [Tissue]
   983   C1279457:Alveolar epithelium [Body Part, Organ, or Organ Component]
   827   C0014609:Epithelium [Tissue]
   777 E C0221908:Epithelial [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "intratracheal instillation of asbestos,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1555389:Instillation, intratracheal [Functional Concept]
   770   C0184959:Instillation [Health Care Activity]
   770   C1720298:Instillation [Functional Concept]

Phrase: "naphthalene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027375:Naphthalene [Organic Chemical,Pharmacologic Substance]
  1000   C0027378:naphthalene [Organic Chemical]

Phrase: "or"

Phrase: "bleomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(19,"

Phrase: "20,"

Phrase: "22,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.22: In addition, EGF receptor (EGFR) expression is increased after bleomycin-induced lung injury (20). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "EGF receptor"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "(EGFR) expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased after bleomycin-induced lung injury"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0273115:Lung Injury [Injury or Poisoning]
   753   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   753   C0024109:Lung [Body Part, Organ, or Organ Component]
   753   C0205217:Increased [Quantitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0819757:LUNG [Tissue]
   753   C1278908:Lung [Body Part, Organ, or Organ Component]
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.23: A direct role of epithelium-derived growth factors in lung injury was shown by Madtes et al. 

Phrase: "A direct role of epithelium-derived growth factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was"

Phrase: "shown by Madtes et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.24: (21), who found that TGF- knockout mice developed less pulmonary fibrosis than wild-type control mice after bleomycin-induced injury. 

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that TGF- knockout mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "developed"

Phrase: "less pulmonary fibrosis than wild-type control mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   744   C0016059:Fibrosis [Pathologic Function]
   744   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   744   C2707265:Pulmonary [Clinical Attribute]
   744   C2709248:Pulmonary [Qualitative Concept]

Phrase: "after bleomycin-induced injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.25: Growth factors also impact lung fibrosis in noninjury models. 

Phrase: "Growth factors also impact lung fibrosis in noninjury models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0034069:LUNG FIBROSIS [Disease or Syndrome]
   742   C0016059:Fibrosis [Pathologic Function]
Processing 00000000.tx.26: Korfhagen and colleagues (7, 14) constructed transgenic mouse strains that expressed human TGF- in type II pneumocytes conditionally or constitutively by placing a TGF- cDNA under the control of the human surfactant protein C (SP-C) promoter. 

Phrase: "Korfhagen"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(7,"

Phrase: "14"

Phrase: ")"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "that expressed human TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "in type II pneumocytes conditionally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0225700:Type-II Pneumocytes [Cell]
   812   C0225698:Pneumocytes [Cell]

Phrase: "or"

Phrase: "constitutively by placing"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0442504:placing [Spatial Concept]
   756 E C1704765:Place [Functional Concept]
   756 E C1882509:Place [Activity]
   756 E C3496241:place [Disease or Syndrome]

Phrase: "a TGF- cDNA under the control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the human surfactant protein C (SP-C) promoter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1442758:surfactant protein C [Gene or Genome]
Processing 00000000.tx.27: Adult transgenic mice spontaneously developed severe pulmonary fibrosis that was directly proportional to the level of TGF- expression (8, 14). 

Phrase: "Adult transgenic mice spontaneously"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "severe pulmonary fibrosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   827   C0016059:Fibrosis [Pathologic Function]
   827   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   827   C2707265:Pulmonary [Clinical Attribute]
   827   C2709248:Pulmonary [Qualitative Concept]
   755 E C0334129:Fibrotic [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "directly proportional to the level of TGF- expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205351:Proportional [Qualitative Concept]

Phrase: "(8,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.28: When TGF--overexpressing mice were bred to a transgenic mouse strain expressing a dominant-negative EGFR in the pulmonary epithelium, TGF--induced pulmonary fibrosis was decreased (6). 

Phrase: "When"

Phrase: "TGF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "--"

Phrase: "overexpressing mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "bred to a transgenic mouse strain"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0025936:Mouse, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]
   719   C0006159:breed [Organism Function]
   719   C1704650:Breed [Classification]

Phrase: "expressing"

Phrase: "a dominant-negative EGFR in the pulmonary epithelium,"

Phrase: "TGF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "--"

Phrase: "induced pulmonary fibrosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   827   C0016059:Fibrosis [Pathologic Function]
   827   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   827   C2707265:Pulmonary [Clinical Attribute]
   827   C2709248:Pulmonary [Qualitative Concept]
   755 E C0334129:Fibrotic [Functional Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.29: In contrast, other studies have shown that inhibition of EGFR activation augments pulmonary fibrosis. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that inhibition of EGFR activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "pulmonary fibrosis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   861   C0016059:Fibrosis [Pathologic Function]
   861   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   861   C2707265:Pulmonary [Clinical Attribute]
   861   C2709248:Pulmonary [Qualitative Concept]
   789 E C0334129:Fibrotic [Functional Concept]
Processing 00000000.tx.30: Suzuki et al. 

Phrase: "Suzuki et al."
Processing 00000000.tx.31: (33) demonstrated that blocking EGFR phosphorylation with the EGFR-specific tyrosine kinase inhibitor ZD1839 increased bleomycin-induced fibrosis. 

Phrase: "(33"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that blocking EGFR phosphorylation with the EGFR-specific tyrosine kinase inhibitor ZD1839"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C1519726:Tyrosine Phosphorylation [Molecular Function]
   736   C0031715:Phosphorylation [Molecular Function]
   736   C1158886:Phosphorylation [Molecular Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "bleomycin-induced fibrosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016059:Fibrosis [Pathologic Function]
   755 E C0334129:Fibrotic [Functional Concept]
Processing 00000000.tx.32: In their study, blockade of EGFR activation reduced regenerative epithelial cell proliferation, but had no effect on proliferation of lung fibroblasts. 

Phrase: "In their study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "blockade of EGFR activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332206:Blockade [Functional Concept]
   770   C3540676:Blockade [Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "regenerative epithelial cell proliferation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1326341:Epithelial Cell Proliferation [Cell Function]
   875   C0334097:Epithelial proliferation [Pathologic Function]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]

Phrase: "but"

Phrase: "had"

Phrase: "no effect on proliferation of lung fibroblasts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.33: Taken together, these data suggested that pulmonary fibrosis occurred, in part, through growth factor receptor and ligand interaction in the pulmonary epithelium. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that pulmonary fibrosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   861   C0016059:Fibrosis [Pathologic Function]
   861   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   861   C2707265:Pulmonary [Clinical Attribute]
   861   C2709248:Pulmonary [Qualitative Concept]
   789 E C0334129:Fibrotic [Functional Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "through growth factor receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ligand interaction in the pulmonary epithelium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.34: Along with EGFR (HER1), human EGFR (HER2), HER3, and HER4 comprise the EGFR receptor tyrosine kinase family. 

Phrase: "Along with EGFR (HER1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034802:HER1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1414313:HER1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "human EGFR (HER2),"

Phrase: "HER3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "and"

Phrase: "HER4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812267:HER4 [Gene or Genome]
  1000   C1704826:HER4 [Gene or Genome]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the EGFR receptor tyrosine kinase family."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]
   717   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.35: In the lung, HER2, HER3, and the ligand neuregulin-1 (NRG-1) are also important mediators of pulmonary epithelial cell proliferation (18, 34, 36). 

Phrase: "In the lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "HER2,"

Phrase: "HER3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "and"

Phrase: "the ligand neuregulin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1367656:NEUREGULIN 1 [Gene or Genome]
   827   C0023688:Ligand [Chemical]
   827   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "(NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: ")"

Phrase: "are"

Phrase: "also important mediators of pulmonary epithelial cell proliferation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   711 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(18,"

Phrase: "34,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.36: Upon ligand binding, HER3 heterodimerizes with HER2, forming a high-affinity receptor for NRG-1. 

Phrase: "Upon ligand binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517880:Ligand Binding [Molecular Function]
   861   C0023688:Ligand [Chemical]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "heterodimerizes with HER2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a high-affinity receptor for NRG-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1334952:Neuregulin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.37: Subsequent phosphorylation of receptor intracellular tyrosines initiates intracellular signaling cascades. 

Phrase: "Subsequent phosphorylation of receptor intracellular tyrosines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "intracellular signaling cascades."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1155494:intracellular signaling cascade [Molecular Function]
   884   C2611812:signaling cascade [Cell Function]
   793   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.38: Our laboratory's recent in vitro studies have shown that, in transformed pulmonary epithelial cell lines, NRG-1/HER2/HER3 interaction is an autocrine process (5). 

Phrase: "Our laboratory's recent in vitro studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   897   C0681827:Laboratory studies [Laboratory Procedure]
   867   C0681828:in vitro study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "in transformed pulmonary epithelial cell lines,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   911   C0007601:Transformed Cell Lines [Cell]
   840   C0007600:Cell lines [Cell]
   840   C0014597:Epithelial cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C0221908:Epithelial [Qualitative Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "NRG-1/HER2/HER3 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "an autocrine process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.39: In addition, HER2 is activated on disruption of a pulmonary epithelial cell monolayer, and receptor activation reduces the time to monolayer reformation, suggesting a role for this autocrine process in recovery of the injured pulmonary epithelium (36). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "HER2"

Phrase: "is"

Phrase: "activated on disruption of a pulmonary epithelial cell monolayer,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0014597:Epithelial cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   742   C0221908:Epithelial [Qualitative Concept]
   742   C0332453:Disruption [Functional Concept]
   742   C0872351:monolayer [Clinical Drug]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1879547:Activated [Activity]
   742   C1948049:Cell [Spatial Concept]
   742   C2707265:Pulmonary [Clinical Attribute]
   742   C2709248:Pulmonary [Qualitative Concept]
   708 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "reduces"

Phrase: "the time to monolayer reformation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for this autocrine process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "of the injured pulmonary epithelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014609:Epithelium [Tissue]
   755 E C0221908:Epithelial [Qualitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.40: In human tissue, our laboratory has also shown that NRG-1 induces pulmonary epithelial cell proliferation (25). 

Phrase: "In human tissue,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0440744:Human tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C0086418:Human [Human]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "has"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "pulmonary epithelial cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1326341:Epithelial Cell Proliferation [Cell Function]
   875   C0334097:Epithelial proliferation [Pathologic Function]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.41: Based on these studies, we hypothesized that activation of the HER2/HER3 receptor would influence recovery from lung injury in vivo. 

Phrase: "Based on these studies,"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0947630:studies [Laboratory Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0557651:Study [Manufactured Object]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that activation of the HER2/HER3 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514758:Receptor Activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "would"

Phrase: "influence"

Phrase: "recovery from lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237820:Recovery [Activity]
   770   C1555688:recovery [Idea or Concept]
   770   C2004454:Recovery [Organism Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.42: To test this hypothesis, our strategy was to study the lung's response to injury in transgenic mice with lung-specific expression of a dominant-negative HER3 receptor (DNHER3) that selectively blocks HER2/HER3 signaling. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "our strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the lung's response to injury"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with lung-specific expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of a dominant-negative HER3 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "that selectively"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "HER2/HER3 signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.43: The DNHER3 receptor was expressed specifically in the pulmonary epithelium under the control of the human SP-C promoter and completely inhibited NRG-1-induced HER2 signaling. 

Phrase: "The DNHER3 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "expressed"

Phrase: "specifically in the pulmonary epithelium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014609:Epithelium [Tissue]
   760   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   760   C2707265:Pulmonary [Clinical Attribute]
   760   C2709248:Pulmonary [Qualitative Concept]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the human SP-C promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1442758:surfactant protein C [Gene or Genome]

Phrase: "and"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "NRG-1-induced HER2 signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
Processing 00000000.tx.44: Our studies found that, in the normal lung, bleomycin injury induced NRG-1 production, HER2 activation [demonstrated by phosphorylated HER2 (pHER2)], protein leak, inflammatory cell infiltration, and collagen deposition. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that,"

Phrase: "in the normal lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0024109:Lung [Body Part, Organ, or Organ Component]
   861   C0819757:LUNG [Tissue]
   861   C1278908:Lung [Body Part, Organ, or Organ Component]
   805 E C2707265:Pulmonary [Clinical Attribute]
   805 E C2709248:Pulmonary [Qualitative Concept]
   768 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "NRG-1 production,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033268:production [Occupational Activity]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "HER2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "["

Phrase: "demonstrated by phosphorylated HER2 (HER2)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Human [Human]

Phrase: "],"

Phrase: "protein leak,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332234:Leak [Functional Concept]
   861   C1608322:Leak NOS [Finding]
   861   C1881366:LEAK [Phenomenon or Process]

Phrase: "inflammatory cell infiltration,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0302158:Inflammatory cell infiltration [Pathologic Function]
           Inflammatory infiltration
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]
   734   C0440752:Inflammatory cell [Cell]

Phrase: "and"

Phrase: "collagen deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.45: In DNHER3 mice, HER2 receptor activation did not occur after lung injury, although NRG-1 production was induced similar to nontransgenic littermates. 

Phrase: "In DNHER3 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "HER2 receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514758:Receptor Activation [Cell Function]
   812   C1879547:Activation [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur after lung injury,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0273115:Lung Injury [Injury or Poisoning]
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0819757:LUNG [Tissue]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "although"

Phrase: "NRG-1 production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033268:production [Occupational Activity]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "was"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "similar to nontransgenic littermates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.46: The lungs of DNHER3 mice had decreased collagen deposition 10 and 21 days after injury compared with nontransgenic littermate control mice. 

Phrase: "The lungs of DNHER3 mice"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   741   C1518039:Mouse Lung [Tissue]
   714 E C0819757:LUNG [Tissue]
   714 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "had"

Phrase: "decreased collagen deposition 10"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C0205216:Decreased [Quantitative Concept]
   812   C0333562:Deposition [Functional Concept]
   812   C0392756:Decreased [Qualitative Concept]
   812   C0442797:decreased [Qualitative Concept]
   812   C1167364:collagen [Cell Component]
   779 E C0547047:Decrease [Quantitative Concept]
   741 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "21 days after injury"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "compared with nontransgenic littermate control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.47: Finally, when challenged with a high dose of bleomycin, mice expressing DNHER3 had a clear survival advantage compared with nontransgenic littermate mice.  

Phrase: "Finally,"

Phrase: "when"

Phrase: "challenged with a high dose of bleomycin,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0444956:High dose [Quantitative Concept]
   748   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0178602:Dose [Quantitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]
   714   C0798503:Challenge [Clinical Attribute]
   714   C0805586:Challenge [Health Care Activity]
   714   C3274764:Challenge [Conceptual Entity]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "a clear survival advantage"

Phrase: "compared with nontransgenic littermate mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.48: MATERIALS AND METHODS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  Mice. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.49: All experimental procedures were approved by the Case Western Reserve University (CWRU) Institutional Animal Care and Use Committee. 

Phrase: "All experimental procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "approved by the Case Western Reserve University (CWRU) Institutional Animal Care"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0178478:animal care [Occupation or Discipline]
   757   C0868975:Institutional care [Health Care Activity]
   739   C0003062:Animal [Animal]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205540:Approved [Qualitative Concept]
   739   C0868928:Case [Functional Concept]
   739   C1705493:Western [Spatial Concept]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]
   739   C1947933:Care [Activity]
   739   C2347957:Reserve [Activity]

Phrase: "and"

Phrase: "Use Committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.50: C57BL/6J transgenic mice expressing DNHER3 in the lung and nontransgenic littermates were housed in the CWRU Animal Resource Center under specific pathogen-free conditions in enclosed filter-topped cages. 

Phrase: "C57BL/6J transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0025921:Mice, C57BL [Mammal]
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "DNHER3 in the lung"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0812265:HER3 [Gene or Genome]
   753   C1704825:HER3 [Gene or Genome]

Phrase: "and"

Phrase: "nontransgenic littermates"

Phrase: "were"

Phrase: "housed in the CWRU Animal Resource Center"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C1328830:animal resource [Qualitative Concept]
   739   C0003062:Animal [Animal]
   739   C0020056:Housed [Manufactured Object]
   739   C0035201:Resource [Idea or Concept]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205099:Center [Spatial Concept]
   739   C0868928:Case [Functional Concept]
   739   C1705493:Western [Spatial Concept]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]
   739   C2347957:Reserve [Activity]
   706 E C0442519:house [Conceptual Entity]
   706 E C2003847:House [Manufactured Object]

Phrase: "under specific pathogen-free conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   756   C0162470:Specific Pathogen Free [Organism]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in enclosed filter-topped cages."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0337189:cages [Manufactured Object]
   779 E C0441239:Cage [Medical Device]
Processing 00000000.tx.51: Food and water were allowed ad libitum. 

Phrase: "Food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "and"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "ad libitum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]
Processing 00000000.tx.52: All mice were observed daily by veterinarians and were maintained and handled using microisolator techniques. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "daily by veterinarians"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0242856:Veterinarians [Professional or Occupational Group]
   790   C0332173:Daily [Temporal Concept]
   756 E C1609078:Veterinarian [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "handled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708320:Handle [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "microisolator techniques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.53: Construction of a DNHER3 receptor. 

Phrase: "Construction of a DNHER3 receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441513:Construction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.54: Using PCR techniques, a DNHER3 cDNA was constructed from a full-length HER3 cDNA template. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR techniques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "a DNHER3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed from a full-length HER3 cDNA template."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0443225:Full [Qualitative Concept]
   744   C0728990:TEMPLATE [Medical Device]
   744   C0812265:HER3 [Gene or Genome]
   744   C1444754:Length [Quantitative Concept]
   744   C1514575:Template [Conceptual Entity]
   744   C1704825:HER3 [Gene or Genome]
   744   C1705542:Template [Idea or Concept]
   744   C1706316:LENGTH [Research Activity]
   711   C2827421:Construct [Classification]
Processing 00000000.tx.55: The HER3 extracellular and transmembrane domains were left intact, whereas the intracellular domain was deleted, starting 20 amino acids beyond the transmembrane domain (F = 5'-AAAAAGTCGACGGAGTCATGAGGGCGAACGACGCTCTG-3', R = 5'-TTTTTGTCGACTTATTTGTCGTCGTCGTCTTTGTAGTCAGCCCTTTTATTCTGAAT-3'). 

Phrase: "The HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "and"

Phrase: "transmembrane domains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "left intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]

Phrase: "whereas"

Phrase: "the intracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: ","

Phrase: "starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "20 amino acids beyond the transmembrane domain"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0937925:AMINO ACIDS 20% [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "(F = 5'-AAAAAGTCGACGGAGTCATGAGGGCGAACGACGCTCTG-3',"

Phrase: "R = 5'-TTTTTGTCGACTTATTTGTCGTCGTCGTCTTTGTAGTCAGCCCTTTTATTCTGAAT-3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.56: The carboxy terminus was epitope tagged with a FLAG sequence for Western blot identification. 

Phrase: "The carboxy terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596260:Carboxy [Organic Chemical]

Phrase: "was"

Phrase: "epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "tagged with a FLAG sequence"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708067:Flag [Functional Concept]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "for Western blot identification."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020792:Identification [Mental Process]
   827   C0205396:Identification [Qualitative Concept]
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]
Processing 00000000.tx.57: DNHER3 cDNA produced from PCR reactions was separated on a 1% agarose/Tris-acetate-EDTA gel, extracted (QIAquick Gel Extraction Kit, Qiagen, Valencia, CA), and ligated into pcDNA3 (Invitrogen, Carlsbad, CA). 

Phrase: "DNHER3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "produced from PCR reactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "separated on a 1% agarose/Tris-acetate-EDTA gel,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   762   C1706746:Agarose Gel [Research Device]
   742   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   742   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0036681:Agarose [Carbohydrate]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0086972:Separated [Finding]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0814229:TRI [Intellectual Product]
   742   C1382104:Gel [Substance]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "(QIAquick Gel Extraction Kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA),"

Phrase: "and"

Phrase: "ligated into pcDNA3"

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)."
Processing 00000000.tx.58: Escherichia coli (HB101 competent cells, Invitrogen) were transformed with DNHER3/pcDNA3 and selected for ampicillin resistance. 

Phrase: "Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014834:Escherichia coli [Bacterium]
   861   C0014833:Escherichia [Bacterium]

Phrase: "(HB101 competent cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "Invitrogen"

Phrase: ")"

Phrase: "were"

Phrase: "transformed with DNHER3/pcDNA3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1510411:Transformed [Pathologic Function]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1704825:HER3 [Gene or Genome]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "selected for ampicillin resistance."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0002682:Ampicillin Resistance [Organism Attribute]
   770   C0002680:Ampicillin [Antibiotic,Organic Chemical]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   737   C1707391:Select [Activity]
   715 E C0700944:Polycillin [Antibiotic,Organic Chemical]
   715 E C0700946:Omnipen [Antibiotic,Organic Chemical]
Processing 00000000.tx.59: DNA from individual colonies was analyzed by EcoR I digestion, and clones that yielded restriction fragments predicted for DNHER3 were expanded and isolated (QIAfilter Plasmid Maxi Kit, Qiagen). 

Phrase: "DNA from individual colonies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "analyzed by EcoR I digestion,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0012238:Digestion [Organism Function]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0936012:Analyzed [Research Activity]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "that yielded restriction fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0332255:fragments [Functional Concept]
   827   C0443288:Restriction [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "predicted for DNHER3"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   760   C0205160:Negative [Qualitative Concept]
   760   C0681842:Predicted [Idea or Concept]
   760   C0812265:HER3 [Gene or Genome]
   760   C1513916:Negative [Finding]
   760   C1527180:Dominant [Functional Concept]
   760   C1704825:HER3 [Gene or Genome]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "were"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "and"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(QIAfilter Plasmid Maxi Kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "Qiagen"

Phrase: ")."
Processing 00000000.tx.60: For in vitro characterization, COS-7 and A549 cells were transfected with the DNHER3/pcDNA3 construct using lipofectamine (Invitrogen), according to the manufacturer's instructions. 

Phrase: "For in vitro characterization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1880022:Characterization [Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "COS-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "A549 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the DNHER3/pcDNA3 construct"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   744   C0205160:Negative [Qualitative Concept]
   744   C0812265:HER3 [Gene or Genome]
   744   C1513916:Negative [Finding]
   744   C1527180:Dominant [Functional Concept]
   744   C1704825:HER3 [Gene or Genome]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]
   744   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lipofectamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.61: Production of transgenic mice expressing lung-specific DNHER3. 

Phrase: "Production of transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "expressing"

Phrase: "lung-specific DNHER3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0812265:HER3 [Gene or Genome]
   804   C1704825:HER3 [Gene or Genome]
Processing 00000000.tx.62: DNHER3 cDNA was cloned into an expression vector under the control of the human 3.7-kb SP-C promoter (a gift from Drs. Jeffrey Whitsett and Stephan Glasser, University of Cincinnati). 

Phrase: "DNHER3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned into an expression vector"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the human 3.7-kb SP-C promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "a gift from Drs. Jeffrey Whitsett"

Phrase: "and"

Phrase: "Stephan Glasser,"

Phrase: "University of Cincinnati"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.63: Following cloning and expansion, the backbone of the SP-C plasmid was removed by endonuclease digestion to yield a transgene consisting of the SP-C promoter, DNHER3 cDNA, FLAG tag, SV40 small T intron, and a poly(A) tail. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "expansion,"

Phrase: "the backbone of the SP-C plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037949:Backbone [Body Part, Organ, or Organ Component]
   744   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed by endonuclease digestion to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0012238:Digestion [Organism Function]
   760   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0849355:Removed [Qualitative Concept]
   760   C2349986:Digestion [Research Activity]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "yield"

Phrase: "a transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "consisting of the SP-C promoter,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C1442758:surfactant protein C [Gene or Genome]
   778   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C1168438:Protein C [Laboratory Procedure]
   778   C1418943:PROTEIN C [Gene or Genome]
   778   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0034085:Surfactant [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748   C0038888:Surfactant [Biomedical or Dental Material]
   748   C0038889:Surfactant [Biologically Active Substance,Lipid]
   748   C0038891:Surfactant [Chemical Viewed Functionally]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C2825078:Surfactant [Pharmacologic Substance]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "DNHER3 cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "FLAG tag,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "SV40 small T intron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "a poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "tail."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039259:Tail [Body Part, Organ, or Organ Component]
Processing 00000000.tx.64: Pronuclear injection of purified DNA was performed by the CWRU Transgenic Core Facility to produce transgenic C57BL/6J mice. 

Phrase: "Pronuclear injection of purified DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "performed by the CWRU Transgenic Core Facility to"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   756   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   756   C1550369:Performed By [Qualitative Concept]
   738   C0003069:Transgenic [Animal]
   738   C0041740:University [Manufactured Object,Organization]
   738   C0444669:Core [Spatial Concept]
   738   C0868928:Case [Functional Concept]
   738   C0884358:Performed [Functional Concept]
   738   C1167518:core [Cell Component]
   738   C1547538:Facility [Idea or Concept]
   738   C1705493:Western [Spatial Concept]
   738   C1706255:CASE [Medical Device]
   738   C1706256:Case [Conceptual Entity]
   738   C1706352:Core [Medical Device]
   738   C1882467:Core [Manufactured Object]
   738   C2347957:Reserve [Activity]
   738   C3274653:Core [Body Substance]
   704 E C2947996:Perform [Pharmacologic Substance]

Phrase: "produce"

Phrase: "transgenic C57BL/6J mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0025936:Mice, Transgenic [Mammal]
   875   C0025921:Mice, C57BL [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.65: Founders with lung-specific expression of DNHER3 were used to develop DNHER3 strains. 

Phrase: "Founders with lung-specific expression of DNHER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0263541:founders [Disease or Syndrome]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "DNHER3 strains."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0080194:Strains [Injury or Poisoning]
   812   C0456178:strains [Intellectual Product]
   779 E C1518614:Strain [Organism]
   779 E C2987481:Strain [Mental Process]
Processing 00000000.tx.66: Genotyping for DNHER3 in the hemizygous F1 generation was performed on extracted tail DNA using primers directed against HER3 and the FLAG sequence (F = 5'-TGGGCCCCACTGTGTGAGCAGCTGCCCCCA-3', R = 5'-GGATCCTCTAGAGTCGACTTA TTTGTCGTCGTCGTCTTTGTAGTC-3'). 

Phrase: "Genotyping for DNHER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1285573:Genotyping [Laboratory Procedure]

Phrase: "in the hemizygous F1 generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0314650:F1 generation [Family Group]
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "was"

Phrase: "performed on extracted tail DNA"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0884358:Performed [Functional Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "directed against HER3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0812265:HER3 [Gene or Genome]
   790   C1704825:HER3 [Gene or Genome]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "the FLAG sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "(F = 5'-TGGGCCCCACTGTGTGAGCAGCTGCCCCCA-3',"

Phrase: "R = 5'-GGATCCTCTAGAGTCGACTTA TTTGTCGTCGTCGTCTTTGTAGTC-3'"

Phrase: ")."
Processing 00000000.tx.67: Bleomycin lung injury. 

Phrase: "Bleomycin lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0273115:Lung Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.68: Intratracheal bleomycin injection was used as a model of lung injury and fibrosis (1517). 

Phrase: "Intratracheal bleomycin injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "used as a model of lung injury"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   804   C0273115:Injury of lung [Injury or Poisoning]
           Lung Injury
   757   C1524063:Use of [Functional Concept]
   748   C0024109:Lung [Body Part, Organ, or Organ Component]
   748   C0819757:LUNG [Tissue]
   748   C1273517:used [Finding]
   748   C1278908:Lung [Body Part, Organ, or Organ Component]
   748   C3161035:Model [Intellectual Product]
   748   C3263722:Injury [Injury or Poisoning]
   748   C3263723:Injury [Injury or Poisoning]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "(1517"

Phrase: ")."
Processing 00000000.tx.69: DNHER3 transgenic mice or nontransgenic littermates were anesthetized with an intraperitoneal injection of a mixture of ketamine HCl, xylazine HCl, and acepromazine in sterile PBS. 

Phrase: "DNHER3 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "or"

Phrase: "nontransgenic littermates"

Phrase: "were"

Phrase: "anesthetized with an intraperitoneal injection of a mixture of ketamine HCl,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   756   C0700541:Ketamine HCl [Organic Chemical,Pharmacologic Substance]
   738   C0021485:injection [Therapeutic or Preventive Procedure]
   738   C0022614:Ketamine [Organic Chemical,Pharmacologic Substance]
   738   C0439962:Mixture [Substance]
   738   C0442120:Intraperitoneal [Spatial Concept]
   738   C1272883:Injection [Biomedical or Dental Material]
   738   C1533685:Injection [Therapeutic or Preventive Procedure]
   738   C1720436:Anesthetized [Finding]
   738   C1828121:Injection [Functional Concept]

Phrase: "xylazine HCl,"

Phrase: "and"

Phrase: "acepromazine in sterile PBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000959:Acepromazine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.70: A single incision was made in the neck, and the trachea was exposed. 

Phrase: "A single incision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0184898:Incision [Therapeutic or Preventive Procedure]
   861   C2338258:Incision [Body Location or Region]

Phrase: "was"

Phrase: "made in the neck,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0027530:Neck [Body Location or Region]
   770   C1281592:Neck [Body Part, Organ, or Organ Component]
   737   C1881534:Make [Functional Concept]
   715 E C0205064:Cervical [Spatial Concept]

Phrase: "and"

Phrase: "the trachea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040578:Trachea [Body Part, Organ, or Organ Component]
  1000   C1278905:Trachea [Body Part, Organ, or Organ Component]
  1000   C3146235:Trachea [Eukaryote]
   928 E C2945595:Tracheal [Spatial Concept]

Phrase: "was"

Phrase: "exposed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]
Processing 00000000.tx.71: A 30-l injection containing 0.025 or 0.08 units of bleomycin (Sigma, St. Louis, MO) diluted in sterile PBS was injected into the trachea using a Tridak stepper (Indicon, Brookfield, CT) and a 30-gauge needle. 

Phrase: "A 30-l injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.025"

Phrase: "or"

Phrase: "0.08 units of bleomycin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439148:Units [Quantitative Concept]
   760   C1519795:Units [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "diluted in sterile PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0232920:Sterile [Qualitative Concept]
   770   C0678108:Sterile [Pathologic Function]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "was"

Phrase: "injected into the trachea"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040578:Trachea [Body Part, Organ, or Organ Component]
   770   C1278905:Trachea [Body Part, Organ, or Organ Component]
   770   C3146235:Trachea [Eukaryote]
   737   C1720154:Inject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Tridak stepper"

Phrase: "(Indicon,"

Phrase: "Brookfield,"

Phrase: "CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "a 30-gauge needle."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027551:Needle [Medical Device]
   827   C1704318:Needle [Medical Device]
   827   C1882041:Needle [Spatial Concept]
Processing 00000000.tx.72: The skin was then closed with surgical glue, and the animals were allowed to recover. 

Phrase: "The skin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0444099:Skin [Body Substance]
  1000   C1123023:Skin [Body System]
  1000   C1278993:Skin [Body System]
   944 E C0221912:Cutaneous [Spatial Concept]
   944 E C0221928:Dermal [Qualitative Concept]
   944 E C1522447:Cutaneous [Functional Concept]
   877 E C0011646:Dermis [Tissue]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "closed with surgical glue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017780:Glue [Manufactured Object]
   770   C0543467:Surgical [Health Care Activity]
   770   C0587267:Closed [Functional Concept]

Phrase: "and"

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]
Processing 00000000.tx.73: Bronchoalveolar lavage fluid and lung collection. 

Phrase: "Bronchoalveolar lavage fluid"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "lung collection."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]
Processing 00000000.tx.74: At specific time points postsurgery (0, 3, 7, 10, 14, or 21 days), mice were killed by CO2 asphyxiation. 

Phrase: "At specific time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "postsurgery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032790:post surgery [Temporal Concept]
  1000   C0241311:Post surgery [Finding]

Phrase: "(0,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "7,"

Phrase: "10,"

Phrase: "14,"

Phrase: "or"

Phrase: "21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "killed by CO2 asphyxiation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0004044:Asphyxiation [Pathologic Function]
   770   C0162388:killed [Social Behavior]
   770   C2347816:Co2+ [Element, Ion, or Isotope]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]
Processing 00000000.tx.75: A midline thorax to neck incision was made, the ribs were removed, the trachea was exposed, and a blunt-end 21-gauge needle was inserted and tied into the trachea. 

Phrase: "A midline thorax to neck incision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0817096:Thorax [Body Location or Region]
   753   C1269614:Thorax [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: ","

Phrase: "the ribs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035561:Ribs [Body Part, Organ, or Organ Component]
   966 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "the trachea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040578:Trachea [Body Part, Organ, or Organ Component]
  1000   C1278905:Trachea [Body Part, Organ, or Organ Component]
  1000   C3146235:Trachea [Eukaryote]
   928 E C2945595:Tracheal [Spatial Concept]

Phrase: "was"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: ","

Phrase: "and"

Phrase: "a blunt-end 21-gauge needle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0027551:Needle [Medical Device]
   804   C1704318:Needle [Medical Device]
   804   C1882041:Needle [Spatial Concept]

Phrase: "was"

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "tied into the trachea."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0040578:Trachea [Body Part, Organ, or Organ Component]
   770   C1278905:Trachea [Body Part, Organ, or Organ Component]
   770   C1416505:TIED [Gene or Genome]
   770   C3146235:Trachea [Eukaryote]
   737 E C0453920:Tie [Manufactured Object]
   737 E C3472712:Tie [Manufactured Object]
Processing 00000000.tx.76: Blood was flushed from the pulmonary capillary bed by injecting PBS into the right ventricle and letting it drain out of a needle inserted into the left ventricle. 

Phrase: "Blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "flushed from the pulmonary capillary bed"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0923302:Pulmonary capillary bed [Body System]
   790   C0489802:Capillary bed [Body Part, Organ, or Organ Component]
   790   C0507816:Pulmonary capillary [Body Part, Organ, or Organ Component]
   753   C0004916:Bed [Manufactured Object]
   753   C0006901:Capillary [Body Part, Organ, or Organ Component]
   753   C0016382:flushed [Sign or Symptom]
   753   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   753   C0596170:BED [Mental or Behavioral Dysfunction]
   753   C0935624:Capillary [Body Part, Organ, or Organ Component]
   753   C1280521:Capillary [Body Part, Organ, or Organ Component]
   753   C2707265:Pulmonary [Clinical Attribute]
   753   C2709248:Pulmonary [Qualitative Concept]
   719 E C1696091:Flush [Functional Concept]

Phrase: "by injecting PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "into the right ventricle"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0225883:Right Ventricle [Body Part, Organ, or Organ Component]
  1000   C1269891:Right ventricle [Body Part, Organ, or Organ Component]
   861   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   861   C0205090:Right [Spatial Concept]
   861   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   789 E C1522565:Ventricular [Spatial Concept]
   761 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "letting"

Phrase: "it"

Phrase: "drain out of a needle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0013103:drain [Therapeutic or Preventive Procedure]
   760   C0027551:Needle [Medical Device]
   760   C0180499:Drain [Medical Device]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1704318:Needle [Medical Device]
   760   C1882041:Needle [Spatial Concept]

Phrase: "inserted into the left ventricle."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0225897:Left Ventricle [Body Part, Organ, or Organ Component]
   806   C1269892:Left ventricle [Body Part, Organ, or Organ Component]
   760   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   760   C0205091:Left [Spatial Concept]
   760   C0441587:Inserted [Health Care Activity]
   760   C1552822:left [Functional Concept]
   760   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]
Processing 00000000.tx.77: The lungs were lavaged with sterile PBS (x3, 0.5 ml each), the collected bronchoalveolar lavage fluid (BALF) was centrifuged (1,500 rpm, 10 min, 4C), and the supernatant was stored for analysis. 

Phrase: "The lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "lavaged with sterile PBS (x3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0232920:Sterile [Qualitative Concept]
   760   C0678108:Sterile [Pathologic Function]
   760   C1421546:X3 [Gene or Genome]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726   C0022100:Lavage [Therapeutic or Preventive Procedure]
   726   C1546689:Lavage [Intellectual Product]

Phrase: "0.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: ","

Phrase: "the collected bronchoalveolar lavage fluid (BALF)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   861   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   861   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C3641255:Lavage Fluid [Body Substance]
   812   C0005889:FLUID [Body Substance]
   812   C0022100:Lavage [Therapeutic or Preventive Procedure]
   812   C0302908:fluid [Substance]
   812   C0444611:Fluid [Qualitative Concept]
   812   C1546689:Lavage [Intellectual Product]
   812   C1704353:Fluid [Substance]

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(1,500 rpm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]

Phrase: "10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "stored for analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.78: Cells in the BALF were applied to slides using a Cytospin centrifuge (ThermoShandon, Pittsburgh, PA). 

Phrase: "Cells in the BALF"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "applied to slides"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0185125:Applied [Health Care Activity]
   790   C0444330:slides [Research Device]
   756 E C1632850:Apply [Functional Concept]
   756 E C1705201:Slide [Manufactured Object]
   756 E C1879355:Apply [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Cytospin centrifuge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0179834:centrifuge [Medical Device]

Phrase: "(ThermoShandon,"

Phrase: "Pittsburgh,"

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.79: Slides were dried overnight and stained with modified Wright stain (Diff-Quik, Dade Behring, Deerfield, IL), and cell count was performed on 150200 nucleated cells. 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "stained with modified Wright stain"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1520152:Modified Wright Stain [Laboratory Procedure]
   781   C1261259:Wright stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Wright
   760   C0392747:Modified [Functional Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Diff-Quik,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082282:Diff Quik [Organic Chemical]

Phrase: "Dade Behring,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0046889:dade [Organic Chemical]

Phrase: "Deerfield,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cell count"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007584:Cell Count [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0750480:Count [Activity]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705566:Count [Quantitative Concept]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "performed on 150200 nucleated cells."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C1180059:Nucleated cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0884358:Performed [Functional Concept]
   760   C1979936:Nucleated [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.80: After BALF collection, the lungs were removed, frozen in liquid nitrogen, and stored at 80C for subsequent biochemical analyses. 

Phrase: "After BALF collection,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C1516698:Collection [Functional Concept]
   812   C1704814:Collection [Idea or Concept]
   756   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "the lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "frozen in liquid nitrogen,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for subsequent biochemical analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
Processing 00000000.tx.81: Western blot analysis. 

Phrase: "Western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.82: Lungs were homogenized in cold lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100) containing protease inhibitors (50 g/ml aprotinin, 10 g/ml leupeptin, 50 g/ml pepstatin, 0.4 mM EDTA, 0.4 mM sodium vanadate, 10 mM sodium fluoride, and 10 mM sodium pyrophosphate) using a Polytron homogenizer. 

Phrase: "Lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "homogenized in cold lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0024348:Lysis [Pathologic Function]
   760   C0234192:Cold [Physiologic Function]
   760   C1536403:lysis [Cell Function]

Phrase: "(50 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "containing protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(50 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "50 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "0.4 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.4 mM sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   804   C0042305:Vanadate [Inorganic Chemical]

Phrase: "10 mM sodium fluoride,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037508:Sodium Fluoride [Biomedical or Dental Material,Inorganic Chemical]
   861   C1171560:sodium fluoride [Pharmacologic Substance]
   861   C1556062:Sodium Fluoride [Intellectual Product]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   805 E C0721463:Luride [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 mM sodium pyrophosphate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Polytron homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.83: Protein concentrations of the lung homogenates and BALF were determined by the Bradford method (Bio-Rad Laboratory, Hercules, CA). 

Phrase: "Protein concentrations of the lung homogenates"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0427716:Protein concentration [Laboratory Procedure]
   773   C1304757:Protein concentration [Laboratory or Test Result]
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "BALF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "were"

Phrase: "determined by the Bradford method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "(Bio-Rad Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "Hercules,"

Phrase: "CA)."
Processing 00000000.tx.84: Equal protein amounts were added to Laemmli sample buffer and boiled for 5 min. 

Phrase: "Equal protein amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "added to Laemmli sample buffer"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C1524062:Added [Functional Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "boiled for 5 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.85: Proteins were separated by electrophoresis on 7.5 or 10% SDS-PAGE gels (Bio-Rad) and electroblotted onto polyvinylidene difluoride membranes. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "on 7.5"

Phrase: "or"

Phrase: "10% SDS-PAGE gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "(Bio-Rad)"

Phrase: "and"

Phrase: "electroblotted onto polyvinylidene difluoride membranes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.86: Nonspecific binding was blocked by incubating blots in 5% nonfat dry milk or 3% BSA in PBS/Tween 20 at 4C. 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked by incubating blots"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C1439852:incubating [Laboratory Procedure]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in 5% nonfat dry milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: "or"

Phrase: "3% BSA in PBS/Tween 20"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.87: Membranes were probed with NRG-1 polyclonal antibody (C-20), HER2 polyclonal antibody (C-18), phosphorylated-HER2 polyclonal antibody (Tyr 1248), HER3 polyclonal antibody (C-17; all from Santa Cruz Biotechnology, Santa Cruz, CA), or FLAG polyclonal antibody (Affinity Bioreagents, Golden, CO). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with NRG-1 polyclonal antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1367656:NEUREGULIN 1 [Gene or Genome]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "(C-20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "HER2 polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(C-18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "phosphorylated-"

Phrase: "HER2 polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Tyr 1248"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "HER3 polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(C-17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ";"

Phrase: "all from Santa Cruz Biotechnology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "or"

Phrase: "FLAG polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Affinity Bioreagents,"

Phrase: "Golden,"

Phrase: "CO"

Phrase: ")."
Processing 00000000.tx.88: Following incubation with secondary antibodies conjugated to horseradish peroxidase (1:5,000 dilution; 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation with secondary antibodies"

Phrase: "conjugated to horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.89: Santa Cruz Biotechnology), specific protein bands were detected by enhanced chemiluminescence autoradiography (Amersham, Piscataway, NJ). 

Phrase: "Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "specific protein bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected by enhanced chemiluminescence autoradiography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004400:Autoradiography [Laboratory Procedure]
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2349975:Enhanced [Activity]

Phrase: "(Amersham,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.90: Relative amounts of individual protein bands were quantified by analysis of digitized images using National Institutes of Health Image software. 

Phrase: "Relative amounts of individual protein bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "quantified by analysis of digitized images"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0200765:Image analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C1709793:Quantify [Quantitative Concept]
   719   C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "National Institutes of Health Image software."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037585:Software [Intellectual Product,Manufactured Object]
   734   C0027468:National Institutes of Health [Health Care Related Organization]
Processing 00000000.tx.91: For immunoprecipitation studies, cell lysates containing 200 g of protein were incubated with appropriate antibody (2 g for 1 h at 4C). 

Phrase: "For immunoprecipitation studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with appropriate antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1548787:Appropriate [Qualitative Concept]

Phrase: "(2 g for 1 h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0560020:g h [Quantitative Concept]
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   760   C0439267:g% [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: The antibody-protein complexes were then incubated with protein A beads for 1 h at 4C with mixing. 

Phrase: "The antibody-protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with protein A beads"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0991566:Beads [Biomedical or Dental Material]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with mixing."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205430:mixing [Functional Concept]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.93: The beads were washed three times in PBS and resuspended in Laemmli sample buffer. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times in PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "resuspended in Laemmli sample buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.94: Western blot analysis was conducted as described above. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "conducted as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C0004927:Conduct [Individual Behavior]
Processing 00000000.tx.95: Histological preparation. 

Phrase: "Histological preparation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.96: Lungs from transgenic DNHER3 mice and nontransgenic littermate controls were prepared for histology by inflation fixation. 

Phrase: "Lungs from transgenic DNHER3 mice"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   741   C1518039:Mouse Lung [Tissue]
   714 E C0819757:LUNG [Tissue]
   714 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "nontransgenic littermate controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "prepared for histology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0019638:Histology [Biomedical Occupation or Discipline]
   790   C0205462:histology [Functional Concept]
   790   C0344441:Histology [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "by inflation fixation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0185023:Fixation [Therapeutic or Preventive Procedure]
   861   C0728733:fixation [Mental Process]
   861   C1522662:Fixation [Laboratory Procedure]
Processing 00000000.tx.97: Following death, the animal's chest was opened, and the ribs were removed to allow uncompromised lung inflation. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "the animal's chest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0817096:Chest [Body Location or Region]
   861   C1527391:Chest [Body Location or Region]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0006141:BREASTS [Body Part, Organ, or Organ Component]
   777 E C1268990:Breast [Body Part, Organ, or Organ Component]
   761 E C0929301:Mammary [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "opened"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Opened [Spatial Concept]

Phrase: ","

Phrase: "and"

Phrase: "the ribs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035561:Ribs [Body Part, Organ, or Organ Component]
   966 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "uncompromised lung inflation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021398:Inflation [Quantitative Concept]
   827   C1318493:Inflation [Health Care Activity]
Processing 00000000.tx.98: The trachea was cannulated, and the lungs were inflated and deflated three times with 10% formalin (1 ml) by means of a 3-ml syringe. 

Phrase: "The trachea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040578:Trachea [Body Part, Organ, or Organ Component]
  1000   C1278905:Trachea [Body Part, Organ, or Organ Component]
  1000   C3146235:Trachea [Eukaryote]
   928 E C2945595:Tracheal [Spatial Concept]

Phrase: "was"

Phrase: "cannulated"

Phrase: ","

Phrase: "and"

Phrase: "the lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "inflated"

Phrase: "and"

Phrase: "deflated three times with 10% formalin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "(1 ml) by means of a 3-ml syringe."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1623737:mL/mL [Quantitative Concept]
   762   C3539687:mL/mL [Quantitative Concept]
Processing 00000000.tx.99: The cannula was then attached to a reservoir containing 10% Formalin, and the lungs were fixed for 1 h at 10-cm pressure. 

Phrase: "The cannula"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0520453:Cannula [Medical Device]
  1000   C1706091:Cannula [Medical Device]
  1000   C3463845:Cannula [Eukaryote]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "attached to a reservoir"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0231441:Attached [Finding]
   770   C0442537:Reservoir [Geographic Area]
   770   C1705182:Reservoir [Medical Device]
   737 E C1314972:ATTACH [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% Formalin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
  1000   C1561470:10% Formalin [Intellectual Product]
   861   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "fixed for 1 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0231441:Fixed [Finding]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "at 10-cm pressure."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
Processing 00000000.tx.100: At the conclusion of fixation, lungs were removed en bloc and transferred to a cassette for paraffin embedding. 

Phrase: "At the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "of fixation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185023:Fixation [Therapeutic or Preventive Procedure]
  1000   C0728733:fixation [Mental Process]
  1000   C1522662:Fixation [Laboratory Procedure]

Phrase: "lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "en bloc"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1516835:En Bloc [Functional Concept]
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1417861:eN [Gene or Genome]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   861   C2987294:EN [Qualitative Concept]
   777 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "transferred to a cassette"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0348011:transferred [Functional Concept]
   770   C0450240:Cassette [Medical Device]
   770   C1706210:Cassette [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "for paraffin embedding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085185:Paraffin Embedding [Laboratory Procedure]
   861   C1707903:Embedding [Laboratory Procedure]
Processing 00000000.tx.101: Following embedding, 5-m sections were cut, transferred to slides, and stained with hematoxylin and eosin (H&E). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "embedding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707903:Embedding [Laboratory Procedure]

Phrase: "5-m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "transferred to slides,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0348011:transferred [Functional Concept]
   790   C0444330:slides [Research Device]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705201:Slide [Manufactured Object]
   756 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "stained with hematoxylin and eosin (H&E)."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.102: Pathological scoring of H&E-stained lung sections. 

Phrase: "Pathological scoring of H&E-stained lung sections."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   809   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   745   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   742   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0024109:Lung [Body Part, Organ, or Organ Component]
   742   C0030664:Pathological [Biomedical Occupation or Discipline]
   742   C0449820:scoring [Quantitative Concept]
   742   C0819757:LUNG [Tissue]
   742   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   742   C1278908:Lung [Body Part, Organ, or Organ Component]
   742   C1521733:Pathological [Functional Concept]
   742   C1552081:scoring [Idea or Concept]
   742   C2986582:Stained [Qualitative Concept]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]
Processing 00000000.tx.103: Lung sections stained with H&E were scored to determine the relative volume densities of epithelia, mesenchyme, and air space (25, 37). 

Phrase: "Lung sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "stained with H&E"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the relative volume densities of epithelia,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1442097:Relative Volume [Quantitative Concept]
   783   C0037786:Relative Densities [Quantitative Concept]
   767 E C1576416:*Relative Density [Qualitative Concept]
   753   C0178587:densities [Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "mesenchyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162415:Mesenchyme [Embryonic Structure]
   928 E C1513143:Mesenchymal [Qualitative Concept]

Phrase: "and"

Phrase: "air space"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001861:Air [Substance]
   861   C1883067:Space [Spatial Concept]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(25,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.104: Following staining, random fields from all sections were digitally photographed at x200 magnification using a SPOT camera (Diagnostic Instruments, Sterling Heights, MI) mounted to a Nikon Optiphot-2 microscope (Nikon, Melville, NY). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "random fields from all sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   726   C1521738:Field [Conceptual Entity]
   726   C2346620:Field [Conceptual Entity]
   726   C2349184:Field [Conceptual Entity]
   726   C3539073:FIELD [Spatial Concept]

Phrase: "were"

Phrase: "digitally"

Phrase: "photographed at x200 magnification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0441468:photograph [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a SPOT camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0179533:Camera [Medical Device]
   861   C1654607:Camera [Eukaryote]
   861   C1706254:CAMERA [Medical Device]

Phrase: "(Diagnostic Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Sterling Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "MI)"

Phrase: "mounted to a Nikon Optiphot-2 microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0181839:Microscope [Medical Device]
   748   C0449878:mounted [Finding]
   748   C1706379:Microscope [Medical Device]
   714 E C0181909:Mount [Medical Device]

Phrase: "(Nikon,"

Phrase: "Melville,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Images of two random fields from each animal (3 nontransgenic littermates and 3 DNHER3 mice for each of 0-, 10-, and 21-day bleomycin time points) were overlaid with an 11 x 11 grid. 

Phrase: "Images of two random fields"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "from each animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "(3 nontransgenic littermates"

Phrase: "and"

Phrase: "3 DNHER3 mice for each of 0-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "10-,"

Phrase: "and"

Phrase: "21-day bleomycin time points"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   811   C0439511:day times [Quantitative Concept]
   806   C2348792:Time Point [Temporal Concept]
   804   C0040223:Time [Temporal Concept]
   804   C3541383:Time [Temporal Concept]
   771   C1552961:Point [Quantitative Concept]
   771   C2347617:point [Quantitative Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "overlaid with an 11 x 11 grid."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C1415284:GRID [Gene or Genome]
   748   C2348395:Grid [Medical Device]
   748   C2825313:Grid [Manufactured Object]
   714   C0444456:Overlay [Spatial Concept]
   714   C1706359:Overlay [Medical Device]
Processing 00000000.tx.106: The area underlying each grid intersection was classified as mesenchyme, epithelia, or air space. 

Phrase: "The area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "underlying"

Phrase: "each grid intersection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2697794:Intersection [Idea or Concept]
   861   C2825197:Intersection [Classification]

Phrase: "was"

Phrase: "classified as mesenchyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0008902:Classified [Classification]
   790   C0162415:Mesenchyme [Embryonic Structure]
   718 E C1513143:Mesenchymal [Qualitative Concept]

Phrase: "epithelia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0014609:Epithelium [Tissue]
   916 E C0221908:Epithelial [Qualitative Concept]

Phrase: "or"

Phrase: "air space."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001861:Air [Substance]
   861   C1883067:Space [Spatial Concept]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.107: Cells directly bordering air space were classified as epithelia, whereas cells separated from the air space by intervening cell layers were classified as mesenchyme. 

Phrase: "Cells directly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "bordering"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205284:Border [Spatial Concept]
   966   C1522411:Border [Body Location or Region]
   966   C2828371:Border [Classification]

Phrase: "air space"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001861:Air [Substance]
   861   C1883067:Space [Spatial Concept]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "classified as epithelia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0008902:Classified [Classification]
   756   C0014609:Epithelium [Tissue]
   706 E C0221908:Epithelial [Qualitative Concept]

Phrase: "whereas"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "separated from the air space"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0001861:Air [Substance]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1883067:Space [Spatial Concept]
   760   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]

Phrase: "by intervening cell layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0934502:layers [Body Part, Organ, or Organ Component]
   793 E C1522408:Layer [Qualitative Concept]
   793 E C1561599:Layer [Intellectual Product]

Phrase: "were"

Phrase: "classified as mesenchyme."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0008902:Classified [Classification]
   790   C0162415:Mesenchyme [Embryonic Structure]
   718 E C1513143:Mesenchymal [Qualitative Concept]
Processing 00000000.tx.108: A total of 121 intersection points was counted for each field, and 242 intersection points were counted for each animal. 

Phrase: "A total of 121 intersection points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "counted for each field,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   770   C1521738:Field [Conceptual Entity]
   770   C2346620:Field [Conceptual Entity]
   770   C2349184:Field [Conceptual Entity]
   770   C3539073:FIELD [Spatial Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "242 intersection points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]

Phrase: "were"

Phrase: "counted for each animal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003062:Animal [Animal]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.109: The total number of mesenchyme, epithelia, and air space points was divided by 242 to determine the volume density of each category for each animal at each time point. 

Phrase: "The total number of mesenchyme,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "epithelia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0014609:Epithelium [Tissue]
   916 E C0221908:Epithelial [Qualitative Concept]

Phrase: "and"

Phrase: "air space points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]

Phrase: "was"

Phrase: "divided by 242 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332849:Divided [Functional Concept]

Phrase: "determine"

Phrase: "the volume density of each category"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0178587:density [Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "for each animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "at each time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.110: Data were averaged to determine volume densities for nontransgenic and DNHER3 mice for each condition. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "volume densities for nontransgenic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0178587:densities [Quantitative Concept]
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "DNHER3 mice for each condition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
Processing 00000000.tx.111: Collagen assay. 

Phrase: "Collagen assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.112: Total soluble collagen content was determined by using the Sircol Collagen Assay (Biocolor, Newtownabbey, UK). 

Phrase: "Total soluble collagen content"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   812   C1167364:collagen [Cell Component]
   741 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Sircol Collagen Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Biocolor,"

Phrase: "Newtownabbey,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.113: Lungs were homogenized in 1 ml of complete lysis buffer and centrifuged for 10 min (10,000 g, 4C). 

Phrase: "Lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "were"

Phrase: "homogenized in 1 ml of complete lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0024348:Lysis [Pathologic Function]
   744   C0205197:Complete [Qualitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C0725685:COMPLEAT [Food]
   744   C1536403:lysis [Cell Function]

Phrase: "and"

Phrase: "centrifuged for 10 min (10,000 g,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0456692:/10 min [Temporal Concept]
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]
   714   C0179834:centrifuge [Medical Device]

Phrase: "4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: Fifty microliters of supernatant were added to 50 l of 0.5 M acetic acid and 1 ml of Sircol dye reagent. 

Phrase: "Fifty microliters of supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "added to 50 l of 0.5 M acetic acid"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0000985:Acetic acid [Organic Chemical]
   760   C0444499:0/5 [Quantitative Concept]
   757   C1440942:M-5 [Immunologic Factor]
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   739   C1524062:Added [Functional Concept]
   706 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "1 ml of Sircol dye reagent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.115: Samples were mixed for 30 min at room temperature to allow the formation of dye-collagen complexes. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "mixed for 30 min"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0205430:Mixed [Functional Concept]
   770   C0702093:/min [Temporal Concept]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "at room temperature to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]
   827   C1547703:Room [Spatial Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the formation of dye-collagen complexes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2246343:collagen formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.116: Samples were centrifuged at 10,000 g to pellet the complexes. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 10,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "to pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "the complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.117: Bound dye was then solubilized in 1 ml of 0.5 M NaOH and analyzed spectrophotometrically at 540 nM. 

Phrase: "Bound dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "solubilized in 1 ml of 0.5 M NaOH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0444499:0/5 [Quantitative Concept]
   762   C1440942:M-5 [Immunologic Factor]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439526:/mL [Quantitative Concept]
   742   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "spectrophotometrically at 540 nM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]
Processing 00000000.tx.118: Collagen concentration was determined by comparison to a standard curve constructed using known amounts of type I collagen. 

Phrase: "Collagen concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "to a standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "known amounts of type I collagen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1550420:Amount type [Classification]
   753   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.119: TGF-1 bioassay. 

Phrase: "TGF-1 bioassay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0005507:Bioassay [Laboratory Procedure]
   804   C1704780:Bioassay [Conceptual Entity]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.120: TGF-1 content was measured in BALF by using a reporter gene bioassay (19). 

Phrase: "TGF-1 content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "measured in BALF"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   806   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   806   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C3641255:Lavage Fluid [Body Substance]
   760   C0005889:FLUID [Body Substance]
   760   C0022100:Lavage [Therapeutic or Preventive Procedure]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1546689:Lavage [Intellectual Product]
   760   C1704353:Fluid [Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a reporter gene bioassay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Bioassay [Laboratory Procedure]
   827   C1704780:Bioassay [Conceptual Entity]
   734   C0206414:Reporter Gene [Gene or Genome]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.121: Mink lung epithelial cells permanently transfected with a construct containing the TGF-1 responsive human plasminogen activator inhibitor-1 promoter fused to a luciferase reporter gene (a gift from Daniel Rifkin, NYU Medical Center, New York, NY) were used. 

Phrase: "Mink lung epithelial cells permanently"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0014597:Epithelial Cells [Cell]
   840   C1273342:Epithelial Cells [Laboratory Procedure]
   804   C0007634:Cells [Cell]
   804   C0221908:Epithelial [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with a construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the TGF-1 responsive human plasminogen activator inhibitor-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "fused to a luciferase reporter gene"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0206414:Reporter Gene [Gene or Genome]
   783   C1334435:Luciferase Gene [Gene or Genome]
   767   C1414861:FUSE gene [Gene or Genome]
       E   FUSE
   753   C0017337:Gene [Gene or Genome]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C0699952:Fused [Functional Concept]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]
   719 E C1708111:Fuse [Manufactured Object]

Phrase: "("

Phrase: "a gift from Daniel Rifkin,"

Phrase: "NYU Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.122: These cells were seeded into individual wells of 12-well tissue culture plates (105 cells/well) in DMEM with 10% FCS and allowed to adhere overnight, followed by 24 h of serum starvation. 

Phrase: "These cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded into individual wells of 12-well tissue culture plates"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   760   C0040284:Tissue culture [Laboratory Procedure]
   760   C0180454:culture plates [Medical Device]
   739   C0010453:Culture [Idea or Concept]
   739   C0027361:Individual [Population Group]
   739   C0040300:Tissue [Tissue]
   739   C0220814:culture [Functional Concept]
   739   C0237401:Individual [Human]
   739   C0430400:Culture [Laboratory Procedure]
   739   C1139930:plates [Medical Device]
   739   C1547928:Tissue [Intellectual Product]
   739   C2242979:Culture [Laboratory Procedure]
   706 E C0005971:Plate [Medical Device]
   706   C0036563:Seed [Plant]
   706   C0205170:Well [Qualitative Concept]
   706   C1705192:Seed [Laboratory Procedure]
   706   C1882540:{Seed} [Quantitative Concept]
   706   C2346495:Seed [Conceptual Entity]
   706   C3146287:Well [Manufactured Object]
   706 E C3537155:Plate [Manufactured Object]

Phrase: "(105 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in DMEM"

Phrase: "with 10% FCS"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adhere"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231441:Adhere [Finding]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "followed by 24 h of serum starvation."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0038187:Starvation [Finding]
   748   C0229671:Serum [Body Substance]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.123: Cells were then stimulated with 500 l of BALF collected from DNHER3 or nontransgenic littermate mice. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with 500 l of BALF"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   770   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   770   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C3641255:Lavage Fluid [Body Substance]
   744   C0005889:FLUID [Body Substance]
   744   C0022100:Lavage [Therapeutic or Preventive Procedure]
   744   C0302908:fluid [Substance]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1546689:Lavage [Intellectual Product]
   744   C1704353:Fluid [Substance]
   744   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "collected from DNHER3"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   760   C0205160:Negative [Qualitative Concept]
   760   C0812265:HER3 [Gene or Genome]
   760   C1513916:Negative [Finding]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1527180:Dominant [Functional Concept]
   760   C1704825:HER3 [Gene or Genome]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "or"

Phrase: "nontransgenic littermate mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.124: Cells were lysed 24 h after BALF exposure, and luciferase activity was measured using the Luciferase Assay System (Promega, Madison, WI). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "24 h after BALF exposure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Luciferase Assay System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.125: TGF-1 content was quantified from luciferase activity using a standard curve constructed from reporter cells exposed to known amounts of TGF-1. 

Phrase: "TGF-1 content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "quantified from luciferase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "constructed from reporter cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0007634:Cells [Cell]
   770   C0335038:Reporter [Professional or Occupational Group]
   770   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   770   C1705915:Reporter [Conceptual Entity]
   770   C1709908:Reporter [Group]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2827421:Construct [Classification]

Phrase: "exposed to known amounts of TGF-1."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332157:Exposed to [Clinical Attribute]
           Exposed
   742   C0018270:'growth' NOS [Organism Function]
   742   C0205309:Known [Qualitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C1265611:amounts [Quantitative Concept]
   742   C1510411:Transforming [Pathologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
Processing 00000000.tx.126: Survival analysis. 

Phrase: "Survival analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038953:Survival Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.127: Survival following lung injury was evaluated by increasing the intratracheal bleomycin dose from 0.025 to 0.08 units. 

Phrase: "Survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was"

Phrase: "evaluated by increasing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0220825:Evaluated [Functional Concept]
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the intratracheal bleomycin dose from 0.025"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]

Phrase: "to 0.08 units."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.128: Mice were injected with bleomycin, as described above, allowed to recover, and then monitored twice a day until death. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "injected with bleomycin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   756   C1720154:Inject [Functional Concept]

Phrase: "as"

Phrase: "described above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "a day until death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
Processing 00000000.tx.129: Statistics. 

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.130: An unpaired t-test was used to compare single variables across animal groups to determine statistical differences. 

Phrase: "An unpaired t-test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1710574:Unpaired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "single variables across animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439828:variables [Qualitative Concept]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "statistical differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.131: All data are presented as means (SD). 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as means"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0449450:Presented [Idea or Concept]
   790   C1704970:Means [Conceptual Entity]
   756 E C0150312:Present [Quantitative Concept]
   756 E C0444504:Mean [Quantitative Concept]
   756 E C2347634:Mean [Quantitative Concept]
   756 E C2348143:Mean [Quantitative Concept]

Phrase: "(SD"

Phrase: ")."
Processing 00000000.tx.132: Data from survival studies were plotted using the Kaplan-Meier method and analyzed by log rank test. 

Phrase: "Data from survival studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0681873:study data [Research Activity]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "plotted"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Kaplan-Meier method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by log rank test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0699794:Rank [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1708728:Log [Intellectual Product]
   760   C2986775:log [Occupational Activity]
Processing 00000000.tx.133: A P value of <0.05 was taken to indicate statistical significance.  

Phrase: "A P value of <0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1709380:P-Value [Quantitative Concept]
   799   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "indicate"

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.134: RESULTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  Deletion of the HER3 cytoplasmic domain produces a dominant-negative receptor. 

Phrase: "RESULTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Deletion of the HER3 cytoplasmic domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "produces"

Phrase: "a dominant-negative receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
Processing 00000000.tx.135: Our in vitro studies identified that HER2 is activated on disruption of a pulmonary epithelial cell monolayer, receptor activation reduces the time to monolayer reformation, and NRG-1 treatment induces pulmonary epithelial cell proliferation in human tissue. 

Phrase: "Our in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that HER2"

Phrase: "is"

Phrase: "activated on disruption of a pulmonary epithelial cell monolayer,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0014597:Epithelial cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   742   C0221908:Epithelial [Qualitative Concept]
   742   C0332453:Disruption [Functional Concept]
   742   C0872351:monolayer [Clinical Drug]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1879547:Activated [Activity]
   742   C1948049:Cell [Spatial Concept]
   742   C2707265:Pulmonary [Clinical Attribute]
   742   C2709248:Pulmonary [Qualitative Concept]
   708 E C1515877:Activate [Functional Concept]

Phrase: "receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "reduces"

Phrase: "the time to monolayer reformation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "NRG-1 treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "pulmonary epithelial cell proliferation in human tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C1326341:Epithelial Cell Proliferation [Cell Function]
   778   C0596290:Cell Proliferation [Cell Function]
   774   C0334097:Epithelial proliferation [Pathologic Function]
   748   C0334094:Proliferation [Pathologic Function]
   748   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.136: These findings led us to hypothesize that the NRG-1/HER2/HER3 ligand-receptor axis was involved in recovery from lung injury in vivo. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hypothesize"

Phrase: "that"

Phrase: "the NRG-1/HER2/HER3 ligand-receptor axis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0004457:Axis [Body Part, Organ, or Organ Component]
   793   C0999597:Axis [Mammal]
   793   C1522496:Axis [Spatial Concept]
   711   C1334952:Neuregulin Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "involved in recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237820:Recovery [Activity]
   790   C1314939:Involved [Functional Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "from lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.137: To test this hypothesis, we chose to inhibit HER2/HER3 activation following injury by using a dominant-negative receptor strategy with a mutant HER3 (DNHER3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "HER2/HER3 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injury by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3263722:Injury [Injury or Poisoning]
   833   C3263723:Injury [Injury or Poisoning]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a dominant-negative receptor strategy with a mutant HER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679199:strategy [Mental Process]

Phrase: "(DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: ")."
Processing 00000000.tx.138: Mutation of HER3 was chosen over HER2 because previous studies had shown that HER2 activation required HER3's intracellular domain (27, 28). 

Phrase: "Mutation of HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "chosen over HER2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C1707391:Chosen [Activity]

Phrase: "because"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that HER2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "HER3's intracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.139: By deleting the HER3 intracellular domain, HER2/HER3 receptor complex formation could occur, but HER2 activation (i.e., phosphorylation) would be eliminated (26). 

Phrase: "By deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880274:Delete [Activity]

Phrase: "the HER3 intracellular domain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "HER2/HER3 receptor complex formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C1819634:receptor formation [Molecular Function]
   799   C0220781:formation [Biologic Function]
   799   C0439634:formation [Spatial Concept]
   799   C1522492:Formation [Functional Concept]

Phrase: "could"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "but"

Phrase: "HER2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "(i.e., phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")"

Phrase: "would"

Phrase: "be"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.140: In addition, HER3 is expressed at levels 10-fold lower than HER2 and is rate limiting in receptor formation. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "is"

Phrase: "expressed at levels 10-fold lower"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0332462:Fold [Spatial Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C2003888:Lower [Activity]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "than HER2"

Phrase: "and"

Phrase: "is"

Phrase: "rate limiting in receptor formation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0439801:limiting [Functional Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.141: Thus high-level expression of a DNHER3 would strongly favor HER2/DNHER3 heterodimer formation. 

Phrase: "Thus high-level expression of a DNHER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C3244092:expression level [Idea or Concept]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "strongly"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "HER2/DNHER3 heterodimer formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0220781:formation [Biologic Function]
   795   C0439634:formation [Spatial Concept]
   795   C1522492:Formation [Functional Concept]
Processing 00000000.tx.142: Using standard PCR techniques, a DNHER3 was developed from a full-length human HER3 cDNA template. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard PCR techniques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]

Phrase: "a DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "developed from a full-length human HER3 cDNA template."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086418:Human [Human]
   742   C0443225:Full [Qualitative Concept]
   742   C0728990:TEMPLATE [Medical Device]
   742   C0812265:HER3 [Gene or Genome]
   742   C1444754:Length [Quantitative Concept]
   742   C1514575:Template [Conceptual Entity]
   742   C1704825:HER3 [Gene or Genome]
   742   C1705542:Template [Idea or Concept]
   742   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.143: The salient features of the DNHER3 cDNA are intact extracellular and transmembrane domains, a deleted intracytoplasmic domain, and an epitope tag (FLAG sequence) at the carboxy terminus (Fig. 1A). 

Phrase: "The salient features of the DNHER3 cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   708   C1521970:Feature [Qualitative Concept]
   708   C1706388:Feature [Conceptual Entity]
   708   C2346469:Feature [Qualitative Concept]
   708   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "intact extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521119:Extracellular [Cell Component]

Phrase: "and"

Phrase: "transmembrane domains,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "a deleted intracytoplasmic domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "an epitope tag (FLAG sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: "at the carboxy terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596260:Carboxy [Organic Chemical]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.144: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.146: In vitro characterization of a dominant-negative HER3 (DNHER3) construct. 

Phrase: "In vitro characterization of a dominant-negative HER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "(DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]
Processing 00000000.tx.147: A: schematic representation of the DNHER3. 

Phrase: "A"

Phrase: ":"

Phrase: "schematic representation of the DNHER3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]
Processing 00000000.tx.148: Wild-type HER3 cDNA composed of a ligand-binding extracellular domain (ECD), transmembrane (TM) domain, and cytoplasmic domain containing the tyrosine kinase (TK) region was used as a template for the construction of DNHER3. 

Phrase: "Wild-type HER3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "composed of a ligand-binding extracellular domain (ECD),"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0682969:Ligand Binding Domain [Amino Acid Sequence]
   778   C1517050:Extracellular Domain [Spatial Concept]
   778   C1517880:Ligand Binding [Molecular Function]
   748   C0023688:Ligand [Chemical]
   748   C0243122:binding [Functional Concept]
   748   C0521119:Extracellular [Cell Component]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "transmembrane (TM) domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "cytoplasmic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Domain [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the tyrosine kinase (TK) region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
   734   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "used as a template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for the construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "of DNHER3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
Processing 00000000.tx.149: DNHER3 consists of intact ECD and TM domains, but with the majority of the cytoplasmic domain deleted. 

Phrase: "DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "consists of intact ECD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1517050:Extracellular Domain [Spatial Concept]
   760   C0205266:Intact [Qualitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C1554187:Intact [Idea or Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "TM domains,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "but with the majority of the cytoplasmic domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1511625:Cytoplasmic Domain [Cell Component]
   744   C0010834:Cytoplasmic [Cell Component]
   744   C0233535:but [Mental or Behavioral Dysfunction]
   744   C0521449:Cytoplasmic [Body Location or Region]
   744   C0680220:majority [Social Behavior]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "deleted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]
Processing 00000000.tx.150: A FLAG epitope sequence was added to the carboxy terminus of the intracellular domain. 

Phrase: "A FLAG epitope sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "added to the carboxy terminus of the intracellular domain."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0596260:Carboxy [Organic Chemical]
   742   C1524062:Added [Functional Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
   708 E C1883712:Add [Functional Concept]
Processing 00000000.tx.151: B: protein lysates from COS-7 cells, with and without transfection, were immunoprecipitated (IP) with an antibody recognizing HER3 extracellular epitope and Western blotted (WB) for FLAG. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "protein lysates from COS-7 cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "with"

Phrase: "and without transfection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   790   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "immunoprecipitated (IP) with an antibody recognizing HER3 extracellular epitope"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0003316:Epitope [Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0521119:Extracellular [Cell Component]
   744   C0812265:HER3 [Gene or Genome]
   744   C1704825:HER3 [Gene or Genome]
   711   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "Western blotted (WB)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   983   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "for FLAG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708067:Flag [Functional Concept]
Processing 00000000.tx.152: C: HER2 and HER3 expressing A549 cells were transfected with increasing concentrations of DNHER3, stimulated with 10 nM neuregulin-1 (NRG-1), lysed, and Western blotted for phosphorylated HER2 (pHER2) to demonstrate DNHER3 function. 

Phrase: "C"

Phrase: ":"

Phrase: "HER2"

Phrase: "and"

Phrase: "HER3 expressing A549 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with increasing concentrations of DNHER3,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   744   C0086045:Concentrations [Mental Process]
   744   C0205160:Negative [Qualitative Concept]
   744   C0442808:Increasing [Functional Concept]
   744   C0812265:HER3 [Gene or Genome]
   744   C1513916:Negative [Finding]
   744   C1527180:Dominant [Functional Concept]
   744   C1704825:HER3 [Gene or Genome]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "stimulated with 10 nM neuregulin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1367656:NEUREGULIN 1 [Gene or Genome]
   753   C0312860:NM [Cell Function]
   753   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: ")"

Phrase: ","

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "Western blotted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   983   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "for phosphorylated HER2 (pHER2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   804   C0242957:HER-2 [Gene or Genome]
   804   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "DNHER3 function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.153: DNHER3 expression was confirmed by Western blotting for FLAG.  

Phrase: "DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "confirmed by Western blotting"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1705493:Western [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "for FLAG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708067:Flag [Functional Concept]
Processing 00000000.tx.154: The DNHER3 cDNA was cloned into the pcDNA3 expression vector under the control of a cytomegalovirus promoter. 

Phrase: "The DNHER3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned into the pcDNA3 expression vector"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of a cytomegalovirus promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.155: The pcDNA3/DNHER3 construct was transiently transfected into COS-7 and A549 cells for in vitro characterization. 

Phrase: "The pcDNA3/DNHER3 construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "transiently"

Phrase: "transfected into COS-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "A549 cells for in vitro characterization."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: These initial studies verified that 1) the expressed DNHER3 protein contained an extracellular HER3 epitope and the FLAG epitope (Fig. 1B); 

Phrase: "These initial studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0205265:Initial [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   861   C1279901:Initial [Qualitative Concept]
   861   C1555582:Initial [Idea or Concept]
   861   C1705685:INITIAL [Functional Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "that 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "the expressed DNHER3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an extracellular HER3 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitope [Immunologic Factor]

Phrase: "and"

Phrase: "the FLAG epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.157: 2) DNHER3 correctly localized to the cell membrane; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "DNHER3 correctly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0812265:HER3 [Gene or Genome]
   812   C1704825:HER3 [Gene or Genome]

Phrase: "localized to the cell membrane"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007603:Cell Membrane [Cell Component]
   806   C3161472:Cell Membrane [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0392752:Localized [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1706182:Membrane [Manufactured Object]
   760   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.158: and 3) in A549 cells, which express HER2 and HER3 and are NRG-1 responsive, transfection with DNHER3 abrogated the response to NRG-1, as evidenced by decreasing HER2 tyrosine phosphorylation with increasing DNHER3 expression (Fig. 1C, pHER2). 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "in A549 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "express"

Phrase: "HER2"

Phrase: "and"

Phrase: "HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "and"

Phrase: "are"

Phrase: "NRG-1 responsive, transfection with DNHER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "abrogated"

Phrase: "the response to NRG-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "as"

Phrase: "evidenced by decreasing HER2 tyrosine phosphorylation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C0442797:Decreasing [Qualitative Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   714   C0332120:Evidence [Functional Concept]
   714 E C0392756:Decrease [Qualitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "with increasing DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 1C,"

Phrase: "pHER2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0242957:HER-2 [Gene or Genome]
   861   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.159: Construction and characterization of transgenic mice expressing DNHER3 in the lung. 

Phrase: "Construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "characterization of transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "expressing"

Phrase: "DNHER3 in the lung."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0812265:HER3 [Gene or Genome]
   753   C1704825:HER3 [Gene or Genome]
Processing 00000000.tx.160: With verification that the mutant HER3 acted in a dominant-negative fashion, we cloned the DNHER3 cDNA into an expression vector under the control of the human SP-C promoter, thus enabling lung-specific expression of DNHER3 in SP-C-expressing cells. 

Phrase: "With verification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237944:Verification [Research Activity]
  1000   C1711411:Verification [Functional Concept]

Phrase: "that"

Phrase: "the mutant HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812265:HER3 [Gene or Genome]
   861   C1704825:HER3 [Gene or Genome]

Phrase: "acted in a dominant-negative fashion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the DNHER3 cDNA into an expression vector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1515563:cDNA Expression [Molecular Biology Research Technique]
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the human SP-C promoter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1442758:surfactant protein C [Gene or Genome]

Phrase: "thus"

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "lung-specific expression of DNHER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in SP-C-expressing cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C1442758:surfactant protein C [Gene or Genome]
Processing 00000000.tx.161: The DNHER3 transgene, consisting of the SP-C promoter, DNHER3 cDNA, FLAG, SV40 small T intron, and a poly(A) tail, was recovered by restriction endonuclease digestion, purified, and sequenced. 

Phrase: "The DNHER3 transgene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282641:Transgene [Gene or Genome]

Phrase: "consisting of the SP-C promoter,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C1442758:surfactant protein C [Gene or Genome]
   778   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C1168438:Protein C [Laboratory Procedure]
   778   C1418943:PROTEIN C [Gene or Genome]
   778   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0034085:Surfactant [Biologically Active Substance,Lipid,Pharmacologic Substance]
   748   C0038888:Surfactant [Biomedical or Dental Material]
   748   C0038889:Surfactant [Biologically Active Substance,Lipid]
   748   C0038891:Surfactant [Chemical Viewed Functionally]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C2825078:Surfactant [Pharmacologic Substance]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "DNHER3 cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "FLAG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708067:Flag [Functional Concept]

Phrase: "SV40 small T intron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "a poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "tail,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "recovered by restriction endonuclease digestion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0012238:Digestion [Organism Function]
   760   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443288:Restriction [Functional Concept]
   760   C0521108:recovered [Qualitative Concept]
   760   C2349986:Digestion [Research Activity]
   726 E C2004454:recover [Organism Function]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.162: Transgenic mice were then produced by standard pronuclear injection techniques using this DNA. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "produced by standard pronuclear injection techniques"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   773   C2960425:Injection technique [Functional Concept]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0025664:techniques [Intellectual Product]
   753   C0449851:Techniques [Functional Concept]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1442989:Standard [Qualitative Concept]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]
   753   C2828392:Standard [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.163: Three different founder mice with germ line integration of DNHER3 DNA were identified. 

Phrase: "Three different founder mice with germ line integration of DNHER3 DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0025914:Mice [Mammal]
   735   C0025929:mice [Mammal]
   735   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.164: The lines generated from these founders were designated 3, 15, and 23. 

Phrase: "The lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "generated from these founders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0263541:founders [Disease or Syndrome]
   770   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "15,"

Phrase: "and"

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.165: Western blot analyses for the FLAG epitope in lung homogenates from F1 generation mice from each of these lines showed different levels of DNHER3 expression. 

Phrase: "Western blot analyses for the FLAG epitope"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   780   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C1705493:Western [Spatial Concept]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "in lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "homogenates from F1 generation mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0314650:F1 generation [Family Group]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "from each"

Phrase: "of these lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "different levels of DNHER3 expression."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C3244092:expression level [Idea or Concept]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.166: Line 15 exhibited the highest level of DNHER3 expression in the lung, and all subsequent experimentation was conducted using hemizygous mice from this line. 

Phrase: "Line 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "the highest level of DNHER3 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in the lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "all subsequent experimentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678323:experimentation [Research Activity]

Phrase: "was"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hemizygous mice from this line."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
Processing 00000000.tx.167: A human HER3 cDNA was used to generate the DNHER3 transgene. 

Phrase: "A human HER3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the DNHER3 transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.168: As in humans, both HER2 and HER3 are normally expressed in rodent lungs. 

Phrase: "As in humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Humans [Human]

Phrase: "both HER2"

Phrase: "and"

Phrase: "HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "are"

Phrase: "normally"

Phrase: "expressed in rodent lungs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   770   C0035804:Rodent [Mammal]
   737 E C0819757:LUNG [Tissue]
   737 E C1278908:Lung [Body Part, Organ, or Organ Component]
Processing 00000000.tx.169: The amino acid sequences of murine and human HER2 and HER3 are highly conserved; 

Phrase: "The amino acid sequences of murine"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "human HER2"

Phrase: "and"

Phrase: "HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: ";"
Processing 00000000.tx.170: murine HER2 is 87.5% homologous to human HER2, and rodent HER3 is 8590% homologous to human HER3 (10, 13, 31). 

Phrase: "murine HER2"

Phrase: "is"

Phrase: "87.5% homologous to human HER2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "rodent HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812265:HER3 [Gene or Genome]
   861   C1704825:HER3 [Gene or Genome]

Phrase: "is"

Phrase: "8590% homologous to human HER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologous [Gene or Genome]

Phrase: "(10,"

Phrase: "13,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.171: No known functional differences exist between rodent and human HER2/HER3. 

Phrase: "No known functional differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "exist between rodent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035804:Rodent [Mammal]
   790   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "human HER2/HER3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0812265:HER3 [Gene or Genome]
   812   C1704825:HER3 [Gene or Genome]
Processing 00000000.tx.172: To verify that DNHER3 expression was restricted to the lung, protein samples from a transgenic F1 animal were analyzed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "restricted to the lung,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0443288:Restricted [Functional Concept]
   770   C0819757:LUNG [Tissue]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "protein samples from a transgenic F1 animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.173: Only lung tissue expressed FLAG protein (Fig. 2A). 

Phrase: "Only lung tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0819757:Lung Tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "expressed"

Phrase: "FLAG protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.174: In addition, the FLAG-containing protein had a mass corresponding to the predicted molecular weight of DNHER3, identifying it as DNHER3. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the FLAG-containing protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "a mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]

Phrase: "corresponding to the predicted molecular weight of DNHER3,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0026385:Molecular Weight [Quantitative Concept]
   760   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   739   C0005910:weight [Organism Attribute]
   739   C0043100:Weight [Quantitative Concept]
   739   C0205160:Negative [Qualitative Concept]
   739   C0681842:Predicted [Idea or Concept]
   739   C0812265:HER3 [Gene or Genome]
   739   C1305866:weight [Diagnostic Procedure]
   739   C1513916:Negative [Finding]
   739   C1521991:Molecular [Qualitative Concept]
   739   C1527180:Dominant [Functional Concept]
   739   C1704825:HER3 [Gene or Genome]
   739   C1705104:Weight [Idea or Concept]
   739   C1882327:%{Predicted} [Quantitative Concept]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]

Phrase: "identifying"

Phrase: "it"

Phrase: "as"

Phrase: "DNHER3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
Processing 00000000.tx.175: DNHER3 retained its ability to dimerize with HER2. 

Phrase: "DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "dimerize with HER2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C0376525:Dimerize [Natural Phenomenon or Process]
Processing 00000000.tx.176: Homogenates of total lung proteins were immunoprecipitated with a HER2 antibody and Western blotting performed with a FLAG antibody. 

Phrase: "Homogenates of total lung proteins"

Phrase: "were"

Phrase: "immunoprecipitated with a HER2 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0086418:Human [Human]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "performed with a FLAG antibody."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0884358:Performed [Functional Concept]
   760   C1708067:Flag [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.177: The presence of a positive FLAG-staining protein band indicated that DNHER3 still associated with HER2 (Fig. 2B). 

Phrase: "The presence of a positive FLAG-staining protein band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that DNHER3 still"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0812265:HER3 [Gene or Genome]
   812   C1704825:HER3 [Gene or Genome]

Phrase: "associated with HER2 (Fig. 2B"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0086418:Human [Human]
   753   C0349966:Fig [Food]
   753   C0450354:2b [Intellectual Product]
   753   C1337208:FIG [Food]
   753   C1706096:2B [Research Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.178: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.179: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.180: Characterization of DNHER3 in transgenic mice. 

Phrase: "Characterization of DNHER3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.181: A: Western blot of tissues from F1 offspring of a transgenic male founder. 

Phrase: "A"

Phrase: ":"

Phrase: "Western blot of tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "from F1 offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "of a transgenic male founder."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0263541:Founder [Disease or Syndrome]
Processing 00000000.tx.182: Protein homogenates from diaphragm, heart, liver, kidney, lung, and thymus were subjected to Western blot analysis for FLAG epitope. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "homogenates from diaphragm,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   790   C0042241:DIAPHRAGM [Medical Device]
   790   C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   790   C1705367:Diaphragm [Medical Device]
   706 E C0229992:Mind, NOS [Mental Process]

Phrase: "heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "thymus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040113:Thymus [Body Part, Organ, or Organ Component]
  1000   C1015036:Thymus [Plant]
  1000   C1515430:THYMUS [Tissue]
   944 E C1306748:Thymus gland [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for FLAG epitope."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]
Processing 00000000.tx.183: FLAG immunoreactivity was only detected in lung tissue and was of the predicted molecular mass for DNHER3 (76 kDa). 

Phrase: "FLAG immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "detected in lung tissue"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C0819757:Lung Tissue [Tissue]
           LUNG
   819 E C1547930:Tissue lung [Intellectual Product]
   819 E C1550668:Tissue lung [Body Substance]
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C0442726:Detected [Finding]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1547928:Tissue [Intellectual Product]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "and"

Phrase: "was of the predicted molecular mass"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0577559:Mass [Finding]
   753   C0681842:Predicted [Idea or Concept]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1421478:WAS [Gene or Genome]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "for DNHER3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "(76 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.184: B: lung homogenates from a DNHER3 mouse (lane 1) and a nontransgenic littermate (lane 2) were immunoprecipitated with a HER2 antibody and subjected to Western blot analysis for the FLAG epitope. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "homogenates from a DNHER3 mouse"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0205160:Negative [Qualitative Concept]
   748   C0812265:HER3 [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C1704825:HER3 [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a nontransgenic littermate"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "immunoprecipitated with a HER2 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0086418:Human [Human]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for the FLAG epitope."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]
Processing 00000000.tx.185: The positive FLAG staining protein band in lane 1 indicates dimerization between HER2 receptor and FLAG-expressing DNHER3. 

Phrase: "The positive FLAG staining protein band in lane 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "indicates"

Phrase: "dimerization between HER2 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "FLAG-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708067:Flag [Functional Concept]

Phrase: "expressing"

Phrase: "DNHER3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
Processing 00000000.tx.186: C: freshly dissected lungs from DNHER3 transgenic mice or nontransgenic littermates were incubated in 10 nM NRG-1 for 0, 2, 10, 20, 40, or 60 min and then homogenized in lysis buffer. 

Phrase: "C"

Phrase: ":"

Phrase: "freshly dissected lungs from DNHER3 transgenic mice"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   728   C1518039:Mouse Lung [Tissue]
   708 E C0819757:LUNG [Tissue]
   708 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "nontransgenic littermates"

Phrase: "were"

Phrase: "incubated in 10 nM NRG-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1367656:NEUREGULIN 1 [Gene or Genome]
   753   C0312860:NM [Cell Function]
   753   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 0,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "10,"

Phrase: "20,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "or"

Phrase: "60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "homogenized in lysis buffer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
Processing 00000000.tx.187: Homogenates were subjected to Western blot analysis for pHER2 (n = 3). 

Phrase: "Homogenates"

Phrase: "were"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for pHER2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0242957:HER-2 [Gene or Genome]
   861   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.188: +, Positive FLAG control consisting of cell lysates from COS-7 cells transfected with DNHER3.  

Phrase: "+,"

Phrase: "Positive FLAG control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1883676:Positive Control [Conceptual Entity]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisting of cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C1881488:Cell Lysate [Physical Object]
           Lysate
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "from COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with DNHER3."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   760   C0205160:Negative [Qualitative Concept]
   760   C0812265:HER3 [Gene or Genome]
   760   C1513916:Negative [Finding]
   760   C1527180:Dominant [Functional Concept]
   760   C1704825:HER3 [Gene or Genome]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.189: As a test of DNHER3 function, freshly dissected lung from DNHER3-expressing mice was minced and incubated in NRG-1 (10 nM) to determine the effect on receptor activation. 

Phrase: "As a test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "of DNHER3 function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "freshly dissected lung from DNHER3-expressing mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C1518039:Mouse Lung [Tissue]
   742   C0024109:Lung [Body Part, Organ, or Organ Component]
   742   C0819757:LUNG [Tissue]
   742   C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "minced"

Phrase: "and"

Phrase: "incubated in NRG-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1367656:NEUREGULIN 1 [Gene or Genome]
   770   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(10 nM) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "determine"

Phrase: "the effect on receptor activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.190: After various incubation times, lung tissue was homogenized and subjected to Western blot analysis for pHER2. 

Phrase: "After various incubation times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "lung tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0819757:Lung Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "homogenized"

Phrase: "and"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for pHER2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0242957:HER-2 [Gene or Genome]
   861   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.191: In lung tissue from DNHER3 mice, HER2 was not activated by NRG-1 exposure at any time point studied (Fig. 2C). 

Phrase: "In lung tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0819757:Lung Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "from DNHER3 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "HER2"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activated by NRG-1 exposure"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1367656:NEUREGULIN 1 [Gene or Genome]
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   760   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "at any time point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2348792:Time Point [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.192: However, NRG-1 activated HER2 in lung tissue from nontransgenic F1 littermates (no DNHER3 expression), as evidenced by increased levels of pHER2 [2.07 (SD 0.11) and 1.76-fold (SD 0.13) increase at 10 and 20 min of activation, respectively]. 

Phrase: "However,"

Phrase: "NRG-1 activated HER2 in lung tissue"

Phrase: "from nontransgenic F1 littermates"

Phrase: "("

Phrase: "no DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "evidenced by increased levels of pHER2"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   793   C0393009:Levels of Evidence [Finding]
           evidence level
   757   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   748   C0205217:Increased [Quantitative Concept]
   748   C0242957:HER-2 [Gene or Genome]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "[2.07"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(SD 0.11"

Phrase: ")"

Phrase: "and"

Phrase: "1.76-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 0.13"

Phrase: ")"

Phrase: "increase at 10"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "20 min of activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: "]."
Processing 00000000.tx.193: NRG-1 is produced and HER2 is activated in the lung following bleomycin injury. 

Phrase: "NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "is"

Phrase: "produced"

Phrase: "and"

Phrase: "HER2"

Phrase: "is"

Phrase: "activated in the lung"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0819757:LUNG [Tissue]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.194: Our initial in vivo study defined the kinetics of NRG-1 production and HER2 activation after injury of the normal lung. 

Phrase: "Our initial in vivo study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0681829:in vivo study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "the kinetics of NRG-1 production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "HER2 activation after injury of the normal lung."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]
Processing 00000000.tx.195: To induce acute lung injury, nontransgenic C57BL6/J littermates were injected intratracheally with 0.025 units of bleomycin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "acute lung injury,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0242488:Acute Lung Injury [Injury or Poisoning]
   901   C0273115:Lung Injury [Injury or Poisoning]
   854   C0740766:Acute Pneumonia [Disease or Syndrome]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0205178:acute [Temporal Concept]
   827   C0819757:LUNG [Tissue]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "nontransgenic C57BL6/J littermates"

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intratracheally with 0.025 units of bleomycin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0439148:Units [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.196: Mice were killed at 0, 3, 7, 10, 14, or 21 days postinjection (3 per time point), BALF was collected, and lung tissue was homogenized for protein analysis (day 0 mice were not exposed to bleomycin). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "killed at 0,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0162388:killed [Social Behavior]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "7,"

Phrase: "10,"

Phrase: "14,"

Phrase: "or"

Phrase: "21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "postinjection"

Phrase: "(3 per time point"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C2348792:Time Point [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C0439086:<3 [Quantitative Concept]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "BALF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "lung tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0819757:Lung Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "homogenized for protein analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1514534:Protein Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "(day 0 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exposed to bleomycin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: ")."
Processing 00000000.tx.197: Bleomycin exposure resulted in protein leak, as evidenced by increased BALF protein (Table 1). 

Phrase: "Bleomycin exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "resulted in protein leak,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332234:Leak [Functional Concept]
   770   C1608322:Leak NOS [Finding]
   770   C1881366:LEAK [Phenomenon or Process]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "as"

Phrase: "evidenced by increased BALF protein"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   778   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   778   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   778   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   778   C3641255:Lavage Fluid [Body Substance]
   748   C0005889:FLUID [Body Substance]
   748   C0022100:Lavage [Therapeutic or Preventive Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205217:Increased [Quantitative Concept]
   748   C0302908:fluid [Substance]
   748   C0442805:Increased [Functional Concept]
   748   C0444611:Fluid [Qualitative Concept]
   748   C1546689:Lavage [Intellectual Product]
   748   C1704353:Fluid [Substance]
   714   C0332120:Evidence [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: Nontransgenic mice studied 21 days after bleomycin injury had BALF protein concentrations 23 times higher than uninjured mice (P = 0.001). 

Phrase: "Nontransgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "21 days after bleomycin injury"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "had"

Phrase: "BALF protein concentrations 23 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0040223:times [Temporal Concept]
   795   C1632851:Times [Quantitative Concept]
   762 E C3541383:Time [Temporal Concept]
   724 E C0442043:Temporal [Spatial Concept]
   724 E C2362314:Temporal [Temporal Concept]

Phrase: "higher than uninjured mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "(P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.199: Total white blood cell count increased steadily over time following bleomycin, becoming eightfold higher at 21 days than at day 0 (Table 2). 

Phrase: "Total white blood cell count"
Meta Candidates (Total=32; Excluded=8; Pruned=0; Remaining=24)
  1000   C1271681:Total white blood cell count [Laboratory Procedure]
           Total white blood count
   937   C0023508:Blood Cell Count, White [Laboratory Procedure]
   937   C0427512:white blood cell count [Laboratory or Test Result]
   884   C0005771:Blood Cell Count [Laboratory Procedure]
   884   C0009555:Blood Cell Count [Laboratory Procedure]
   884   C0023516:White blood cell [Cell]
           White Cell
   840   C0005773:Blood cell [Cell]
   840   C0007584:Cell Count [Laboratory Procedure]
   812 E C2328697:Hemal cell [Cell]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0007457:White [Population Group]
   804   C0007634:Cell [Cell]
   804   C0043157:White [Population Group]
   804   C0220938:White [Qualitative Concept]
   804   C0229664:Blood [Body Substance]
   804   C0439175:% total [Quantitative Concept]
   804   C0439810:Total [Qualitative Concept]
   804   C0750480:Count [Activity]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1705566:Count [Quantitative Concept]
   804   C1948049:Cell [Spatial Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "steadily over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "becoming"

Phrase: "eightfold higher at 21 days"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "at day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: Neutrophil recruitment peaked on day 3 postinjury, and lymphocyte recruitment peaked on day 10. 

Phrase: "Neutrophil recruitment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751982:Neutrophil Recruitment [Physiologic Function]
   861   C2949735:Recruitment [Activity]

Phrase: "peaked on day 3 postinjury,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C0444505:peaked [Quantitative Concept]

Phrase: "and"

Phrase: "lymphocyte recruitment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0024264:Lymphocyte [Cell]
   861   C2949735:Recruitment [Activity]

Phrase: "peaked on day 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C0444505:peaked [Quantitative Concept]
Processing 00000000.tx.201: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.202: Protein leak in nontransgenic and DNHER3 mice  View this table: [in this window] [in a new window]  Table 2. 

Phrase: "Protein leak in nontransgenic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332234:Leak [Functional Concept]
   770   C1608322:Leak NOS [Finding]
   770   C1881366:LEAK [Phenomenon or Process]

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.203: Analysis of BALF from bleomycin-treated nontransgenic and DNHER3 mice: cell counts  Bleomycin lung injury induced NRG-1 secretion into BALF. 

Phrase: "Analysis of BALF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from bleomycin-treated nontransgenic"

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "cell counts  Bleomycin lung injury"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0599732:cell injury [Cell or Molecular Dysfunction]
   840   C0273115:Lung Injury [Injury or Poisoning]
   804   C3263722:Injury [Injury or Poisoning]
   804   C3263723:Injury [Injury or Poisoning]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "NRG-1 secretion into BALF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
Processing 00000000.tx.204: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.205: 3A, only trace amounts of NRG-1 were detected in BALF collected from uninjured mice. 

Phrase: "3A,"

Phrase: "only trace amounts of NRG-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0442822:trace amount [Quantitative Concept]
   753   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected in BALF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   806   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   806   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C3641255:Lavage Fluid [Body Substance]
   760   C0005889:FLUID [Body Substance]
   760   C0022100:Lavage [Therapeutic or Preventive Procedure]
   760   C0302908:fluid [Substance]
   760   C0442726:Detected [Finding]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1546689:Lavage [Intellectual Product]
   760   C1704353:Fluid [Substance]

Phrase: "collected from uninjured mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
Processing 00000000.tx.206: Bleomycin injury induced a 7.3-fold (SD 1.61) increase in NRG-1 levels present in BALF by day 3 (P = 0.0009). 

Phrase: "Bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a 7.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 1.61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0019728:SD-1 [Immunologic Factor]

Phrase: ")"

Phrase: "increase in NRG-1 levels"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1367656:NEUREGULIN 1 [Gene or Genome]
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "present in BALF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   806   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   806   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C3641255:Lavage Fluid [Body Substance]
   760   C0005889:FLUID [Body Substance]
   760   C0022100:Lavage [Therapeutic or Preventive Procedure]
   760   C0150312:Present [Quantitative Concept]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1546689:Lavage [Intellectual Product]
   760   C1704353:Fluid [Substance]

Phrase: "by day 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(P = 0.0009"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.207: This increase was sustained even 21 days postinjury with NRG-1 concentration 9.6-fold (SD 0.21) higher (P = 0.001). 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "even 21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "postinjury with NRG-1 concentration 9.6-fold"

Phrase: "(SD 0.21"

Phrase: ")"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "(P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.208: View larger version (29K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.210: NRG-1 secretion and HER2 receptor activation after injury. 

Phrase: "NRG-1 secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "HER2 receptor activation after injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]
Processing 00000000.tx.211: A: bronchoalveolar lavage fluid (BALF) from nontransgenic littermates (top) and DNHER3 mice (bottom) collected 0, 3, 7, 10, 14, or 21 days following bleomycin instillation was subjected to Western blot analysis for NRG-1. 

Phrase: "A"

Phrase: ":"

Phrase: "bronchoalveolar lavage fluid"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "(BALF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: ")"

Phrase: "from nontransgenic littermates"

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "0,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "7,"

Phrase: "10,"

Phrase: "14,"

Phrase: "or"

Phrase: "21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin instillation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0184959:Instillation [Health Care Activity]
   861   C1720298:Instillation [Functional Concept]

Phrase: "was"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for NRG-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
Processing 00000000.tx.212: Blots shown are representative of 3 experiments. 

Phrase: "Blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of 3 experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.213: B: lungs taken from bleomycin-injured nontransgenic littermates and DNHER3 mice were homogenized in lysis buffer containing protease inhibitors and subjected to Western blot analysis for HER2 activation, as defined by tyrosine pHER2. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "taken from bleomycin-injured nontransgenic littermates"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   753   C0332664:Injured [Functional Concept]
   753   C1883727:Taken [Conceptual Entity]
   719 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "homogenized in lysis buffer containing protease inhibitors"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332256:Containing [Functional Concept]
   748   C1536403:lysis [Cell Function]
   748   C1947941:Protease [Enzyme]
   748   C2700400:Containing [Activity]
   745 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for HER2 activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "as"

Phrase: "defined by tyrosine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "pHER2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0242957:HER-2 [Gene or Genome]
   861   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.214: Lung proteins were also analyzed for total HER2 and HER3 to verify stability of total receptor mass. 

Phrase: "Lung proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "also"

Phrase: "analyzed for total HER2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "HER3 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812265:HER3 [Gene or Genome]
   861   C1704825:HER3 [Gene or Genome]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "stability of total receptor mass."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.215: Blots are representative of 3 experiments.  

Phrase: "Blots"

Phrase: "are"

Phrase: "representative of 3 experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.216: Bleomycin lung injury also resulted in HER2 activation (Fig. 3B, left). 

Phrase: "Bleomycin lung injury also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0273115:Lung Injury [Injury or Poisoning]
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]

Phrase: "resulted in HER2 activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086418:Human [Human]
   760   C1879547:Activation [Activity]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.217: Low levels of pHER2 were detected in lungs not exposed to bleomycin (day 0). 

Phrase: "Low levels of pHER2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected in lungs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C0819757:LUNG [Tissue]
   756 E C1278908:Lung [Body Part, Organ, or Organ Component]
   718 E C2707265:Pulmonary [Clinical Attribute]
   718 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exposed to bleomycin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.218: Bleomycin injection produced a 1.3-fold (SD 0.28) increase in HER2 phosphorylation at 3 days postinstillation (P = 0.03). 

Phrase: "Bleomycin injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "produced"

Phrase: "a 1.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 0.28"

Phrase: ")"

Phrase: "increase in HER2 phosphorylation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0086418:Human [Human]
   760   C0442805:Increase [Functional Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "at 3 days postinstillation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1442459:3 Days [Temporal Concept]

Phrase: "(P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.219: HER2 activation continued to increase, with maximum activation at day 10, 2.4 (SD 0.78) times higher than at day 0 (P = 0.01). 

Phrase: "HER2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "with maximum activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "at day 10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "2.4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(SD 0.78"

Phrase: ")"

Phrase: "times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "at day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.220: Receptor activation decreased thereafter, but remained greater than baseline. 

Phrase: "Receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "thereafter,"

Phrase: "but"

Phrase: "remained"

Phrase: "greater than baseline."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.221: Total receptor mass, as defined by levels of HER2 and its dimerization partner HER3, increased slightly on day 3 [40% (SD 15)], but then was unchanged throughout the course of bleomycin exposure. 

Phrase: "Total receptor mass,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "as"

Phrase: "defined by levels of HER2"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0086418:Human [Human]
   753   C0441889:Levels [Qualitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its dimerization partner HER3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0812265:HER3 [Gene or Genome]
   827   C1704825:HER3 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "slightly on day 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C0750482:Slightly [Idea or Concept]

Phrase: "[40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "(SD 15"

Phrase: ")"

Phrase: "],"

Phrase: "but"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "was"

Phrase: "unchanged throughout the course of bleomycin exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0442739:Unchanged [Finding]
   748   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.222: Injury induces NRG-1 production but not HER2 activation in DNHER3 mouse lungs. 

Phrase: "Injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "NRG-1 production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033268:production [Occupational Activity]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "but"

Phrase: "not HER2 activation in DNHER3 mouse lungs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]
Processing 00000000.tx.223: The response of DNHER3 transgenic mice to bleomycin injury was studied next. 

Phrase: "The response of DNHER3 transgenic mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "to bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "next."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]
Processing 00000000.tx.224: We first examined the production of NRG-1 by DNHER3 mice to ensure that any changes in response to injury were due to the presence of DNHER3 and not confounded by alterations in ligand production. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the production of NRG-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "by DNHER3 mice to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "any"

Phrase: "changes in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1705241:Change [Quantitative Concept]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "were due to the presence of DNHER3"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0678226:Due to [Functional Concept]
           due
   764   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   742   C0205160:Negative [Qualitative Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0812265:HER3 [Gene or Genome]
   742   C1513916:Negative [Finding]
   742   C1527180:Dominant [Functional Concept]
   742   C1704825:HER3 [Gene or Genome]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confounded by alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1515926:Alteration [Idea or Concept]

Phrase: "in ligand production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.225: As observed in wild-type mice, bleomycin lung injury resulted in an increase in soluble protein detected in BALF [Table 1; 29-fold (SD 9) at 21 days; P = 0.01], and an influx of white blood cells into BALF [Table 2; 5.1-fold (SD 0.8) increase at 21 days]. 

Phrase: "As"

Phrase: "observed in wild-type mice,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "bleomycin lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0273115:Lung Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "resulted in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in soluble protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected in BALF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   806   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   806   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   806   C3641255:Lavage Fluid [Body Substance]
   760   C0005889:FLUID [Body Substance]
   760   C0022100:Lavage [Therapeutic or Preventive Procedure]
   760   C0302908:fluid [Substance]
   760   C0442726:Detected [Finding]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1546689:Lavage [Intellectual Product]
   760   C1704353:Fluid [Substance]

Phrase: "[Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "; 29-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 9"

Phrase: ")"

Phrase: "at 21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "; P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "],"

Phrase: "and"

Phrase: "an influx of white blood cells"

Phrase: "into BALF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "[Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "; 5.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 0.8"

Phrase: ")"

Phrase: "increase at 21 days"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C0442805:Increase [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.226: These changes over time paralleled those observed in nontransgenic littermate mice and indicated that the level of injury induced by bleomycin was similar in wild-type and DNHER3 mice. 

Phrase: "These changes over time"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "paralleled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2348042:Parallel [Qualitative Concept]
   966   C2826345:PARALLEL [Research Activity]

Phrase: "those"

Phrase: "observed in nontransgenic littermate mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the level of injury"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "induced by bleomycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "similar in wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "DNHER3 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.227: NRG-1 in BALF also increased in response to bleomycin treatment, with NRG-1 levels 11-fold (SD 4.1) higher than baseline at 10 days postinjection (Fig. 3A), similar to the response in nontransgenic littermates. 

Phrase: "NRG-1 in BALF also"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   778   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   778   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   778   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1367656:NEUREGULIN 1 [Gene or Genome]
   778   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   778   C3641255:Lavage Fluid [Body Substance]
   748   C0005889:FLUID [Body Substance]
   748   C0022100:Lavage [Therapeutic or Preventive Procedure]
   748   C0302908:fluid [Substance]
   748   C0444611:Fluid [Qualitative Concept]
   748   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   748   C1546689:Lavage [Intellectual Product]
   748   C1704353:Fluid [Substance]

Phrase: "increased in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to bleomycin treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "with NRG-1 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "11-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 4.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0019728:SD-1 [Immunologic Factor]

Phrase: ")"

Phrase: "higher than baseline"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "at 10 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547061:10 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "postinjection"

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: ","

Phrase: "similar to the response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in nontransgenic littermates."
Processing 00000000.tx.228: Low-level basal phosphorylation of HER2 was present, similar to levels seen in nontransgenic littermate animals. 

Phrase: "Low-level basal phosphorylation of HER2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "present, similar to levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "seen in nontransgenic littermate animals."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0003062:Animals [Animal]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.229: However, bleomycin injury did not induce receptor activation at any time point examined (Fig. 3B, right). 

Phrase: "However,"

Phrase: "bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "receptor activation at any time point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.230: Therefore, expression of DNHER3 effectively blocked in vivo signaling through the HER2/HER3 receptor complex. 

Phrase: "Therefore,"

Phrase: "expression of DNHER3 effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "in vivo signaling through the HER2/HER3 receptor complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1514762:Receptor Signaling [Molecular Function]
   739   C0037083:Signaling [Cell Function]
   739   C3537152:signaling [Biologic Function]
Processing 00000000.tx.231: DNHER3 expression prevents injury-induced inflammation and collagen deposition. 

Phrase: "DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "injury-induced inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "collagen deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.232: Over time, bleomycin-induced lung injury produces fibrosis (9, 11, 29). 

Phrase: "Over time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "bleomycin-induced lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0273115:Lung Injury [Injury or Poisoning]
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]

Phrase: "produces"

Phrase: "fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "(9,"

Phrase: "11,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.233: To determine the role of HER2 receptor activation in the fibrotic response, lungs from bleomycin-injured nontransgenic littermate and DNHER3 transgenic mice were used to determine collagen content and fixed for histological examination. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of HER2 receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the fibrotic response,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "lungs from bleomycin-injured nontransgenic littermate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   719 E C0819757:LUNG [Tissue]
   719 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "DNHER3 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "collagen content"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1167364:collagen [Cell Component]
   789 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "fixed for histological examination."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0019637:histologic examination [Laboratory Procedure]
   770   C0205462:Histological [Functional Concept]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]
Processing 00000000.tx.234: Figure 4 displays representative H&E stains of lung sections from nontransgenic littermates and transgenic DNHER3 mice killed at 0, 10, or 21 days postbleomycin injury. 

Phrase: "Figure 4"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "representative H&E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   812   C1882932:Representative [Activity]

Phrase: "stains of lung sections"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0024109:Lung [Body Part, Organ, or Organ Component]
   770   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   770   C0819757:LUNG [Tissue]
   770   C1278908:Lung [Body Part, Organ, or Organ Component]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]
   715 E C2707265:Pulmonary [Clinical Attribute]
   715 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "from nontransgenic littermates"

Phrase: "and"

Phrase: "transgenic DNHER3 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0025936:Mice, Transgenic [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "killed at 0,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0162388:killed [Social Behavior]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "10,"

Phrase: "or"

Phrase: "21 days postbleomycin injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.235: Lungs from both littermate controls and DNHER3 mice showed no cellular infiltration or morphological abnormalities before bleomycin exposure. 

Phrase: "Lungs from both littermate controls"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   726 E C0819757:LUNG [Tissue]
   726 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no cellular infiltration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1516369:Cellular Infiltration [Cell Function]
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "or"

Phrase: "morphological abnormalities before bleomycin exposure."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   739   C0332447:Morphologic abnormality, NOS [Anatomical Abnormality]
   726 E C1704258:Abnormality [Finding]
Processing 00000000.tx.236: By 10 days following bleomycin injury, nontransgenic lungs had significant inflammatory cell and fibroblast infiltration into alveolar spaces. 

Phrase: "By 10 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547061:10 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "nontransgenic lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   827 E C0819757:LUNG [Tissue]
   827 E C1278908:Lung [Body Part, Organ, or Organ Component]
   789 E C2707265:Pulmonary [Clinical Attribute]
   789 E C2709248:Pulmonary [Qualitative Concept]
   761 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "had"

Phrase: "significant inflammatory cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0440752:Inflammatory cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0333348:Inflammatory [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "fibroblast infiltration into alveolar spaces."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332448:Infiltration [Pathologic Function]
   760   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   760   C1523986:Infiltration [Functional Concept]
Processing 00000000.tx.237: By 21 days, the vast majority of alveolar space was taken up by the cellular infiltrate. 

Phrase: "By 21 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "the vast majority of alveolar space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "was"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by the cellular infiltrate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1692321:Cellular infiltrate [Pathologic Function]
   861   C0332448:Infiltrate [Pathologic Function]
   861   C1546677:Infiltrate [Intellectual Product]
   861   C1549537:Infiltrate [Functional Concept]
Processing 00000000.tx.238: Epithelia and air space volume density decreased in response to bleomycin injury (Table 3; P = 0.048 and P = 0.0018, respectively), while mesenchyme volume density increased dramatically (P = 0.0001). 

Phrase: "Epithelia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0014609:Epithelium [Tissue]
   916 E C0221908:Epithelial [Qualitative Concept]

Phrase: "and"

Phrase: "air space volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0178587:density [Quantitative Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "decreased in response"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "to bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "; P = 0.048"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P = 0.0018,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "mesenchyme volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0178587:density [Quantitative Concept]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "dramatically"

Phrase: "(P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.239: View larger version (93K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(93K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.240: 4. 

Phrase: "4."
Processing 00000000.tx.241: Hematoxylin and eosin staining of bleomycin-injured lungs. 

Phrase: "Hematoxylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "eosin staining of bleomycin-injured lungs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
Processing 00000000.tx.242: Lungs from wild-type and DNHER3 mice were fixed at 10 cmH2O with 10% formalin at 0, 10, or 21 days post-bleomycin injury. 

Phrase: "Lungs from wild-type"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   737 E C0819757:LUNG [Tissue]
   737 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fixed at 10 cmH2O"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0231441:Fixed [Finding]
   770   C0439476:cmH2O [Quantitative Concept]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "with 10% formalin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
  1000   C1561470:10% Formalin [Intellectual Product]
   861   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "at 0,"

Phrase: "10,"

Phrase: "or"

Phrase: "21 days post-bleomycin injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3263722:Injury [Injury or Poisoning]
   804   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.243: Tissues were embedded in paraffin, sectioned, and stained with hematoxylin and eosin. 

Phrase: "Tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "embedded in paraffin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: ","

Phrase: "and"

Phrase: "stained with hematoxylin and eosin."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.244: Stained sections from wild-type mice are shown in the top panels, and sections from DNHER3 mice are shown in the bottom panels.  

Phrase: "Stained sections from wild-type mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "are"

Phrase: "shown in the top panels,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441833:Panel [Idea or Concept]
   760   C1704458:Top [Spatial Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]
   726   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "sections from DNHER3 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "are"

Phrase: "shown in the bottom panels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Panel [Idea or Concept]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.245: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.246: Volume density in nontransgenic and DNHER3 mice  DNHER3-expressing mouse lungs showed a very different response to injury. 

Phrase: "Volume density in nontransgenic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0178587:density [Quantitative Concept]
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "DNHER3 mice  DNHER3-expressing mouse lungs"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   824   C1518039:Mouse Lung [Tissue]
   790   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   756 E C0819757:LUNG [Tissue]
   756 E C1278908:Lung [Body Part, Organ, or Organ Component]
   718 E C2707265:Pulmonary [Clinical Attribute]
   718 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a very different response to injury."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.247: The cellular infiltration was markedly reduced at both 10 and 21 days postbleomycin injury compared with wild-type mice, with large areas of normal-appearing lung present at 21 days (Fig. 4). 

Phrase: "The cellular infiltration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1516369:Cellular Infiltration [Cell Function]
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced at both 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "21 days postbleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]

Phrase: "compared with wild-type mice,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "with large areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "of normal-appearing lung present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0150312:Present [Quantitative Concept]
   812   C0449450:Present [Idea or Concept]

Phrase: "at 21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.248: Epithelia volume density was decreased, but not significantly, while air space volume density decreased (P = 0.015) and mesenchyme volume density increased (P < 0.01; Table 3). 

Phrase: "Epithelia volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0178587:density [Quantitative Concept]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "not significantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "while"

Phrase: "air space volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0178587:density [Quantitative Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P = 0.015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "mesenchyme volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0178587:density [Quantitative Concept]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.249: However, at 21 days postbleomycin injury, mesenchymal cell expansion was less in DNHER3 than in nontransgenic littermate control mice: 35.2 (SD 2.90) vs. 

Phrase: "However,"

Phrase: "at 21 days postbleomycin injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]

Phrase: "mesenchymal cell expansion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007595:cell expansion [Cell Function]
   734   C1257975:Mesenchymal cell [Cell]

Phrase: "was"

Phrase: "less in DNHER3"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   760   C0205160:Negative [Qualitative Concept]
   760   C0439092:less [Intellectual Product]
   760   C0547044:Less [Qualitative Concept]
   760   C0812265:HER3 [Gene or Genome]
   760   C1513916:Negative [Finding]
   760   C1527180:Dominant [Functional Concept]
   760   C1704825:HER3 [Gene or Genome]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "than"

Phrase: "in nontransgenic littermate control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "35.2"

Phrase: "(SD 2.90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0019737:SD-2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439083:>90 [Quantitative Concept]
   827   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "vs."
Processing 00000000.tx.250: 61.6% (SD 0.21) (P = 0.01). 

Phrase: "61.6%"

Phrase: "(SD 0.21"

Phrase: ")"

Phrase: "(P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.251: In addition, air space volume density decreased to a lesser extent in DNHER3 mice than in wild type: 47.1 (SD 0.42) vs. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "air space volume density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0178587:density [Quantitative Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "decreased to a lesser extent"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0547044:Lesser [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "in DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "than"

Phrase: "in wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "47.1"

Phrase: "(SD 0.42"

Phrase: ")"

Phrase: "vs."
Processing 00000000.tx.252: 23.0% (SD 2.55) (P = 0.004). 

Phrase: "23.0%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "(SD 2.55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0019737:SD-2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "(P = 0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.253: Lungs from nontransgenic littermate and DNHER3 transgenic mice were next homogenized and assayed for total collagen content (Fig. 5). 

Phrase: "Lungs from nontransgenic littermate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   737 E C0819757:LUNG [Tissue]
   737 E C1278908:Lung [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "DNHER3 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "homogenized"

Phrase: "and"

Phrase: "assayed for total collagen content"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0423896:Content [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1167364:collagen [Cell Component]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.254: In nontransgenic mice, lung collagen content rose over the entire 21-day study period to 148.03 g/mg lung protein (SD 38.71). 

Phrase: "In nontransgenic mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lung collagen content rose over the entire 21-day study period"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035853:Rose [Plant]
   738   C0995005:ROSE [Pharmacologic Substance]

Phrase: "to 148.03 g/mg lung protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SD 38.71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.255: In DNHER3 mice, lung collagen content was the same as in control mice at day 10. 

Phrase: "In DNHER3 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "lung collagen content"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as in control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "at day 10."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.256: However, 21 days after bleomycin injury, DNHER3 lung collagen was 72.47 g/mg lung protein (SD 20.42), one-half that of wild-type mice (P = 0.04). 

Phrase: "However,"

Phrase: "21 days after bleomycin injury,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "DNHER3 lung collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   804   C1167364:collagen [Cell Component]
   733 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "72.47 g/mg lung protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SD 20.42"

Phrase: ")"

Phrase: ","

Phrase: "one-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "that of wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(P = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.257: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.258: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.259: Collagen deposition is decreased in DNHER3 mice. 

Phrase: "Collagen deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "is"

Phrase: "decreased in DNHER3 mice."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205160:Negative [Qualitative Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1704825:HER3 [Gene or Genome]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.260: Total collagen formation is shown in lungs from nontransgenic littermates and DNHER3 mice killed at 10 or 21 days following bleomycin injection. 

Phrase: "Total collagen formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2246343:collagen formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "shown in lungs"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   756 E C0819757:LUNG [Tissue]
   756 E C1278908:Lung [Body Part, Organ, or Organ Component]
   756   C1547282:Show [Intellectual Product]
   718 E C2707265:Pulmonary [Clinical Attribute]
   718 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "from nontransgenic littermates"

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "killed at 10"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0162388:killed [Social Behavior]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "or"

Phrase: "21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.261: Values are means (SD); 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "(SD"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.262: n = 3 for each group. 

Phrase: "n = 3 for each group."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0441848:Group N [Intellectual Product]
   797   C0441869:Group 3 [Intellectual Product]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441833:Group [Idea or Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1553036:[n] [Quantitative Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.263: *P = 0.04.  

Phrase: "*P = 0.04."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.264: Injury-induced TGF-1 production is ablated in DNHER3 transgenic mice. 

Phrase: "Injury-induced TGF-1 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "ablated in DNHER3 transgenic mice."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0025936:Mice, Transgenic [Mammal]
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205160:Negative [Qualitative Concept]
   748   C0812265:HER3 [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C1704825:HER3 [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.265: We hypothesized that HER2 signaling during injury regulated profibrotic cascades. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that HER2 signaling during injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "profibrotic cascades."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.266: Therefore, loss of signaling in the DNHER3 strain would explain the decrease in fibrosis. 

Phrase: "Therefore,"

Phrase: "loss of signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "in the DNHER3 strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0080194:Strain [Injury or Poisoning]
   812   C0456178:strain [Intellectual Product]
   812   C1518614:Strain [Organism]
   812   C2987481:Strain [Mental Process]

Phrase: "would"

Phrase: "explain"

Phrase: "the decrease in fibrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.267: Principal among fibrotic mediators is TGF-1 (9, 11, 30). 

Phrase: "Principal among fibrotic mediators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205225:Principal [Qualitative Concept]
   770   C0401925:Principal [Professional or Occupational Group]

Phrase: "is"

Phrase: "TGF-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "(9,"

Phrase: "11,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.268: To determine whether the loss of HER2 signaling affected the TGF-1 response, BALF from DNHER3 transgenic mice and nontransgenic littermates was assayed for total TGF-1 content using a luciferase reporter gene bioassay (Fig. 6A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the loss of HER2 signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the TGF-1 response,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "BALF from DNHER3 transgenic mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   764   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   764   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   764   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   764   C3641255:Lavage Fluid [Body Substance]
   745   C1521806:Mouse Fluid [Tissue]
   742   C0005889:FLUID [Body Substance]
   742   C0022100:Lavage [Therapeutic or Preventive Procedure]
   742   C0302908:fluid [Substance]
   742   C0444611:Fluid [Qualitative Concept]
   742   C1546689:Lavage [Intellectual Product]
   742   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "nontransgenic littermates"

Phrase: "was"

Phrase: "assayed for total TGF-1 content"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0423896:Content [Mental Process]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0456205:Content [Conceptual Entity]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a luciferase reporter gene bioassay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Bioassay [Laboratory Procedure]
   812   C1704780:Bioassay [Conceptual Entity]
   708   C1334435:Luciferase Gene [Gene or Genome]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.269: In nontransgenic mice, bleomycin injury induced TGF-1 in BALF. 

Phrase: "In nontransgenic mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "TGF-1 in BALF."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   800   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   770   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C3641255:Lavage Fluid [Body Substance]
   744   C0005889:FLUID [Body Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0022100:Lavage [Therapeutic or Preventive Procedure]
   744   C0220844:growth [Physiologic Function]
   744   C0302908:fluid [Substance]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1546689:Lavage [Intellectual Product]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704353:Fluid [Substance]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
Processing 00000000.tx.270: Ten days after bleomycin instillation, TGF-1 level was 2.8-fold (SD 0.61) higher than that of uninjured mice [2.47 (SD 0.31) and 0.89 ng/ml (SD 0.13), respectively; P = 0.001], and, by 21 days, TGF-1 was 2.5-fold (SD 0.25) higher [2.21 ng/ml (SD 0.13); P = 0.001 compared with uninjured mice]. 

Phrase: "Ten days after bleomycin instillation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1710369:TEN-DAY [Intellectual Product]
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "TGF-1 level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "2.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SD 0.61"

Phrase: ")"

Phrase: "higher than that of uninjured mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "[2.47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(SD 0.31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0141793:SD 31 [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "0.89 ng/ml (SD 0.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0439275:ng/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: "; P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "],"

Phrase: "and"

Phrase: ","

Phrase: "by 21 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "TGF-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "2.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "(SD 0.25"

Phrase: ")"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "[2.21 ng/ml (SD 0.13"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0439275:ng/mL [Quantitative Concept]
   818   C1412940:2-21 [Gene or Genome]
   795   C0439526:/mL [Quantitative Concept]
   795   C0740116:+2 [Quantitative Concept]
   795   C2827735:2+ [Quantitative Concept]
   795   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "; P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with uninjured mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1707455:Compared [Activity]

Phrase: "]."
Processing 00000000.tx.271: DNHER3 mice showed a very different response. 

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a very different response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.272: Injury did not increase TGF-1 in BALF. 

Phrase: "Injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "TGF-1 in BALF."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   800   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   770   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C3641255:Lavage Fluid [Body Substance]
   744   C0005889:FLUID [Body Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0022100:Lavage [Therapeutic or Preventive Procedure]
   744   C0220844:growth [Physiologic Function]
   744   C0302908:fluid [Substance]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1546689:Lavage [Intellectual Product]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704353:Fluid [Substance]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
Processing 00000000.tx.273: Although absolute levels of TGF-1 were higher at day 0 in DNHER3 mice than in nontransgenic littermate controls [2.93 (SD 0.35) and 0.89 ng/ml (SD 0.13), respectively], they did not increase with injury. 

Phrase: "Although"

Phrase: "absolute levels of TGF-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher at day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "than"

Phrase: "in nontransgenic littermate controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "[2.93"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(SD 0.35"

Phrase: ")"

Phrase: "and"

Phrase: "0.89 ng/ml (SD 0.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0439275:ng/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: "],"

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase with injury."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   790   C0442805:Increase [Functional Concept]
   790   C3263722:Injury [Injury or Poisoning]
   790   C3263723:Injury [Injury or Poisoning]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.274: The level of TGF-1 in BALF from DNHER3 mice 21 days after bleomycin injection was the same as on day 0. 

Phrase: "The level of TGF-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in BALF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "from DNHER3 mice 21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0439228:days [Temporal Concept]
   766 E C0332173:/day [Temporal Concept]
   766 E C0439505:/day [Temporal Concept]

Phrase: "after bleomycin injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "the same as on day 0."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1278655:SAME AS [Classification]
   804   C0332173:/day [Temporal Concept]
   804   C0439228:day [Temporal Concept]
   804   C0439505:/day [Temporal Concept]
   804   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.275: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.276: 6. 

Phrase: "6."
Processing 00000000.tx.277: Transforming growth factor (TGF)-1 induction does not occur in DNHER3 mice while TGF- receptor levels are unchanged. 

Phrase: "Transforming growth factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(TGF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ")-"

Phrase: "1 induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur in DNHER3 mice"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205160:Negative [Qualitative Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1704825:HER3 [Gene or Genome]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "while"

Phrase: "TGF- receptor levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0441889:Levels [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.278: A: BALF collected from nontransgenic littermates and DNHER3 mice 0, 10, or 21 days following bleomycin injury was analyzed for total TGF-1 content by luciferase reporter gene assay. 

Phrase: "A"

Phrase: ":"

Phrase: "BALF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   901   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   901   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   901   C3641255:Lavage Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0022100:Lavage [Therapeutic or Preventive Procedure]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1546689:Lavage [Intellectual Product]
   827   C1704353:Fluid [Substance]

Phrase: "collected from nontransgenic littermates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "DNHER3 mice 0,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0205160:Negative [Qualitative Concept]
   804   C0812265:HER3 [Gene or Genome]
   804   C1513916:Negative [Finding]
   804   C1527180:Dominant [Functional Concept]
   804   C1704825:HER3 [Gene or Genome]
   804   C2825415:Negative [Conceptual Entity]
   804   C2825491:Negative [Qualitative Concept]

Phrase: "10,"

Phrase: "or"

Phrase: "21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was"

Phrase: "analyzed for total TGF-1 content"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0423896:Content [Mental Process]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0456205:Content [Conceptual Entity]
   744   C0936012:Analyzed [Research Activity]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "by luciferase reporter gene assay."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   875   C1334435:Luciferase Gene [Gene or Genome]
   861   C0206414:Reporter Gene [Gene or Genome]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0017337:Gene [Gene or Genome]
   812   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C0335038:Reporter [Professional or Occupational Group]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   812   C1705915:Reporter [Conceptual Entity]
   812   C1709908:Reporter [Group]
Processing 00000000.tx.279: Values are means (SD). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "(SD"

Phrase: ")."
Processing 00000000.tx.280: *P = 0.001 compared with day 0 value. 

Phrase: "*P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with day 0 value."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C1522609:Value [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.281: B: lung homogenates from nontransgenic littermates and DNHER3 mice collected 0, 10, or 21 days following bleomycin injury were subjected to Western blot analysis for TGF- receptors I and II. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "homogenates from nontransgenic littermates"

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "0,"

Phrase: "10,"

Phrase: "or"

Phrase: "21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "were"

Phrase: "subjected to Western blot analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "for TGF- receptors I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "II."
Processing 00000000.tx.282: Blots are representative of 2 experiments.  

Phrase: "Blots"

Phrase: "are"

Phrase: "representative of 2 experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.283: Lung homogenates from nontransgenic littermate and DNHER3 mice were analyzed for TGF- receptor levels by Western blotting to determine whether the lack of response to TGF-1 in DNHER3 animals was due to changes in TGF- receptor expression. 

Phrase: "Lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "homogenates from nontransgenic littermate"

Phrase: "and"

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "analyzed for TGF- receptor levels"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0441889:Levels [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0936012:Analyzed [Research Activity]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "by Western blotting to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the lack of response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "to TGF-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "in DNHER3 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "was due to changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1421478:WAS [Gene or Genome]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in TGF- receptor expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.284: Figure 6B shows that TGF- receptor I and II levels were the same in nontransgenic littermate and DNHER3 mice before injury (day 0). 

Phrase: "Figure 6B"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that TGF- receptor I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "II levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0441926:ii level [Intellectual Product]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "the same in nontransgenic littermate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445247:Same [Qualitative Concept]

Phrase: "and"

Phrase: "DNHER3 mice before injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "(day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.285: Following injury, no differences were observed between groups in either TGF- receptor. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "no differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed between groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1441672:Observed [Functional Concept]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "in either TGF- receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.286: DNHER3 expression improves survival following lung injury. 

Phrase: "DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "improves"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.287: With decreased fibrosis, we postulated that DNHER3 expression may also decrease mortality following severe lung injury. 

Phrase: "With decreased fibrosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016059:Fibrosis [Pathologic Function]
   789 E C0334129:Fibrotic [Functional Concept]

Phrase: "we"

Phrase: "postulated"

Phrase: "that DNHER3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "also"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "severe lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0273115:Lung Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.288: To test this hypothesis, we induced lung injury with a threefold higher level of bleomycin (0.08 units). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "lung injury with a threefold higher level of bleomycin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0273115:Injury of lung [Injury or Poisoning]
           Lung Injury
   742   C3263722:Injury [Injury or Poisoning]
   742   C3263723:Injury [Injury or Poisoning]

Phrase: "(0.08 units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.289: Nontransgenic littermate mice began to die as soon as 8 days postinjection (Fig. 7) with 50% mortality at 14 days and 80% at 29 days. 

Phrase: "Nontransgenic littermate mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "die as soon"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   734   C0011065:Expired [Organism Function]
   734   C0231800:Expired [Organ or Tissue Function]
   734   C1704631:Expire [Idea or Concept]
   706 E C0184532:dying [Organism Function]
   706 E C1546956:Died [Finding]
   706 E C1553404:terminated [Idea or Concept]
   706 E C2348570:Terminated [Functional Concept]

Phrase: "as 8 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "postinjection"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "with 50% mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026565:Mortality [Quantitative Concept]
   861   C0026566:mortality [Quantitative Concept]

Phrase: "at 14 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "80% at 29 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.290: In contrast, 50% mortality was not reached in DNHER3-expressing mice, and no animal died before 10 days. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "50% mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026565:Mortality [Quantitative Concept]
   861   C0026566:mortality [Quantitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reached in DNHER3-expressing mice,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205160:Negative [Qualitative Concept]
   748   C0812265:HER3 [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C1704825:HER3 [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   714   C2584321:Reach [Organism Function]

Phrase: "and"

Phrase: "no animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "died before 10 days."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C1547061:10 days [Temporal Concept]
   770   C0011065:Died [Organism Function]
   770   C0439228:days [Temporal Concept]
   770   C1546956:Died [Finding]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.291: In the DNHER3 strain, bleomycin lung injury resulted in 35% mortality, whereas 65% of the mice survived to 30 days. 

Phrase: "In the DNHER3 strain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0080194:Strain [Injury or Poisoning]
   812   C0456178:strain [Intellectual Product]
   812   C1518614:Strain [Organism]
   812   C2987481:Strain [Mental Process]

Phrase: "bleomycin lung injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0273115:Lung Injury [Injury or Poisoning]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "resulted in 35% mortality,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "whereas"

Phrase: "65% of the mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0450385:65 [Intellectual Product]

Phrase: "survived to 30 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   737   C0310255:SURVIVE [Pharmacologic Substance]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.292: Thus survival following bleomycin injection was significantly improved in DNHER3 mice compared with wild-type mice (P = 0.04). 

Phrase: "Thus survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "improved in DNHER3 mice"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0184511:Improved [Qualitative Concept]
   753   C0205160:Negative [Qualitative Concept]
   753   C0332272:Improved [Qualitative Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1561611:Improved [Intellectual Product]
   753   C1704825:HER3 [Gene or Genome]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "compared with wild-type mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(P = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.293: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.294: 7. 

Phrase: "7."
Processing 00000000.tx.295: Inhibition of HER2/HER3 receptor function improves survival following lung injury. 

Phrase: "Inhibition of HER2/HER3 receptor function"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   774   C1514761:Receptor Inhibition [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "improves"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.296: Lung injury in nontransgenic littermates and DNHER3-expressing mice (n = 17 each) was induced with 0.08 units of bleomycin and monitored for survival. 

Phrase: "Lung injury in nontransgenic littermates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0273115:Lung Injury [Injury or Poisoning]
   760   C3263722:Injury [Injury or Poisoning]
   760   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "DNHER3-expressing mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(n = 17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: "was"

Phrase: "induced with 0.08 units of bleomycin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0205263:Induced [Functional Concept]
   748   C0439148:Units [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: "and"

Phrase: "monitored for survival."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0038952:Survival [Activity]
   790   C0220921:survival [Functional Concept]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.297: Data are expressed as a Kaplan-Meier plot. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as a Kaplan-Meier plot."
Processing 00000000.tx.298: *P = 0.04 for the comparison of DNHER3 to nontransgenic littermates.   

Phrase: "*P = 0.04 for the comparison of DNHER3"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   739   C0205160:Negative [Qualitative Concept]
   739   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0812265:HER3 [Gene or Genome]
   739   C1513916:Negative [Finding]
   739   C1527180:Dominant [Functional Concept]
   739   C1704825:HER3 [Gene or Genome]
   739   C1707455:Comparison [Activity]
   739   C2603361:P' [Clinical Attribute]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]

Phrase: "to nontransgenic littermates."
Processing 00000000.tx.299: DISCUSSION TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  The present study examined our hypothesis that signaling through the HER2/HER3 receptor complex is important in the recovery of the lung from injury. 

Phrase: "DISCUSSION TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that signaling through the HER2/HER3 receptor complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1514762:Receptor Signaling [Molecular Function]
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "important in the recovery of the lung"

Phrase: "from injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.300: Using a bleomycin model of injury, NRG-1 production and HER2 receptor activation were increased in the lungs of C57BL/6J nontransgenic littermate mice. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a bleomycin model of injury,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "NRG-1 production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033268:production [Occupational Activity]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "HER2 receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514758:Receptor Activation [Cell Function]
   812   C1879547:Activation [Activity]

Phrase: "were"

Phrase: "increased in the lungs of C57BL/6J nontransgenic littermate mice."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   757   C0025921:Mice, C57BL [Mammal]
           C57BL
   739   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0205217:Increased [Quantitative Concept]
   739   C0442805:Increased [Functional Concept]
   724   C1518039:Mouse Lung [Tissue]
   706 E C0819757:LUNG [Tissue]
   706 E C1278908:Lung [Body Part, Organ, or Organ Component]
Processing 00000000.tx.301: These changes were associated with protein leak, inflammatory cell infiltration, mesenchyme volume expansion, increased BALF TGF-1, and collagen deposition in the lung, all of which increased over time. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "associated with protein leak,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332234:Leak [Functional Concept]
   770   C1608322:Leak NOS [Finding]
   770   C1881366:LEAK [Phenomenon or Process]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "inflammatory cell infiltration,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0302158:Inflammatory cell infiltration [Pathologic Function]
           Inflammatory infiltration
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]
   734   C0440752:Inflammatory cell [Cell]

Phrase: "mesenchyme volume expansion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "BALF TGF-1,"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   845   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   845   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   818   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   818   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   818   C3641255:Lavage Fluid [Body Substance]
   795   C0005889:FLUID [Body Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0022100:Lavage [Therapeutic or Preventive Procedure]
   795   C0220844:growth [Physiologic Function]
   795   C0302908:fluid [Substance]
   795   C0444611:Fluid [Qualitative Concept]
   795   C1510411:Transforming [Pathologic Function]
   795   C1521761:Factor [Functional Concept]
   795   C1546689:Lavage [Intellectual Product]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C1704353:Fluid [Substance]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "collagen deposition in the lung,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "increased over time."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.302: Transgenic mice incapable of signaling through the HER2 receptor due to the expression of a lung-specific DNHER3 also increased NRG-1 production, but receptor activation did not occur. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "incapable of signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "through the HER2 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "due to the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of a lung-specific DNHER3 also increased NRG-1 production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "but"

Phrase: "receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.303: Expansion of the mesenchyme volume and collagen deposition in the lungs of these mice was reduced compared with that in nontransgenic littermate control mice. 

Phrase: "Expansion of the mesenchyme volume"

Phrase: "and"

Phrase: "collagen deposition in the lungs of these mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in nontransgenic littermate control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.304: BALF TGF-1, while at a higher basal level, did not increase in DNHER3 mice. 

Phrase: "BALF TGF-1,"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   845   C0006279:Bronchoalveolar Lavage Fluid [Body Substance]
   845   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0189381:bronchoalveolar lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   818   C0396473:broncho-alveolar lavage [Diagnostic Procedure]
   818   C1535502:Bronchoalveolar Lavage [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   818   C3641255:Lavage Fluid [Body Substance]
   795   C0005889:FLUID [Body Substance]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0022100:Lavage [Therapeutic or Preventive Procedure]
   795   C0220844:growth [Physiologic Function]
   795   C0302908:fluid [Substance]
   795   C0444611:Fluid [Qualitative Concept]
   795   C1510411:Transforming [Pathologic Function]
   795   C1521761:Factor [Functional Concept]
   795   C1546689:Lavage [Intellectual Product]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C1704353:Fluid [Substance]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]

Phrase: "while at a higher basal level,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205112:Basal [Spatial Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C0750519:while [Idea or Concept]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase in DNHER3 mice."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205160:Negative [Qualitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1704825:HER3 [Gene or Genome]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.305: No differences were seen in TGF- receptor I or TGF- receptor II expression between transgenic and nontransgenic mice. 

Phrase: "No differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "seen in TGF- receptor I"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021966:I- [Inorganic Chemical]
   748   C0205397:Seen [Qualitative Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "or"

Phrase: "TGF- receptor II expression between transgenic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nontransgenic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.306: Finally, when challenged with an increased dose of bleomycin, DNHER3 mice displayed a survival advantage compared with nontransgenic littermates. 

Phrase: "Finally,"

Phrase: "when"

Phrase: "challenged with an increased dose of bleomycin,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C1707810:Dose Increased [Therapeutic or Preventive Procedure]
   748   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0178602:Dose [Quantitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   714   C0798503:Challenge [Clinical Attribute]
   714   C0805586:Challenge [Health Care Activity]
   714   C3274764:Challenge [Conceptual Entity]

Phrase: "DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a survival advantage"

Phrase: "compared with nontransgenic littermates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]
Processing 00000000.tx.307: These data support our hypothesis that the HER2/HER3 heterodimer plays an important role in the lung's recovery from injury. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the HER2/HER3 heterodimer"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the lung's recovery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "from injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.308: The epithelial cell HER2/HER3 axis has not been previously shown to play a role in lung injury or fibrosis, yet expression of other growth factors, such as TGF-, clearly plays a critical role in the development of pulmonary fibrosis (14). 

Phrase: "The epithelial cell HER2/HER3 axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0004457:Axis [Body Part, Organ, or Organ Component]
   799   C0999597:Axis [Mammal]
   799   C1522496:Axis [Spatial Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in lung injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "fibrosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "yet expression of other growth factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "such as TGF-,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "clearly"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in the development of pulmonary fibrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.309: Our current results support and extend these studies. 

Phrase: "Our current results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "these studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.310: These experiments suggest that autocrine activation of epithelial cell growth factor receptors (EGFR, HER2) causes fibrosis, and fibrosis can be prevented by inhibition of growth factor receptor signaling. 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that autocrine activation of epithelial cell growth factor receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   807   C2244505:activation of cell growth [Cell Function]
   784   C2249824:activation of growth [Organism Function]
   762   C1326120:cell activation [Cell Function]
   745   C1514758:Receptor Activation [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "(EGFR,"

Phrase: "HER2)"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "fibrosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "and"

Phrase: "fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "prevented by inhibition of growth factor receptor signaling."
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   800   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   800   C2249823:inhibition of growth [Organism Function]
   793   C1512280:Growth Factor Inhibition [Physiologic Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514762:Receptor Signaling [Molecular Function]
   767   C1514761:Receptor Inhibition [Cell Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0037083:Signaling [Cell Function]
   744   C0220844:growth [Physiologic Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3463820:Inhibition [Activity]
   744   C3537152:signaling [Biologic Function]
   711   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.311: These results differ from our laboratory's recently published in vitro work (36), where HER2 activation improved epithelial cell monolayer reformation following injury. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "differ from our laboratory's recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0332185:Recently [Temporal Concept]
   760   C3244292:laboratory [Functional Concept]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "in vitro work"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0043227:Work [Occupational Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "where HER2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "epithelial cell monolayer reformation"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.312: Significant differences in study conditions most likely explain the differences in results. 

Phrase: "Significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "in study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "explain"

Phrase: "the differences in results."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.313: In our in vitro study, only one cell type was present. 

Phrase: "In our in vitro study,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0681828:in vitro study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "only one cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007634:Cell Type [Cell]
           Cell
   861   C0449475:cell type [Intellectual Product]
   812   C0332307:Type [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.314: In vivo, an integrated system made up of multiple interacting cell types (epithelial cells, mesenchymal cells, inflammatory cells), growth factors, and cellular stimuli is present. 

Phrase: "In vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "an integrated system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "made up of multiple interacting cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1881534:Make [Functional Concept]

Phrase: "(epithelial cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0014597:Epithelial Cells [Cell]
  1000   C1273342:Epithelial Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0221908:Epithelial [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "mesenchymal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1257975:Mesenchymal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "inflammatory cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0440752:inflammatory cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0333348:Inflammatory [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "cellular stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "is"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.315: The injury stimulus used in vitro was direct mechanical wounding, whereas a more complex injury stimulus was used in this in vivo study. 

Phrase: "The injury stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimulus [Phenomenon or Process]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "was"

Phrase: "direct mechanical wounding,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   793   C0043250:Wound [Injury or Poisoning]
   734 E C0021501:wounds [Qualitative Concept]
   734 E C0332797:Wounded [Functional Concept]

Phrase: "whereas"

Phrase: "a more complex injury stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0234402:Stimulus [Phenomenon or Process]

Phrase: "was"

Phrase: "used in this in vivo study."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   820   C0681829:in vivo study [Research Activity]
   783   C1515655:In Vivo [Spatial Concept]
           vivo
   767   C0869040:study use [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C1273517:used [Finding]
   753   C2603343:Study [Research Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.316: Bleomycin administration in our in vivo studies results in oxidant injury, upregulating a variety of growth factors and activating intracellular signal pathways. 

Phrase: "Bleomycin administration in our in vivo studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "results in oxidant injury,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0085403:oxidant [Chemical Viewed Functionally]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]

Phrase: "upregulating"

Phrase: "a variety of growth factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "activating intracellular signal pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037080:Signal Pathways [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.317: Differences in in vitro vs. in vivo results have also been seen in other examples of pulmonary epithelia wound healing (3, 23). 

Phrase: "Differences in in vitro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "vs. in vivo results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1517589:In Vivo Result [Conceptual Entity]
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "seen in other examples of pulmonary epithelia wound healing"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   764   C0043240:Wound Healing [Organism Function]
           Healing
   762 E C0574776:healing wound [Finding]
   762 E C1265679:healing wound [Anatomical Abnormality]
   742   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   742   C0043250:Wound [Injury or Poisoning]
   742   C0205249:Healing [Functional Concept]
   742   C0205397:Seen [Qualitative Concept]
   742   C2707265:Pulmonary [Clinical Attribute]
   742   C2709248:Pulmonary [Qualitative Concept]
   708   C0014609:Epithelium [Tissue]
   708 E C0016204:Wind NOS [Sign or Symptom]
   708 E C0042789:see [Organism Function]
   708 E C0043187:Wind [Natural Phenomenon or Process]
   708   C1707959:Example [Conceptual Entity]
   708 E C1947903:See [Activity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.318: Using airway epithelial cells lacking CC chemokine receptor 2 (CCR2), Christensen et al. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "airway epithelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "CC chemokine receptor 2 (CCR2),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0253486:CC Chemokine Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1955905:CC Chemokine Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0282552:CC chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C3538933:CC [Cell Component]

Phrase: "Christensen et al."
Processing 00000000.tx.319: (3) reported the loss of monocyte chemoattractant protein-1-induced signaling through CCR2-delayed closure of a mechanical wound in vitro. 

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the loss of monocyte chemoattractant protein-1-induced signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1517945:Loss [Quantitative Concept]

Phrase: "through CCR2-delayed closure"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0185003:Closure [Therapeutic or Preventive Procedure]
   799   C1521802:Closure [Research Activity]
   743 E C0447303:Occlusal [Body Location or Region]
   743 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   743 E C1947917:Occlusal [Functional Concept]
   734   C0253486:CC Chemokine Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "of a mechanical wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043250:Wound [Injury or Poisoning]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.320: However, in vivo, CCR2(/) mice are protected against bleomycin-induced fibrosis (23). 

Phrase: "However,"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "CCR2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0253486:CC Chemokine Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1955905:CC Chemokine Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0282552:CC chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C3538933:CC [Cell Component]

Phrase: "(/"

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "protected against bleomycin-induced fibrosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   760   C0016059:Fibrosis [Pathologic Function]
   760   C0205263:Induced [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.321: Previous studies have demonstrated that HER2 inactivation has profound effects during development. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that HER2 inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "profound effects during development."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.322: HER2 null mice die before embryonic day 11 due to cardiac trabeculation defects. 

Phrase: "HER2 null mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0206745:Null Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "die before embryonic day 11"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   704   C0011065:Expired [Organism Function]
   704   C0231800:Expired [Organ or Tissue Function]
   704   C1704631:Expire [Idea or Concept]

Phrase: "due to cardiac trabeculation defects."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C0741916:Cardiac defects [Disease or Syndrome]
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]
   734   C2610489:cardiac trabeculation [Organ or Tissue Function]
Processing 00000000.tx.323: When mice that specifically express rat HER2 in the heart were crossed into the null HER2 background, the cardiac pheneotype was rescued (24). 

Phrase: "When"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that specifically"

Phrase: "express"

Phrase: "rat HER2 in the heart"

Phrase: "were"

Phrase: "crossed into the null HER2 background,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0086418:Human [Human]
   748   C0205203:Crossed [Spatial Concept]
   748   C0456148:Null [Quantitative Concept]
   748   C1706907:Background [Conceptual Entity]
   714 E C2828360:Cross [Conceptual Entity]

Phrase: "the cardiac pheneotype"

Phrase: "was"

Phrase: "rescued"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.324: Similarly, when HER2 was conditionally deleted in the heart, adult mice displayed chamber dilation, cardiac wall thinning, and decreased contractility (24). 

Phrase: "Similarly,"

Phrase: "when"

Phrase: "HER2"

Phrase: "was"

Phrase: "conditionally"

Phrase: "deleted in the heart,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C1880274:Deleted [Activity]

Phrase: "adult mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "chamber dilation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012359:Dilation [Pathologic Function]
   861   C0393293:Dilation [Therapeutic or Preventive Procedure]
   861   C0700124:Dilation [Functional Concept]

Phrase: "cardiac wall thinning,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332528:Thinning [Qualitative Concept]
   793 E C0205168:Thin [Qualitative Concept]
   734   C0446987:Cardiac wall [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "decreased contractility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1846086:Decreased contractility [Finding]
   789   C0026820:Contractile [Physiologic Function]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.325: HER2 activation has also been shown to be critically important for central nervous system development. 

Phrase: "HER2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "critically important for central nervous system development."
Processing 00000000.tx.326: In transgenic mice expressing a kinase-inactive HER2, sympathetic chain ganglia formation was not initiated (1). 

Phrase: "In transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "a kinase-inactive HER2,"

Phrase: "sympathetic chain ganglia formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   740   C0228973:Sympathetic chain ganglion [Tissue]
   708   C0017071:Sympathetic Ganglia [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.327: Although HER2 knockout mice die at embryonic day 10.5, these mice exhibited generalized effects on the developing neural crest, characterized by severe cranial ganglia defects, reduction in Schwann cells, enteric ganglia, and adrenal chromaffin cells (4). 

Phrase: "Although"

Phrase: "HER2 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "die at embryonic day 10.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "generalized effects on the developing neural crest,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "characterized by severe cranial ganglia defects,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   753   C0037303:Cranial [Body Part, Organ, or Organ Component]
   753   C0205082:Severe [Qualitative Concept]
   753   C0243067:defects [Functional Concept]
   753   C1880022:Characterized [Activity]
   753   C3163632:Cranial [Spatial Concept]
   719 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "reduction in Schwann cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "enteric ganglia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0501399:Enteric ganglion [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "adrenal chromaffin cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0376604:Chromaffin Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.328: HER2/HER3 activation has also been reported to be damaging. 

Phrase: "HER2/HER3 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "damaging."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]
Processing 00000000.tx.329: Zanazzi et al. 

Phrase: "Zanazzi et al."
Processing 00000000.tx.330: (38) have shown that addition of glial growth factor, a NRG-1 isoform, to cultured Schwann cells inhibited myelination in unmyelinated cells and caused demyelination in mature myelinated cultures. 

Phrase: "(38"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that addition of glial growth factor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "a NRG-1 isoform,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   734   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1367656:NEUREGULIN 1 [Gene or Genome]

Phrase: "to cultured Schwann cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0036387:Schwann Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "myelination in unmyelinated cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596991:myelination [Cell Function]

Phrase: "and"

Phrase: "caused demyelination in mature myelinated cultures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0011304:Demyelination [Pathologic Function]
Processing 00000000.tx.331: In neural tissue of Alzheimer disease patients and transgenic mice expressing mutations of -amyloid precursor protein, NRG-1 and its receptors are upregulated in reactive astrocytes surrounding neuritic plaques (2). 

Phrase: "In neural tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027757:Neural tissue [Tissue]
  1000   C1762608:Neural tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "of Alzheimer disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "mutations of -amyloid precursor protein,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "and"

Phrase: "its receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "upregulated in reactive astrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0333735:Reactive Astrocyte [Cell]
   770   C0004112:Astrocytes [Cell]
   770   C0205332:Reactive [Qualitative Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.332: In the epidermal response to ultraviolet radiation and in breast cancers overexpressing HER2, activation of HER receptors by NRG-1 can lead to cell cycle arrest and apoptosis (16, 17). 

Phrase: "In the epidermal response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "to ultraviolet radiation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0041625:Ultraviolet radiation [Natural Phenomenon or Process]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]
   861   C1532472:Ultraviolet [Qualitative Concept]

Phrase: "and"

Phrase: "in breast cancers"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0006142:breast cancers [Neoplastic Process]
   867 E C0678222:Breast Cancer [Neoplastic Process]
   851 E C0153661:thoracic cancer [Neoplastic Process]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "HER2,"

Phrase: "activation of HER receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1514758:Receptor Activation [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "by NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "can"

Phrase: "lead to cell cycle arrest"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   862   C1155873:Cell Cycle Arrest [Cell Function]
   862   C1516332:Cell Cycle Arrest [Cell Function]
   806   C0007586:Cell Cycle [Cell Function]
   806   C1155839:Cell Cycle [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0237477:Arrest [Temporal Concept]
   760   C0392351:arrest [Governmental or Regulatory Activity]
   760   C1269647:Cell [Cell]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1511572:Cycle [Temporal Concept]
   760   C1522538:Lead [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.333: In human keratinocyte cell lines, inhibition of HER receptors by either pharmaceutical or immunological means prevents ultraviolet-B-induced apoptosis (17). 

Phrase: "In human keratinocyte cell lines,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   906   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "inhibition of HER receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1514761:Receptor Inhibition [Cell Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by either pharmaceutical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   861   C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "immunological means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "ultraviolet-B-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.334: In SKBr3 breast cancer cell lines overexpressing HER2, NRG-1 induces apoptosis, as evidenced by caspase-9 and caspase-7 activation and poly(ADP-ribose)polymerase cleavage (15). 

Phrase: "In SKBr3 breast cancer cell lines"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   884   C1512505:Breast Cancer Cell [Cell]
   840   C0006142:Breast Cancer [Neoplastic Process]
   840   C0007600:Cell lines [Cell]
   840   C0334227:Cancer Cell [Cell]
   840   C0678222:Breast Cancer [Neoplastic Process]
   831   C0230087:Mammary line [Body Location or Region]
   804   C0006141:Breast [Body Part, Organ, or Organ Component]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C0998265:Cancer [Eukaryote]
   804   C1268990:Breast [Body Part, Organ, or Organ Component]
   804   C1269647:Cell [Cell]
   804   C1306459:Cancer [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   790 E C0153661:thoracic cancer [Neoplastic Process]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
   748 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   748 E C1521735:Pectoral [Qualitative Concept]
   721 E C0817096:Chest [Body Location or Region]
   721 E C1527391:Chest [Body Location or Region]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "HER2,"

Phrase: "NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "as"

Phrase: "evidenced by caspase-9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   737   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "caspase-7 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0537969:caspase-7 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "poly(ADP-ribose)polymerase cleavage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0010813:cleavage [Cell Function]
   804   C0596311:Cleavage [Phenomenon or Process]
   804   C1330957:cleavage [Cell Function]
   771   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
   771   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   717   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.335: In light of these results, the loss of HER2 signaling in the DNHER3 strain may protect from NRG-1/HER2/HER3-dependent apoptosis induced by bleomycin. 

Phrase: "In light of these results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "the loss of HER2 signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in the DNHER3 strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0080194:Strain [Injury or Poisoning]
   812   C0456178:strain [Intellectual Product]
   812   C1518614:Strain [Organism]
   812   C2987481:Strain [Mental Process]

Phrase: "may"

Phrase: "protect from NRG-1/HER2/HER3-dependent apoptosis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1367656:NEUREGULIN 1 [Gene or Genome]
   742   C0086418:Human [Human]
   742   C0162638:Apoptosis [Cell Function]
   742   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
   742   C0812265:HER3 [Gene or Genome]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C1704825:HER3 [Gene or Genome]
   742   C3244310:dependent [Functional Concept]

Phrase: "induced by bleomycin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.336: Our present results are specific to HER2 and HER3. 

Phrase: "Our present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "specific to HER2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "HER3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]
Processing 00000000.tx.337: It is not clear, however, which is the actual mediator of the effect. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "however,"

Phrase: "which"

Phrase: "is"

Phrase: "the actual mediator of the effect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.338: We speculate that the loss of HER2 signaling is the important event, as HER3's kinase domain is catalytically impaired in vivo. 

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "the loss of HER2 signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "the important event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "as"

Phrase: "HER3's kinase domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "catalytically"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.339: However, HER3 can be transphosphorylated by HER2 and has unique intracellular docking motifs to activate intracellular signal pathways. 

Phrase: "However,"

Phrase: "HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "transphosphorylated by HER2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "and"

Phrase: "has"

Phrase: "unique intracellular docking motifs to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1514562:Motif [Amino Acid Sequence]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "intracellular signal pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037080:Signal Pathways [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.340: Specific inhibition of HER2 will be necessary to understand the role of HER2 vs. 

Phrase: "Specific inhibition of HER2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "will"

Phrase: "be"

Phrase: "necessary to"

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the role of HER2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "vs."
Processing 00000000.tx.341: HER3. 

Phrase: "HER3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812265:HER3 [Gene or Genome]
  1000   C1704825:HER3 [Gene or Genome]
Processing 00000000.tx.342: In addition, the response does not seem to involve HER4. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "HER4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812267:HER4 [Gene or Genome]
  1000   C1704826:HER4 [Gene or Genome]
Processing 00000000.tx.343: HER4 can homodimerize or heterodimerize with HER2 to form a functional NRG-1 receptor (12), but we have been unable to detect HER4 in the lungs of mice by RT-PCR or Western blotting. 

Phrase: "HER4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812267:HER4 [Gene or Genome]
  1000   C1704826:HER4 [Gene or Genome]

Phrase: "can"

Phrase: "homodimerize"

Phrase: "or"

Phrase: "heterodimerize with HER2 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Human [Human]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a functional NRG-1 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1334952:Neuregulin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "we"

Phrase: "have"

Phrase: "been"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "HER4 in the lungs of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0812267:HER4 [Gene or Genome]
   753   C1704826:HER4 [Gene or Genome]

Phrase: "by RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "or"

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.344: Therefore, HER4 either is not present or is below our detection limits. 

Phrase: "Therefore,"

Phrase: "HER4 either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812267:HER4 [Gene or Genome]
   861   C1704826:HER4 [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "is below our detection limits."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C2718050:Detection Limits [Quantitative Concept]
   760   C0439801:limits [Functional Concept]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.345: Regardless of expression level, if HER4 is present, it does not affect the interpretation of our data, as the DNHER3 receptor would not impact HER4 activation. 

Phrase: "Regardless of expression level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "if"

Phrase: "HER4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812267:HER4 [Gene or Genome]
  1000   C1704826:HER4 [Gene or Genome]

Phrase: "is"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the interpretation of our data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0459471:Interpretation [Intellectual Product]
   760   C3173575:Interpretation [Clinical Attribute]

Phrase: "as"

Phrase: "the DNHER3 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "would"

Phrase: "not impact HER4 activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]
Processing 00000000.tx.346: The mechanism resulting in decreased fibrosis and mortality in the DNHER3 strain is not clear. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "resulting in decreased fibrosis"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0016059:Fibrosis [Pathologic Function]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "mortality in the DNHER3 strain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026565:Mortality [Quantitative Concept]
   748   C0026566:mortality [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.347: No differences were noted in cellular infiltration, and only the day 3 BALF protein content differed between DNHER3 and nontransgenic animals, so loss of HER2/HER3 signaling did not decrease lung injury. 

Phrase: "No differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "noted in cellular infiltration,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1516369:Cellular Infiltration [Cell Function]
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "and"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the day 3 BALF protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0423896:Content [Mental Process]
   795   C0456205:Content [Conceptual Entity]

Phrase: "differed between DNHER3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   760   C0205160:Negative [Qualitative Concept]
   760   C0812265:HER3 [Gene or Genome]
   760   C1513916:Negative [Finding]
   760   C1527180:Dominant [Functional Concept]
   760   C1704825:HER3 [Gene or Genome]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "nontransgenic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "so"

Phrase: "loss of HER2/HER3 signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.348: Further defining any role of HER2/HER3 in injury will require a comparison to receptor inhibition after bleomycin exposure. 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "defining"

Phrase: "any role of HER2/HER3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "will"

Phrase: "require"

Phrase: "a comparison to receptor inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "after bleomycin exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.349: Another mechanism behind the decreased fibrosis and possibly decreased mortality appears to be, in part, a lack of TGF-1 induction, directly or indirectly, by HER2/HER3 signaling. 

Phrase: "Another mechanism behind the decreased fibrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "possibly decreased mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026565:Mortality [Quantitative Concept]
   827   C0026566:mortality [Quantitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "a lack of TGF-1 induction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0476242:Lack of growth [Finding]
   793   C1442754:Lack of growth [Finding]
   744   C0332268:lack [Qualitative Concept]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly,"

Phrase: "by HER2/HER3 signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.350: Surprisingly, TGF-1 levels were higher in DNHER3 mice than nontransgenic littermate controls at baseline, yet this had little effect on basal collagen or bleomycin-induced fibrosis. 

Phrase: "Surprisingly,"

Phrase: "TGF-1 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "higher in DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than nontransgenic littermate controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "at baseline,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "yet"

Phrase: "this"

Phrase: "had"

Phrase: "little effect on basal collagen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "bleomycin-induced fibrosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016059:Fibrosis [Pathologic Function]
   755 E C0334129:Fibrotic [Functional Concept]
Processing 00000000.tx.351: The small increases that were observed in bleomycin-induced collagen formation may have been due to other factors known to play a part in the profibrotic cascade, such as TNF-, IL-1, IFN-, IL-4, and IL-13. 

Phrase: "The small increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "observed in bleomycin-induced collagen formation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C2246343:collagen formation [Molecular Function]
   753   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0205263:Induced [Functional Concept]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1167364:collagen [Cell Component]
   753   C1441672:Observed [Functional Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "been due to other factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C3146286:Due [Idea or Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a part in the profibrotic cascade,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "such as TNF-,"

Phrase: "IL-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "IFN-,"

Phrase: "IL-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "IL-13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:IL 13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.352: The lack of TGF-1 induction in DNHER3 mice suggests that HER2/HER3 signaling may modulate the fibrotic environment through regulation of this profibrotic cytokine. 

Phrase: "The lack of TGF-1 induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0476242:Lack of growth [Finding]
   793   C1442754:Lack of growth [Finding]
   744   C0332268:lack [Qualitative Concept]

Phrase: "in DNHER3 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that HER2/HER3 signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the fibrotic environment through regulation of this profibrotic cytokine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.353: The lack of increased basal collagen levels in the DNHER3 strain with its elevated basal expression of TGF-1 further suggests that TGF-1 alone is not sufficient to induce fibrosis and requires HER2/HER3 signaling. 

Phrase: "The lack of increased basal collagen levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "in the DNHER3 strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0080194:Strain [Injury or Poisoning]
   812   C0456178:strain [Intellectual Product]
   812   C1518614:Strain [Organism]
   812   C2987481:Strain [Mental Process]

Phrase: "with its elevated basal expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of TGF-1 further"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1517331:Further [Spatial Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   771 E C0205108:far [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that TGF-1 alone"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205171:Alone [Quantitative Concept]
   804   C0439044:alone [Finding]
   804   C0679994:alone [Group Attribute]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]

Phrase: "and"

Phrase: "requires"

Phrase: "HER2/HER3 signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.354: No changes in TGF- receptor expression in DNHER3 animals were seen to account for reduced fibrosis, both at baseline and following injury, in the face of increased TGF-1 levels. 

Phrase: "No changes in TGF- receptor expression"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   754   C0442739:No change [Finding]
   754   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "in DNHER3 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for reduced fibrosis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016059:Fibrosis [Pathologic Function]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "both at baseline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C0238767:Both [Spatial Concept]
   790   C1442488:Baseline [Quantitative Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "in the face"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015450:Face [Body Location or Region]
  1000   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "of increased TGF-1 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.355: Lung homogenates from both DNHER3 and nontransgenic littermate mice had similar basal levels of TGF- receptors I and II. 

Phrase: "Lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "homogenates from both DNHER3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1704825:HER3 [Gene or Genome]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "nontransgenic littermate mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "similar basal levels of TGF- receptors I"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   762   C0441925:i levels [Intellectual Product]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "II."
Processing 00000000.tx.356: Additionally, the expression pattern of TGF- receptor I and II was identical with injury in both groups of mice. 

Phrase: "Additionally,"

Phrase: "the expression pattern of TGF- receptor I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1156245:Growth pattern [Finding]
   762   C1623229:growth pattern [Cell Function]
   742   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "II"

Phrase: "was"

Phrase: "identical with injury"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "in both"

Phrase: "groups of mice."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]
Processing 00000000.tx.357: Reduced fibrosis observed in DNHER3 mice, therefore, cannot be explained by changes in TGF- receptor expression. 

Phrase: "Reduced fibrosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016059:Fibrosis [Pathologic Function]
   789 E C0334129:Fibrotic [Functional Concept]

Phrase: "observed in DNHER3 mice,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205160:Negative [Qualitative Concept]
   753   C0812265:HER3 [Gene or Genome]
   753   C1441672:Observed [Functional Concept]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1704825:HER3 [Gene or Genome]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "therefore,"

Phrase: "cannot"

Phrase: "be"

Phrase: "explained by changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in TGF- receptor expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.358: Not yet determined, however, is whether NRG-1 mediates the deleterious effects of HER2/HER3 signaling or whether other ligands are responsible for receptor activation. 

Phrase: "Not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "determined"

Phrase: ","

Phrase: "however,"

Phrase: "is"

Phrase: "whether"

Phrase: "NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the deleterious effects of HER2/HER3 signaling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "whether"

Phrase: "other ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "are"

Phrase: "responsible for receptor activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.359: In addition, it is unknown whether the observed changes are due to a direct epithelial cell effect or an indirect effect, such as altered epithelial cell/mesenchymal cell interaction. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "whether"

Phrase: "the observed changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "are due to a direct epithelial cell effect"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0014597:Epithelial cell [Cell]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0007634:Cell [Cell]
   744   C0221908:Epithelial [Qualitative Concept]
   744   C0439851:Direct [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1280500:Effect [Qualitative Concept]
   744   C1551058:Are [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1947931:Direct [Qualitative Concept]
   744   C1948049:Cell [Spatial Concept]
   744   C2348382:Effect [Qualitative Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "an indirect effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "such as altered epithelial cell/mesenchymal cell interaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0007582:cell-cell interaction [Cell Function]
           Cell Interaction
   799   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.360: These findings suggest a novel strategy for the treatment of human acute lung injury. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a novel strategy for the treatment of human acute lung injury."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0679199:strategy [Mental Process]
Processing 00000000.tx.361: We speculate that blocking HER2/HER3 receptor activation may inhibit the fibrotic process and improve recovery following lung injury.  

Phrase: "We"

Phrase: "speculate"

Phrase: "that blocking HER2/HER3 receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the fibrotic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "improve"

Phrase: "recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "lung injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0273115:Lung Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.362: GRANTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  This work was supported by National Heart, Lung, and Blood Institute Grant HL-60156.  

Phrase: "GRANTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Heart,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C1521721:Supported [Conceptual Entity]
   770   C3245503:national [Intellectual Product]
   737 E C0183683:Support [Medical Device]

Phrase: "Lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "Blood Institute Grant HL-60156."
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0018173:Grant [Quantitative Concept]
   804   C0021622:institute [Organization]
   804   C0229664:Blood [Body Substance]
   804   C1272753:Institute [Idea or Concept]
   804   C1548284:Grant [Idea or Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.363: ACKNOWLEDGMENTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  We gratefully acknowledge Drs. 

Phrase: "ACKNOWLEDGMENTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We gratefully"

Phrase: "acknowledge"

Phrase: "Drs."
Processing 00000000.tx.364: Joseph Zabner and Paola Vermeer of the University of Iowa for helpful discussions and critical comments of this paper.  

Phrase: "Joseph Zabner"

Phrase: "and"

Phrase: "Paola Vermeer of the University of Iowa"

Phrase: "for helpful discussions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "critical comments of this paper."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0282411:Comments [Intellectual Product]
   760   C0947611:comments [Intellectual Product]
   760   C1705247:Comments [Conceptual Entity]
Processing 00000000.tx.365: FOOTNOTES  Address for reprint requests and other correspondence: J. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "J."
Processing 00000000.tx.366: A. 

Phrase: "A."
Processing 00000000.tx.367: Kern, Dept. of Medicine, Pulmonary and Critical Care Division, Univ. 

Phrase: "Kern,"

Phrase: "Dept."

Phrase: "of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Pulmonary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024109:pulmonary [Body Part, Organ, or Organ Component]
  1000   C2707265:Pulmonary [Clinical Attribute]
  1000   C2709248:Pulmonary [Qualitative Concept]

Phrase: "and"

Phrase: "Critical Care Division,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1293097:Division [Therapeutic or Preventive Procedure]
   827   C2919030:Division [Organization]
   827   C2919031:Division [Activity]
   734   C0010337:Critical Care [Health Care Activity]

Phrase: "Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:UNIV [Manufactured Object,Organization]
Processing 00000000.tx.368: Hospitals of Cleveland, Wearn 610, 11100 Euclid Ave., Cleveland, OH 44106 (E-mail: Jeffrey.Kern{at}uhhs.com ) The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "Hospitals of Cleveland,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
   790   C1609061:Hospitals [Intellectual Product]
   756 E C1510665:Hospital [Qualitative Concept]

Phrase: "Wearn 610,"

Phrase: "11100 Euclid Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44106"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Jeffrey.Kern{at}uhhs.com )"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.369: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.370: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.371: REFERENCES TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS REFERENCES  Chan R, Hardy WR, Laing MA, Hardy SE, and Muller WJ. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Chan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hardy WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "Laing MA,"

Phrase: "Hardy SE,"

Phrase: "and"

Phrase: "Muller WJ."
Processing 00000000.tx.372: The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development. 

Phrase: "The catalytic activity of the ErbB-2 receptor tyrosine kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0243102:catalytic activity [Molecular Function]
   760   C1264638:Catalytic activity [Functional Concept]
   760   C1547012:*Catalytic Activity [Quantitative Concept]
   757   C1150423:kinase activity [Molecular Function]
   757   C1152633:receptor activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "essential for embryonic development."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.373: Mol Cell Biol 22: 10731078, 2002.[Abstract/Free FullText] Chaudhury AR, Gerecke KM, Wyss JM, Morgan DG, Gordon MN, and Carroll SL. 

Phrase: "Mol Cell Biol 22"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "10731078,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chaudhury AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Gerecke KM,"

Phrase: "Wyss JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Morgan DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Gordon MN,"

Phrase: "and"

Phrase: "Carroll SL."
Processing 00000000.tx.374: Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. 

Phrase: "Neuregulin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "and"

Phrase: "erbB4 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "is"

Phrase: "associated with neuritic plaques"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Alzheimer disease brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and in a transgenic model of Alzheimer disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1519606:Transgenic Model [Experimental Model of Disease]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0683033:disease model [Intellectual Product]
   767   C0684309:Disease model [Experimental Model of Disease]
   744   C0003069:Transgenic [Animal]
   744   C0012634:Disease [Disease or Syndrome]
   744   C1515981:And [Idea or Concept]
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.375: J Neuropathol Exp Neurol 62: 4254, 2003.[ISI][Medline] Christensen PJ, Du M, Moore B, Morris S, Toews GB, and Paine R 3rd. 

Phrase: "J Neuropathol Exp Neurol 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "4254,"

Phrase: "2003."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Christensen PJ,"

Phrase: "Du M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Moore B,"

Phrase: "Morris S,"

Phrase: "Toews GB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]

Phrase: "and"

Phrase: "Paine R 3rd."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205090:R- [Spatial Concept]
   827   C0205437:3rd [Quantitative Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.376: Expression and functional implications of CCR2 expression on murine alveolar epithelial cells. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "functional implications of CCR2 expression"

Phrase: "on murine alveolar epithelial cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   890   C0225698:Alveolar epithelial cell [Cell]
           Alveolar cell
   861   C0014597:Epithelial Cells [Cell]
   861   C1273342:Epithelial Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C0221908:Epithelial [Qualitative Concept]
   812   C1440080:Alveolar [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.377: Am J Physiol Lung Cell Mol Physiol 286: L68L72, 2004.[Abstract/Free FullText] Erickson SL, O'Shea KS, Ghaboosi N, Loverro L, Frantz G, Bauer M, Lu LH, and Moore MW. 

Phrase: "Am"

Phrase: "J Physiol Lung Cell Mol Physiol 286"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   861   C2346604:J/mol [Quantitative Concept]
   795   C0007634:Cell [Cell]
   795   C0024109:Lung [Body Part, Organ, or Organ Component]
   795   C0027960:Mole [Neoplastic Process]
   795   C0324740:Mole [Mammal]
   795   C0439189:Mole [Quantitative Concept]
   795   C0819757:LUNG [Tissue]
   795   C1269647:Cell [Cell]
   795   C1278908:Lung [Body Part, Organ, or Organ Component]
   795   C1456781:mole [Neoplastic Process]
   795   C1704653:Cell [Medical Device]
   795   C1824986:mol [Gene or Genome]
   795   C1948049:Cell [Spatial Concept]
   740 E C2707265:Pulmonary [Clinical Attribute]
   740 E C2709248:Pulmonary [Qualitative Concept]
   712 E C0026367:Molar [Body Part, Organ, or Organ Component]
   703 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: ":"

Phrase: "L68L72,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Erickson SL,"

Phrase: "O'Shea KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541894:ks [Quantitative Concept]

Phrase: "Ghaboosi N,"

Phrase: "Loverro L,"

Phrase: "Frantz G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bauer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lu LH,"

Phrase: "and"

Phrase: "Moore MW."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]
Processing 00000000.tx.378: ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. 

Phrase: "ErbB3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0812265:ERBB3 [Gene or Genome]

Phrase: "is"

Phrase: "required for normal cerebellar"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1514873:Required [Functional Concept]
   770   C1707522:Cerebellar [Tissue]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "cardiac development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2263229:cardiac development [Physiologic Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "a comparison with ErbB2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "heregulin-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.379: Development 124: 49995011, 1997.[Abstract/Free FullText] Gollamudi M, Nethery D, Liu J, and Kern JA. 

Phrase: "Development 124"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "49995011,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gollamudi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nethery D,"

Phrase: "Liu J,"

Phrase: "and"

Phrase: "Kern JA."
Processing 00000000.tx.380: Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines. 

Phrase: "Autocrine activation of ErbB2/ErbB3 receptor complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "by NRG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "in non-small cell lung cancer cell lines."
Meta Candidates (Total=31; Excluded=5; Pruned=0; Remaining=26)
   913   C0007131:Non-Small Cell Lung Cancer [Neoplastic Process]
   913   C2984258:Non-small cell lung cancer [Functional Concept]
   913   C3539721:Non-Small Cell Lung Cancer [Intellectual Product]
   877   C0149925:Small Cell Lung Cancer [Neoplastic Process]
   877   C2984312:Small cell lung cancer [Functional Concept]
   877   C3540630:Small Cell Lung Cancer [Intellectual Product]
   861   C0007600:Cell lines [Cell]
   852   C0262584:Small Cell Cancer [Neoplastic Process]
   845   C0445128:Non-small cell [Qualitative Concept]
   818   C0242379:Lung Cancer [Neoplastic Process]
   818   C0334227:Cancer Cell [Cell]
   818   C0684249:LUNG CANCER [Neoplastic Process]
   795   C0006826:Cancer [Neoplastic Process]
   795   C0007634:Cell [Cell]
   795   C0024109:Lung [Body Part, Organ, or Organ Component]
   795   C0205132:lines [Spatial Concept]
   795   C0700321:Small [Quantitative Concept]
   795   C0819757:LUNG [Tissue]
   795   C0998265:Cancer [Eukaryote]
   795   C1269647:Cell [Cell]
   795   C1278908:Lung [Body Part, Organ, or Organ Component]
   795   C1306459:Cancer [Finding]
   795   C1518422:Non [Functional Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   788   C2749705:Small lungs [Finding]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]
   740 E C2707265:Pulmonary [Clinical Attribute]
   740 E C2709248:Pulmonary [Qualitative Concept]
   703 E C0032285:Pneumonia [Disease or Syndrome]
Processing 00000000.tx.381: Lung Cancer 43: 135143, 2004.[CrossRef][ISI][Medline] Hardie WD, Kerlakian CB, Bruno MD, Huelsman KM, Wert SE, Glasser SW, Whitsett JA, and Korfhagen TR. 

Phrase: "Lung Cancer 43"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0242379:Lung Cancer [Neoplastic Process]
   901   C0684249:LUNG CANCER [Neoplastic Process]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0819757:LUNG [Tissue]
   827   C0998265:Cancer [Eukaryote]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   827   C1306459:Cancer [Finding]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: ":"

Phrase: "135143,"

Phrase: "2004."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hardie WD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019202:WD [Disease or Syndrome]
   861   C0332135:WD [Qualitative Concept]
   861   C1862191:WD [Intellectual Product]
   861   C3538902:WD [Gene or Genome]

Phrase: "Kerlakian CB,"

Phrase: "Bruno MD,"

Phrase: "Huelsman KM,"

Phrase: "Wert SE,"

Phrase: "Glasser SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Whitsett JA,"

Phrase: "and"

Phrase: "Korfhagen TR."
Processing 00000000.tx.382: Reversal of lung lesions in transgenic transforming growth factor alpha mice by expression of mutant epidermal growth factor receptor. 

Phrase: "Reversal of lung"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443290:Reversal [Functional Concept]

Phrase: "lesions in transgenic transforming growth factor alpha mice"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   833   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822 E C1336620:TRANSFORMING GROWTH FACTOR, ALPHA [Gene or Genome]
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0025936:Mice, Transgenic [Mammal]
   744   C0003069:Transgenic [Animal]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0220844:growth [Physiologic Function]
   744   C0221198:Lesion [Finding]
   744   C0439095:Alpha [Intellectual Product]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1546698:Lesion [Intellectual Product]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "by expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of mutant epidermal growth factor receptor."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   937   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   937   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   884   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   884   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   884   C1323367:epidermal growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0014520:Epidermal [Tissue]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0221920:Epidermal [Spatial Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
Processing 00000000.tx.383: Am J Respir Cell Mol Biol 15: 499508, 1996.[Abstract] Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, and Korfhagen TR. 

Phrase: "Am"

Phrase: "J Respir Cell Mol Biol 15"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0007634:Cell [Cell]
   799   C0027960:Mole [Neoplastic Process]
   799   C0205535:RESPIR [Functional Concept]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1456781:mole [Neoplastic Process]
   799   C1704653:Cell [Medical Device]
   799   C1824986:mol [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "499508,"

Phrase: "1996."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hardie WD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019202:WD [Disease or Syndrome]
   861   C0332135:WD [Qualitative Concept]
   861   C1862191:WD [Intellectual Product]
   861   C3538902:WD [Gene or Genome]

Phrase: "Le Cras TD,"

Phrase: "Jiang K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tichelaar JW,"

Phrase: "Azhar M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Korfhagen TR."
Processing 00000000.tx.384: Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. 

Phrase: "Conditional expression of transforming growth factor-alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in adult mouse lung"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C1518039:Mouse Lung [Tissue]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0819757:LUNG [Tissue]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "pulmonary fibrosis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   861   C0016059:Fibrosis [Pathologic Function]
   861   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   861   C2707265:Pulmonary [Clinical Attribute]
   861   C2709248:Pulmonary [Qualitative Concept]
   789 E C0334129:Fibrotic [Functional Concept]
Processing 00000000.tx.385: Am J Physiol Lung Cell Mol Physiol 286: L741L749, 2004.[Abstract/Free FullText] Hardie WD, Piljan-Gentle A, Dunlavy MR, Ikegami M, and Korfhagen TR. 

Phrase: "Am"

Phrase: "J Physiol Lung Cell Mol Physiol 286"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   861   C2346604:J/mol [Quantitative Concept]
   795   C0007634:Cell [Cell]
   795   C0024109:Lung [Body Part, Organ, or Organ Component]
   795   C0027960:Mole [Neoplastic Process]
   795   C0324740:Mole [Mammal]
   795   C0439189:Mole [Quantitative Concept]
   795   C0819757:LUNG [Tissue]
   795   C1269647:Cell [Cell]
   795   C1278908:Lung [Body Part, Organ, or Organ Component]
   795   C1456781:mole [Neoplastic Process]
   795   C1704653:Cell [Medical Device]
   795   C1824986:mol [Gene or Genome]
   795   C1948049:Cell [Spatial Concept]
   740 E C2707265:Pulmonary [Clinical Attribute]
   740 E C2709248:Pulmonary [Qualitative Concept]
   712 E C0026367:Molar [Body Part, Organ, or Organ Component]
   703 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: ":"

Phrase: "L741L749,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hardie WD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019202:WD [Disease or Syndrome]
   861   C0332135:WD [Qualitative Concept]
   861   C1862191:WD [Intellectual Product]
   861   C3538902:WD [Gene or Genome]

Phrase: "Piljan-Gentle A,"

Phrase: "Dunlavy MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Ikegami M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Korfhagen TR."
Processing 00000000.tx.386: Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha. 

Phrase: "Dose-dependent lung remodeling in transgenic mice"

Phrase: "expressing"

Phrase: "transforming growth factor-alpha."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0439095:Alpha [Intellectual Product]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.387: Am J Physiol Lung Cell Mol Physiol 281: L1088L1094, 2001.[Abstract/Free FullText] Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, and Drew AF. 

Phrase: "Am"

Phrase: "J Physiol Lung Cell Mol Physiol 281"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   861   C2346604:J/mol [Quantitative Concept]
   795   C0007634:Cell [Cell]
   795   C0024109:Lung [Body Part, Organ, or Organ Component]
   795   C0027960:Mole [Neoplastic Process]
   795   C0324740:Mole [Mammal]
   795   C0439189:Mole [Quantitative Concept]
   795   C0819757:LUNG [Tissue]
   795   C1269647:Cell [Cell]
   795   C1278908:Lung [Body Part, Organ, or Organ Component]
   795   C1456781:mole [Neoplastic Process]
   795   C1704653:Cell [Medical Device]
   795   C1824986:mol [Gene or Genome]
   795   C1948049:Cell [Spatial Concept]
   740 E C2707265:Pulmonary [Clinical Attribute]
   740 E C2709248:Pulmonary [Qualitative Concept]
   712 E C0026367:Molar [Body Part, Organ, or Organ Component]
   703 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: ":"

Phrase: "L1088L1094,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hattori N,"

Phrase: "Degen JL,"

Phrase: "Sisson TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Liu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Moore BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Pandrangi RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Simon RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "and"

Phrase: "Drew AF."
Processing 00000000.tx.388: Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. 

Phrase: "Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   744   C0016059:Fibrosis [Pathologic Function]
   744   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   744   C2707265:Pulmonary [Clinical Attribute]
   744   C2709248:Pulmonary [Qualitative Concept]
Processing 00000000.tx.389: J Clin Invest 106: 13411350, 2000.[Abstract/Free FullText] Hellyer NJ, Kim HH, Greaves CH, Sierke SL, and Koland JG. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "106"

Phrase: ":"

Phrase: "13411350,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hellyer NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Kim HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Greaves"

Phrase: "CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558269:Ch. [Professional or Occupational Group]
  1000   C1552984:[Ch] [Quantitative Concept]

Phrase: "Sierke SL,"

Phrase: "and"

Phrase: "Koland JG."
Processing 00000000.tx.390: Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein. 

Phrase: "Cloning of the rat ErbB3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of the recombinant protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.391: Gene 165: 279284, 1995.[CrossRef][ISI][Medline] Izbicki G, Segel MJ, Christensen TG, Conner MW, and Breuer R. 

Phrase: "Gene 165"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "279284,"

Phrase: "1995."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Izbicki G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Segel MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Christensen TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Conner MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "and"

Phrase: "Breuer R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.392: Time course of bleomycin-induced lung fibrosis. 

Phrase: "Time course of bleomycin-induced lung fibrosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0449247:Time course [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0750729:Course [Temporal Concept]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.393: Int J Exp Pathol 83: 111119, 2002.[CrossRef][ISI][Medline] Jones JT, Akita RW, and Sliwkowski MX. 

Phrase: "Int J Exp Pathol 83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0063789:INT [Organic Chemical]
   804   C1417055:EXP [Gene or Genome]
   804   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "111119,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jones JT,"

Phrase: "Akita RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "and"

Phrase: "Sliwkowski MX."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]
Processing 00000000.tx.394: Binding specificities and affinities of egf domains for ErbB receptors. 

Phrase: "Binding specificities"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   777 E C0205369:Specific [Qualitative Concept]
   777 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "affinities of egf domains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for ErbB receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.395: FEBS Lett 447: 227231, 1999.[CrossRef][ISI][Medline] Katoh M and Katoh M. 

Phrase: "FEBS Lett 447"

Phrase: ":"

Phrase: "227231,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katoh M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Katoh M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.396: Identification and characterization of mouse Erbb2 gene in silico. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of mouse Erbb2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "in silico."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3489666:In Silico [Machine Activity]
Processing 00000000.tx.397: Int J Oncol 23: 831835, 2003.[ISI][Medline] Korfhagen TR, Swantz RJ, Wert SE, McCarty JM, Kerlakian CB, Glasser SW, and Whitsett JA. 

Phrase: "Int J Oncol 23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0063789:INT [Organic Chemical]
   812   C0450348:23 [Quantitative Concept]
   812   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "831835,"

Phrase: "2003."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Korfhagen TR,"

Phrase: "Swantz RJ,"

Phrase: "Wert SE,"

Phrase: "McCarty JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Kerlakian CB,"

Phrase: "Glasser SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "and"

Phrase: "Whitsett JA."
Processing 00000000.tx.398: Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. 

Phrase: "Respiratory epithelial cell expression of human transforming growth factor-alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "lung fibrosis in transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0034069:LUNG FIBROSIS [Disease or Syndrome]
   760   C0016059:Fibrosis [Pathologic Function]
Processing 00000000.tx.399: J Clin Invest 93: 16911699, 1994.[ISI][Medline] Le XF, Marcelli M, McWatters A, Nan B, Mills GB, O'Brian CA, and Bast RC Jr. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "93"

Phrase: ":"

Phrase: "16911699,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Le XF,"

Phrase: "Marcelli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "McWatters"

Phrase: "A,"

Phrase: "Nan B,"

Phrase: "Mills GB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]

Phrase: "O'Brian CA,"

Phrase: "and"

Phrase: "Bast RC Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.400: Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity. 

Phrase: "Heregulin-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "mediated by down-regulation of Bcl-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0013081:Down-Regulation [Cell Function,Molecular Function]
   778   C0376515:Bcl-2 [Gene or Genome]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "activation of caspase-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1159825:Caspase Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "is"

Phrase: "potentiated by impairment of protein kinase C alpha activity."
Meta Candidates (Total=27; Excluded=3; Pruned=0; Remaining=24)
   818   C0256371:Protein Kinase C Alpha [Amino Acid, Peptide, or Protein,Enzyme]
   810   C1150572:protein kinase C activity [Molecular Function]
   810 E C1335261:PROTEIN KINASE C, ALPHA [Gene or Genome]
   790   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   784   C1150527:protein kinase activity [Molecular Function]
   784 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   781   C3642159:Protein C Activity [Laboratory Procedure]
   766 E C2261495:protein phosphokinase activity [Molecular Function]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1150423:kinase activity [Molecular Function]
   762   C1158819:alpha protein [Genetic Function]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C1537044:protein activity [Molecular Function]
   762   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439095:Alpha [Intellectual Product]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0684336:Impairment [Pathologic Function]
   742   C1561536:*Activity [Idea or Concept]
   742   C2003941:Alpha [Intellectual Product]
   742   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.401: Oncogene 20: 82588269, 2001.[CrossRef][ISI][Medline] Le XF, Varela CR, and Bast RC Jr. 

Phrase: "Oncogene 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: ":"

Phrase: "82588269,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Le XF,"

Phrase: "Varela CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "and"

Phrase: "Bast RC Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.402: Heregulin-induced apoptosis. 

Phrase: "Heregulin-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.403: Apoptosis 7: 483491, 2002.[CrossRef][ISI][Medline] Lewis DA, Zweig B, Hurwitz SA, and Spandau DF. 

Phrase: "Apoptosis 7"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "483491,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lewis DA,"

Phrase: "Zweig B,"

Phrase: "Hurwitz SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "and"

Phrase: "Spandau DF."
Processing 00000000.tx.404: Inhibition of erbB receptor family members protects HaCaT keratinocytes from ultraviolet-B-induced apoptosis. 

Phrase: "Inhibition of erbB receptor family members"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1514761:Receptor Inhibition [Cell Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "protects"

Phrase: "HaCaT keratinocytes from ultraviolet-B-induced apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C3269240:keratinocyte apoptosis [Cell Function]
   748   C0022567:Keratinocytes [Cell]
Processing 00000000.tx.405: J Invest Dermatol 120: 483488, 2003.[CrossRef][ISI][Medline] Liu J and Kern JA. 

Phrase: "J"

Phrase: "Invest"

Phrase: "Dermatol 120"

Phrase: ":"

Phrase: "483488,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu J"

Phrase: "and"

Phrase: "Kern JA."
Processing 00000000.tx.406: Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. 

Phrase: "Neuregulin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the JAK-STAT pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "regulates"

Phrase: "lung epithelial cell proliferation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1326341:Epithelial Cell Proliferation [Cell Function]
   875   C0334097:Epithelial proliferation [Pathologic Function]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.407: Am J Respir Cell Mol Biol 27: 306313, 2002.[Abstract/Free FullText] Liu JY, Morris GF, Lei WH, Corti M, and Brody AR. 

Phrase: "Am"

Phrase: "J Respir Cell Mol Biol 27"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0007634:Cell [Cell]
   799   C0027960:Mole [Neoplastic Process]
   799   C0205535:RESPIR [Functional Concept]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1456781:mole [Neoplastic Process]
   799   C1704653:Cell [Medical Device]
   799   C1824986:mol [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "306313,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu JY,"

Phrase: "Morris GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Lei WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Corti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Brody AR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]
Processing 00000000.tx.408: Up-regulated expression of transforming growth factor-alpha in the bronchiolar-alveolar duct regions of asbestos-exposed rats. 

Phrase: "Up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "expression of transforming growth factor-alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the bronchiolar-alveolar duct regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "of asbestos-exposed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.409: Am J Pathol 149: 205217, 1996.[Abstract] Madtes DK, Busby HK, Strandjord TP, and Clark JG. 

Phrase: "Am"

Phrase: "J Pathol 149"

Phrase: ":"

Phrase: "205217,"

Phrase: "1996."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Madtes DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Busby HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Strandjord TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "and"

Phrase: "Clark JG."
Processing 00000000.tx.410: Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. 

Phrase: "Expression of transforming growth factor-alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "epidermal growth factor receptor"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "bleomycin-induced lung injury in rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0273115:Lung Injury [Injury or Poisoning]
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.411: Am J Respir Cell Mol Biol 11: 540551, 1994.[Abstract] Madtes DK, Elston AL, Hackman RC, Dunn AR, and Clark JG. 

Phrase: "Am"

Phrase: "J Respir Cell Mol Biol 11"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0007634:Cell [Cell]
   799   C0027960:Mole [Neoplastic Process]
   799   C0205535:RESPIR [Functional Concept]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1456781:mole [Neoplastic Process]
   799   C1704653:Cell [Medical Device]
   799   C1824986:mol [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "540551,"

Phrase: "1994."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Madtes DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Elston AL,"

Phrase: "Hackman RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Dunn AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "and"

Phrase: "Clark JG."
Processing 00000000.tx.412: Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. 

Phrase: "Transforming growth factor-alpha deficiency"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   875   C1842086:Growth deficiency [Finding]
   804   C0011155:Deficiency [Functional Concept]
   804   C0162429:Deficiency [Disease or Syndrome]
   804   C1623416:deficiency [Qualitative Concept]
   771   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   733 E C1636779:% deficient [Quantitative Concept]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reduces"

Phrase: "pulmonary fibrosis in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0034069:Pulmonary Fibrosis [Disease or Syndrome]
   760   C0016059:Fibrosis [Pathologic Function]
   760   C0024109:pulmonary [Body Part, Organ, or Organ Component]
   760   C2707265:Pulmonary [Clinical Attribute]
   760   C2709248:Pulmonary [Qualitative Concept]
Processing 00000000.tx.413: Am J Respir Cell Mol Biol 20: 924934, 1999.[Abstract/Free FullText] Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TR, Raghu G, Hudson LD, and Clark JG. 

Phrase: "Am"

Phrase: "J Respir Cell Mol Biol 20"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0007634:Cell [Cell]
   799   C0027960:Mole [Neoplastic Process]
   799   C0205535:RESPIR [Functional Concept]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1456781:mole [Neoplastic Process]
   799   C1704653:Cell [Medical Device]
   799   C1824986:mol [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "924934,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Madtes DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Rubenfeld G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Klima LD,"

Phrase: "Milberg JA,"

Phrase: "Steinberg KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Martin TR,"

Phrase: "Raghu G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hudson LD,"

Phrase: "and"

Phrase: "Clark JG."
Processing 00000000.tx.414: Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. 

Phrase: "Elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   738   C0441889:Levels [Qualitative Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "with acute respiratory distress syndrome."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0035222:Respiratory Distress Syndrome, Acute [Disease or Syndrome]
   923   C0035220:respiratory distress syndrome [Disease or Syndrome]
   923   C0748355:Acute respiratory distress [Disease or Syndrome]
   923   C1704437:Respiratory Distress Syndrome [Disease or Syndrome]
   861   C0476273:Respiratory distress [Sign or Symptom]
   812   C0039082:Syndrome [Disease or Syndrome]
   812   C0205178:acute [Temporal Concept]
   812   C0231303:Distress [Mental Process]
   812   C0521346:respiratory [Functional Concept]
   812   C1546767:Respiratory [Intellectual Product]
   741 E C0231304:Distressful [Functional Concept]
Processing 00000000.tx.415: Am J Respir Crit Care Med 158: 424430, 1998.[Abstract/Free FullText] Moore BB, Paine R, Christensen PJ 3rd, Moore TA, Sitterding S, Ngan R, Wilke CA, Kuziel WA, and Toews GB. 

Phrase: "Am"

Phrase: "J Respir Crit Care Med 158"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0205535:RESPIR [Functional Concept]
   799   C1947933:Care [Activity]

Phrase: ":"

Phrase: "424430,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Moore BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Paine R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Christensen PJ 3rd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205437:3rd [Quantitative Concept]

Phrase: "Moore TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Sitterding S,"

Phrase: "Ngan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wilke CA,"

Phrase: "Kuziel WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "and"

Phrase: "Toews GB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]
Processing 00000000.tx.416: Protection from pulmonary fibrosis in the absence of CCR2 signaling. 

Phrase: "Protection from pulmonary fibrosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of CCR2 signaling."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1514762:Receptor Signaling [Molecular Function]
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0253486:CC Chemokine Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   717   C1955905:CC Chemokine Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.417: J Immunol 167: 43684377, 2001.[Abstract/Free FullText] Negro A, Brar BK, and Lee KF. 

Phrase: "J Immunol 167"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "43684377,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Negro A,"

Phrase: "Brar BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "and"

Phrase: "Lee KF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427198:KF [Gene or Genome]
Processing 00000000.tx.418: Essential roles of Her2/erbB2 in cardiac development and function. 

Phrase: "Essential roles of Her2/erbB2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in cardiac development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2263229:cardiac development [Physiologic Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.419: Recent Prog Horm Res 59: 112, 2004.[Abstract/Free FullText] Patel NV, Acarregui MJ, Snyder JM, Klein JM, Sliwkowski MX, and Kern JA. 

Phrase: "Recent Prog Horm Res 59"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332185:Recent [Temporal Concept]
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "112,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Patel NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "Acarregui MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Snyder JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Klein JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Sliwkowski MX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]

Phrase: "and"

Phrase: "Kern JA."
Processing 00000000.tx.420: Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. 

Phrase: "Neuregulin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626201:Neuregulin 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367656:NEUREGULIN 1 [Gene or Genome]
   861   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "and"

Phrase: "human epidermal growth factor receptors 2"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   988   C0069515:human epidermal growth factor receptor 2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   988   C3496586:epidermal growth factor receptor 2, human [Amino Acid, Peptide, or Protein]
   901   C0034802:Receptors, Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1509244:human epidermal growth factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C2825836:HUMAN EPIDERMAL GROWTH FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   861   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1323367:epidermal growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0014520:Epidermal [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0086418:Human [Human]
   799   C0220844:growth [Physiologic Function]
   799   C0221920:Epidermal [Spatial Concept]
   799   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in human lung development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.421: Am J Respir Cell Mol Biol 22: 432440, 2000.[Abstract/Free FullText] Ram TG, Schelling ME, and Hosick HL. 

Phrase: "Am"

Phrase: "J Respir Cell Mol Biol 22"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0007634:Cell [Cell]
   799   C0027960:Mole [Neoplastic Process]
   799   C0205535:RESPIR [Functional Concept]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1456781:mole [Neoplastic Process]
   799   C1704653:Cell [Medical Device]
   799   C1824986:mol [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "432440,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ram TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Schelling"

Phrase: "ME,"

Phrase: "and"

Phrase: "Hosick HL."
Processing 00000000.tx.422: Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification. 

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "HER-2/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069515:HER-2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C0242957:HER-2 [Gene or Genome]
  1000   C0879250:HER-2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "HER-3 function with a dominant negative form of HER-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0031843:function [Physiologic Function]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated by heregulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0597718:Heregulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0626201:Heregulin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0752253:Heregulin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1522638:Heregulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "in breast cancer cells with HER-2 gene amplification."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   807   C1705143:Breast Cancer 2 Gene [Gene or Genome]
   798   C1837221:BREAST CANCER CELL 2 [Gene or Genome]
   773   C1512505:Breast Cancer Cell [Cell]
   764   C0006142:Breast Cancer [Neoplastic Process]
   764   C0334227:cancer cells [Cell]
   764   C0678222:Breast Cancer [Neoplastic Process]
   762   C0029016:cancer gene [Gene or Genome]
   762   C0919437:Cancer Gene [Gene or Genome]
   745   C1861886:CELL Gene [Gene or Genome]
   742   C0006826:Cancer [Neoplastic Process]
   742   C0007634:Cells [Cell]
   742   C0998265:Cancer [Eukaryote]
   742   C1306459:Cancer [Finding]
   742   C3282337:Cells [Cell]
   714 E C0153661:thoracic cancer [Neoplastic Process]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.423: Cell Growth Differ 11: 173183, 2000.[Abstract/Free FullText] Riese DJ 2nd, van Raaij TM, Plowman GD, Andrews GC, and Stern DF. 

Phrase: "Cell Growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ"

Phrase: "11"

Phrase: ":"

Phrase: "173183,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Riese DJ 2nd,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012836:DJ [Geographic Area]
   827   C0205436:2nd [Quantitative Concept]

Phrase: "van Raaij TM, Plowman GD,"

Phrase: "Andrews GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "and"

Phrase: "Stern DF."
Processing 00000000.tx.424: The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. 

Phrase: "The cellular response to neuregulins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "governed by complex interactions of the erbB receptor family."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1333436:erbB Receptor Family [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   762   C1372999:Receptor Interactions [Molecular Function]
   762   C1523873:receptor complex [Cell Component]
   742   C0015576:Family [Family Group]
   742   C0243036:ERB-B [Gene or Genome]
   742   C0439855:Complex [Qualitative Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C1704727:Family [Conceptual Entity]
   742   C1706111:ERBB [Gene or Genome]
   708   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.425: Mol Cell Biol 15: 57705776, 1995.[Abstract] Schaefer G, Akita RW, and Sliwkowski MX. 

Phrase: "Mol Cell Biol 15"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "57705776,"

Phrase: "1995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schaefer G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Akita RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "and"

Phrase: "Sliwkowski MX."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]
Processing 00000000.tx.426: A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. 

Phrase: "A discrete three-amino acid segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441635:Segment [Spatial Concept]
   733 E C0205122:Segmental [Spatial Concept]

Phrase: "(LVI) at the C-terminal end of kinase-impaired ErbB3"

Phrase: "is"

Phrase: "required for transactivation of ErbB2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040624:Transactivation [Genetic Function]
   760   C1514873:Required [Functional Concept]
Processing 00000000.tx.427: J Biol Chem 274: 859866, 1999.[Abstract/Free FullText] Shimabukuro DW, Sawa T, and Gropper MA. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "859866,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro DW,"

Phrase: "Sawa T,"

Phrase: "and"

Phrase: "Gropper MA."
Processing 00000000.tx.428: Injury and repair in lung and airways. 

Phrase: "Injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "repair in lung"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0189537:lung repair [Therapeutic or Preventive Procedure]
   790   C0043240:Repair, NOS [Organism Function]
   790   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "airways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178987:airways [Medical Device]
  1000   C0458827:Airways [Body Part, Organ, or Organ Component]
Processing 00000000.tx.429: Crit Care Med 31: S524S531, 2003.[CrossRef][ISI][Medline] Shukla A, Meisler N, and Cutroneo KR. 

Phrase: "Crit Care Med 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450355:31 [Intellectual Product]
   812   C1947933:Care [Activity]

Phrase: ":"

Phrase: "S524S531,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shukla A,"

Phrase: "Meisler N,"

Phrase: "and"

Phrase: "Cutroneo KR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]
Processing 00000000.tx.430: Perspective article: transforming growth factor-beta: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts. 

Phrase: "Perspective article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706852:Article [Intellectual Product]

Phrase: ":"

Phrase: "transforming growth factor-beta"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2004068:Beta [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: ":"

Phrase: "crossroad of glucocorticoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0562506:crossroad [Manufactured Object]

Phrase: "and"

Phrase: "bleomycin regulation of collagen synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   926   C2246344:regulation of collagen synthesis [Cell Function]
   844   C1157723:regulation of synthesis [Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in lung fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.431: Wound Repair Regen 7: 133140, 1999.[CrossRef][ISI][Medline] Stein RA and Staros JV. 

Phrase: "Wound Repair Regen 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0043240:Wound Repair [Organism Function]
           Repair, NOS
   812   C0043250:Wound [Injury or Poisoning]
   812   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "133140,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stein RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "and"

Phrase: "Staros JV."
Processing 00000000.tx.432: Evolutionary analysis of the ErbB receptor and ligand families. 

Phrase: "Evolutionary analysis of the ErbB receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "ligand families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.433: J Mol Evol 50: 397412, 2000.[ISI][Medline] Strandjord TP, Clark JG, Guralnick DE, and Madtes DK. 

Phrase: "J Mol Evol 50"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "397412,"

Phrase: "2000."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strandjord TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Clark JG,"

Phrase: "Guralnick DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "Madtes DK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]
Processing 00000000.tx.434: Immunolocalization of transforming growth factor-alpha, epidermal growth factor (EGF), and EGF-receptor in normal and injured developing human lung. 

Phrase: "Immunolocalization of transforming growth factor-alpha,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   716   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "(EGF"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "EGF-receptor in normal"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   882   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   882   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   833   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1323367:epidermal growth factor [Molecular Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0018270:normal growth [Organism Function]
           'growth' NOS
   783   C0578019:Normal growth [Finding]
   753   C0014520:Epidermal [Tissue]
   753   C0220844:growth [Physiologic Function]
   753   C0221920:Epidermal [Spatial Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "injured developing human lung."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0024109:Lung [Body Part, Organ, or Organ Component]
   812   C0819757:LUNG [Tissue]
   812   C1278908:Lung [Body Part, Organ, or Organ Component]
   756 E C2707265:Pulmonary [Clinical Attribute]
   756 E C2709248:Pulmonary [Qualitative Concept]
   719 E C0032285:Pneumonia [Disease or Syndrome]
Processing 00000000.tx.435: Pediatr Res 38: 851856, 1995.[Abstract] Suzuki H, Aoshiba K, Yokohori N, and Nagai A. 

Phrase: "Pediatr Res 38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "851856,"

Phrase: "1995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Suzuki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Aoshiba K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yokohori N,"

Phrase: "and"

Phrase: "Nagai A."
Processing 00000000.tx.436: Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis. 

Phrase: "Epidermal growth factor receptor tyrosine kinase inhibition"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   884   C1512280:Growth Factor Inhibition [Physiologic Function]
   877   C1519725:Receptor Tyrosine Kinase Inhibition [Cell Function]
   845   C1514761:Receptor Inhibition [Cell Function]
   795   C0021467:Inhibition [Mental Process]
   795   C0021469:Inhibition [Molecular Function]
   795   C1628982:% inhibition [Quantitative Concept]
   795   C3463820:Inhibition [Activity]
   744   C0034802:Epidermal Growth Factor Receptor Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
           Epidermal Growth Factor Receptor
   724 E C0311403:Inhibited [Qualitative Concept]
   710   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "a murine model of pulmonary fibrosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.437: Cancer Res 63: 50545059, 2003.[Abstract/Free FullText] Tesfaigzi J, Johnson NF, and Lechner JF. 

Phrase: "Cancer Res 63"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "50545059,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tesfaigzi J,"

Phrase: "Johnson NF,"

Phrase: "and"

Phrase: "Lechner JF."
Processing 00000000.tx.438: Induction of EGF receptor and erbB-2 during endotoxin-induced alveolar type II cell proliferation in the rat lung. 

Phrase: "Induction of EGF receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   716   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   716   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "erbB-2 during endotoxin-induced alveolar type II cell proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0441730:Type 2 [Classification]
   739   C0243036:ERB-B [Gene or Genome]
   739   C1706111:ERBB [Gene or Genome]

Phrase: "in the rat lung."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1882727:Rat Lung [Body Part, Organ, or Organ Component]
   861   C0024109:Lung [Body Part, Organ, or Organ Component]
   861   C0819757:LUNG [Tissue]
   861   C1278908:Lung [Body Part, Organ, or Organ Component]
   805 E C2707265:Pulmonary [Clinical Attribute]
   805 E C2709248:Pulmonary [Qualitative Concept]
   768 E C0032285:Pneumonia [Disease or Syndrome]
Processing 00000000.tx.439: Int J Exp Pathol 77: 143154, 1996.[CrossRef][ISI][Medline] Van Winkle LS, Isaac JM, and Plopper CG. 

Phrase: "Int J Exp Pathol 77"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0063789:INT [Organic Chemical]
   804   C1417055:EXP [Gene or Genome]
   804   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "143154,"

Phrase: "1996."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Van Winkle LS,"

Phrase: "Isaac JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "and"

Phrase: "Plopper CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]
Processing 00000000.tx.440: Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. 

Phrase: "Distribution of epidermal growth factor receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]
   716   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   716   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "ligands during bronchiolar epithelial repair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023688:Ligands [Chemical]

Phrase: "from naphthalene-induced Clara cell injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0599732:cell injury [Cell or Molecular Dysfunction]
   804   C3263722:Injury [Injury or Poisoning]
   804   C3263723:Injury [Injury or Poisoning]

Phrase: "in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.441: Am J Pathol 151: 443459, 1997.[Abstract] Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, and Welsh MJ. 

Phrase: "Am"

Phrase: "J Pathol 151"

Phrase: ":"

Phrase: "443459,"

Phrase: "1997."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vermeer PD,"

Phrase: "Einwalter LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Moninger TO,"

Phrase: "Rokhlina T,"

Phrase: "Kern JA,"

Phrase: "Zabner J,"

Phrase: "and"

Phrase: "Welsh MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.442: Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. 

Phrase: "Segregation of receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0080141:segregation [Social Behavior]

Phrase: "and"

Phrase: "ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "regulates"

Phrase: "activation of epithelial growth factor receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2249824:activation of growth [Organism Function]
   783   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]
Processing 00000000.tx.443: Nature 422: 322326, 2003.[CrossRef][ISI][Medline] Weibel ER. 

Phrase: "Nature 422"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "322326,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weibel ER."
Processing 00000000.tx.444: Stereological Methods. 

Phrase: "Stereological Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.445: Practical Methods for Biological Morphometry. 

Phrase: "Practical Methods for Biological Morphometry."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.446: New York: Academic, 1979. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Academic, 1979."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1510747:Academic [Organization]
   861   C1550724:academic [Idea or Concept]
   861   C3242376:academic [Intellectual Product]
Processing 00000000.tx.447: Zanazzi G, Einheber S, Westreich R, Hannocks MJ, Bedell-Hogan D, Marchionni MA, and Salzer JL. 

Phrase: "Zanazzi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Einheber S,"

Phrase: "Westreich R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hannocks MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bedell-Hogan D,"

Phrase: "Marchionni MA,"

Phrase: "and"

Phrase: "Salzer JL."
Processing 00000000.tx.448: Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. 

Phrase: "Glial growth factor/neuregulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0752253:Neuregulin [Amino Acid, Peptide, or Protein,Hormone]
           Glial Growth Factor
   756   C0119268:Glial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0626201:Glial Growth Factor [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Schwann cell myelination"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0596991:myelination [Cell Function]
   755 E C0026973:Myelinated [Cell Component]
   734   C0036387:Schwann cell [Cell]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "demyelination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011304:Demyelination [Pathologic Function]
Processing 00000000.tx.449: J Cell Biol 152: 12891299, 2001.[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 99/1/298 most recent 01360.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Nethery, D. 

Phrase: "J Cell Biol 152"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "12891299,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "99/1/298 most recent 01360.2004v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1706852:Article [Intellectual Product]

Phrase: "by Nethery,"

Phrase: "D."
Processing 00000000.tx.450: E. 

Phrase: "E."
Processing 00000000.tx.451: Articles by Kern, J. 

Phrase: "Articles by Kern,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.452: A. 

Phrase: "A."
Processing 00000000.tx.453: Articles citing this Article PubMed PubMed Citation Articles by Nethery, D. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Nethery,"

Phrase: "D."
Processing 00000000.tx.454: E. 

Phrase: "E."
Processing 00000000.tx.455: Articles by Kern, J. 

Phrase: "Articles by Kern,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.456: A. 

Phrase: "A."
Processing 00000000.tx.457: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Visit Other APS Journals Online Copyright  2005 by the American Physiological Society.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "Visit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Visit [Behavior]
  1000   C1512346:visit [Health Care Activity]
  1000   C2826704:VISIT [Intellectual Product]

Phrase: "Other APS Journals Online Copyright  2005 by the American Physiological Society."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0009993:Copyright [Intellectual Product]
   738   C0037455:society [Organization]
   738   C0162443:journals [Intellectual Product,Manufactured Object]
   738   C0205394:Other [Qualitative Concept]
   738   C0205463:Physiological [Functional Concept]
   738   C0596070:American [Population Group]
   738   C1552856:copyright [Idea or Concept]

